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Abstract
Vertebrate heart development involves a precise sequence of morphogenetic events from 
which a complex structure is formed from a linear heart tube. To study the heart development 
in mammals is difficult because most alterations of heart structure are lethal. Therefore we use 
alternative model, Xenopus laevis embryos. The aim of this project is try to establish a new 
experimental model to help understanding the mechanism that regulates cardiac cell 
diversification and heart morphogenesis. In order to achieve these goals we use two assays. 
The cardiogenesis assay involves the use of animal cap explants excised from the animal pole 
of blastula embryos. It has been previously established that it is possible to induce 
differentiation of cardiac tissue in the same explants via the injection of GATA-4 mRNA. 
Here it is shown that GATA-4 reliably induces the expression of ventricular and proepicardial 
markers, providing an assay to study the mechanisms of cardiac cell fate diversification. 
However, despite these, cardiomyocytes generated in animal pole explants they do not 
undergo significant morphogenesis and physiological maturation. In order to study these later 
aspects of heart development we required a different assay in which was possible to generate a 
structure similar to the heart. Using GATA-4 injected AC explants transplanted into host 
embryos we obtained secondary beating hearts in which regionally restricted cardiac gene 
expression was observed in addition to growth and a limited degree of morphogenesis. We 
demonstrated that the host plays an essential role as it provides a wide range of permissive 
regions which allow the development of the SH. Moreover, we also showed that the 
competence to generate a secondary heart is lost in reaggregates transplanted at stage 28. The 
host cells however do not contribute to the SH indicating that the role of the host is providing 
signals which allow the development of the SH. In the future we aim to investigate the 
signalling pathways which mediate the host-SH interaction and the mechanism by which they 
allow the development of the secondary structure.
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1.0 Introduction
1.0 Introduction
Embryonic development is regulated by numerous inductive signals that determine 
specification of different cell types. Specification is a process through which naive cells are 
induced to enter a developmental pathway. A specified cell may not ultimately form the tissue 
that it has been directed toward until it is determined, by which point the specified cell 
expresses cell-specific proteins that confirm its particular identity (Slack, 1991). Following 
specification, functionally distinct differentiated cells interact to generate a specific organ 
during morphogenesis.
1.1 Embryonic development o f  Xenopus laevis
1.1.1 Xenopus laevis embryo as a model organism
The African clawed toad Xenopus laevis is one of the major animal models used in 
developmental biology. In the first half of 20th century it became popular after it has been 
discovered that ovulation in female Xenopus can be induced by the injection of the human 
hormone chorionic gonadotropin (HcG). This permitted a constant supply of embryos in 
contrast to the seasonal availability of other amphibian species as urodele and newt. 
Advantages in using frogs in research include large and robust embryos that are available in 
large numbers. Development takes place outside the mother and as such embryos are 
accessible at all well-documented developmental stages (fig. 1.1) for experimental procedures. 
Examples of contribution of Xenopus as a model for developmental study are numerous and
1
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include the generation of embryonic fate, specification maps and discovery of the mechanisms 
that specify embryonic axes (Beck and Slack, 2001). Gene function analysis can be easily 
achieved by overexpression of mRNA in early cleavage embryos. The capacity of Xenopus 
embryo to translate the mRNA injected into the blastomeres has led to many contributions to 
the study of the early developmental events and the identification of the major classes of 
inducing factors. Gene function analysis can be also achieved through gene knockdown using 
antisense morpholino (MO). MOs are designed to block the mRNA translation or to block 
specific region of the gene avoiding the splicing event of the pre-mRNA (Heasman, 2002). 
Xenopus is also used to study the late events in embryo development using the transgenic 
technology. Additional benefit of transgenesis is the ability to study the expression of a target 
gene using integrated transgenes as green fluorescent protein (GFP) in living embryos. GFP is 
used to study the regulation of gene expression and as a real time marker of cell fate. More 
recently the use of an model organism database, Xenbase, has become the principal resource 
for gene expression analysis, anatomy, development and community information for Xenopus 
laevis and Xenopus tropicalis (Bowes et al., 2010).
2
EARLY DEVELOPMENT
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Figure 1.1 Life cycle of Xenopus laevis. Modified from (Mereau et al., 2007), Xenopus life cycle is composed by different and critical 
developmental steps starting from fertilization followed by cleavage and gastrulation in which three embryonic tissues are developed. Neurula 
tube formation is followed by organogenesis which ends after four day with the metamorphosis. Adult frog becomes sexually mature after 12 
months.
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1.1.2 Early events in Xenopus development
The unfertilized egg has heavily pigmented animal pole and unpigmented vegetal pole. The 
animal-vegetal division represents the first axis in the egg before fertilization. Fertilization can 
occur anywhere in the animal pole, but the point of the sperm entry is important to generate 
the first embryonic axis, the dorsal-ventral (D-V) axis. The first step after fertilization is 
characterised by a series of cell divisions between the animal and the vegetal pole in a phase 
called Cleavage. Upon the 12th cell cycle (4000-cells stage) the zygotic gene transcription 
starts with the inclusion of the G-phase in mitosis due to the demethylation of the genomic 
DNA. This phase is called Mid Blastula Transition (MBT). At the 15th cycle the frequency of 
cleavage slows down due to the stop of the mitosis and shortly afterwards the embryo begins 
to gastrulate (Heasman, 2006). During gastrulation the morphology of the embryo is 
reorganised to form the three germ layers: the ectoderm, precursor of epidermis and nervous 
system, the endoderm, precursor of the epithelium of the digestive tube and its associated 
organs and mesoderm, precursor of blood, heart, muscle, kidney, gonads, bone and connective 
tissue (Gilbert, 2006; Heasman, 2006). Each germ layer gives rise to different cell types which 
are not randomly distributed in the embryo but organised into complex tissues and organs. The 
pattern distribution of different organs is a process regulated via inductive cell-cell interaction 
and it depends directly from the embryo patterning and the establishment of the body axis.
4
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1.1.3 Embryonic axis formation
During the early development two main body axes are established, the dorsoventral axis (D-V) 
the anteroposterior axis (A-V) (De Robertis and Kuroda, 2004). Dorsoventral axis is 
established in the embryos by migration of the dorsal determinants (Weaver and Kimelman,
2004). Dorsal determinants are composed of the components of Wingless-type MMTV 
integration site (Wnt) signalling (reviewed in section 1.1.5.3). During oogenesis Wnt pathway 
components GSK3-binding protein GBP and Dishevelled (Dsh) lie in the vegetal pole of the 
embryo (Weaver and Kimelman, 2004). After sperm enters the animal pole, embryogenesis is 
activated and egg cortex rotates 30° with respect to the internal cytoplasm (fig. 1.2 B). The 
rotation is driven by microtubules nucleated by the centriole. The microtubule movement 
mediated via kinesis dependent motor serves as a truck on which molecules as Dsh, GBP can 
move dorsally. Once located in the dorsal side of the embryo GBP and Dsh regulate the 
activation of p-catenin signal which accumulates dorsally and becomes localised in the nuclei 
with the peak level during mid-blastula stages (fig. 1.2 A) (De Robertis and Kuroda, 2004; 
Rowning et al., 1997; Schneider et al., 1996; Weaver and Kimelman, 2004).
5
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Animal
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One-cell stage Two-cell stage Early gastrula stage
O
Vegetal
Dorsalizing
activity
Stabilized Dorsal
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Cortical rotation and dorsalizing activity
B
Core ^ 
cytoplasm
Shear
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Figure 1.2 Xenopus dorsoventral axis formation. Modified from Weaver and Kimelman, 2004. (A) 
Sperm entry in the animal pole generates a translocation of the dorsalising activity which leads to p- 
catenin stabilization in the dorsal side in the opposite point of the sperm entry. By the two cell-stage 
the maternal p-catenin has become asymmetrically stabilised in the dorsal region where activate genes 
of the dorsal organiser or Spemann’s Organiser. (B) The cortical rotation moves in the same direction 
as the dorsal determinants which initially are located in the shear zone between the outer cortex and the 
core cytoplasm. The black bars at the vegetal pole show the position of the core and the outer cortex 
before the fertilisation occurs. After the sperm entry, the outer cortex moves 30° with respect to the 
core toward the dorsal side together with the dorsal determinants.
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After fertilization, W nt-11 mRNA is vegetally localised and during the cortical rotation 
movements becomes enriched in the dorsal side of the embryo (Tao et al., 2005). During 
cleavage stages, W nt-11 activates signalling via the canonical Wnt-pathway. P-catenin is 
therefore synthesised and interacts with Xtcf3 in dorsal nuclei to activate Wnt target genes 
after MBT (Tao et al., 2005). The activation of the dorsal signalling pathway is also regulated 
from Wnt-5a signalling which together with W nt-11 activate the canonical P-catenin and non- 
canonical JNK pathways in early embryo. Maternal Dkk-1 antagonises both the canonical and 
non-canonical Wnt pathways to regulate the D-V axis formation (Cha et al., 2008). The 
importance of the microtubule transport of the dorsal determinant has been demonstrated using 
Xenopus embryo exposed to the UV light. Embryo exposed to the UV irradiation in the 
vegetal pole lacks of the dorsal structures resulting completely ventralised. The ventralised 
phenotype is obtained due to the disruption in the microtubule assembly which prevents the 
migration of dorsal determinants (Weaver and Kimelman, 2004). Therefore, p-catenin 
localisation in the dorsal side is abolished and causes the accumulation of P-catenin in the 
nuclei of the vegetal pole (Schneider et al., 1996). Ventralised embryo phenotype can be 
easily rescued by injection of synthetic mRNAs encoding, for instance, chordin (BMP 
antagonist, section 1.1.5.1) or mediators of Wnt and Nodal pathways. Injections of Wnts, 
Nodal or BMP antagonist generate a region of low BMP signalling that is normally required 
for formation the dorsal structure.(De Robertis et al., 2000).At mid-blastula stages P-catenin 
nuclei localization in the dorsal side of the embryo determines the generation of two signalling 
centres, the Blastula Chordin and Noggin Expression centre (BCNE centre) centre in the 
animal pole and the Nieuwkoop centre in the vegetal region (fig. 1.3) (De Robertis and 
Kuroda, 2004). BCNE_(De Robertis and Kuroda, 2004) is involved in the formation of the 
anterior neural tissue and expresses Nodal-related protein Xnr-3 and BMP antagonist Chordin
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and Noggin. At gastrula stage, the same set of genes is expressed in the signalling centre 
Spemann’s Organiser under the control of Nodal-related signals (fig. 1.3). The Nieuwkoop 
centre is established in the vegetal pole through the action of p-catenin gradient and the 
maternal factors VegT (T-box transcription factor) and Vgl (Transforming growth factor P) 
expression. VegT induces the expression of potent mesoderm inducers Xenopus Nodal-related 
factors (Xnrl, 2, 4, 5 and 6) (fig. 1.3). The levels of Xnrs are further increased in the area of 
high Wnt signalling, in the Nieuwkoop Centre, thereby creating a gradient. During late 
blastula stages high levels of Nodal on the dorsal side of the embryo lead to the establishment 
of the Spemann’s Organiser. Low levels of Nodal lead the formation of the ventral mesoderm 
(De Robertis and Kuroda, 2004; De Robertis et al., 2000). Maternal control of the pattern 
formation occurs before the establishment of the three germ layers and is fundamental in the 
embryonic pre-pattern formation before the zygotic gene transcription occurs. The key 
proteins involved are VegT, Vgl and Wnt-11. The role of these factors has been established 
using depletion of maternal and zygotic protein models during embryo development 
(Heasman, 2006; White and Heasman, 2008). VegT depleted embryos do not form endoderm, 
show reduced mesoderm-inducing signal and lack of gastrulation movements. Similarly, Vgl 
is required for proper endoderm development and mesoderm induction (White and Heasman, 
2008). Wnt-11 depleted embryos fail to form the neural folds and are ventralised 
demonstrating the important role of Wnt-11 in the dorsal axis formation. Maternal control 
appears to be essential for the establishment of pre-patteming and is the key regulator of the 
zygotic genes activation at the MBT (Heasman, 2006).
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Figure 1.3 Organizer and three germ layers formation. Modified from De Robertis et al., 2004 and 
Agius et at., 2000. At blastula stage (st.8) the embryo shows the Nieuwkoop centre in the vegetal pole 
and the BCNE centre in the animal pole. Both are dependent from the P-catenin localization in the 
dorsal side. The Nieuwkoop centre is located in the junction between P-catenin and VegT and Vgl 
gene expression and BCNE is involved in the formation of the anterior neural tissue via the expression 
of Chordin, Noggin and Xnr-3. Higher P-catenin signal in the dorsal side and the expression of VegT 
and Vgl in the ventral side generates a high gradient of nodal signal in the endoderm where the 
Nieuwkoop centre is located (st.9). This gradient induces the formation of the overlying mesoderm. 
During gastrula stage (st.10) high level of nodal generates the Spemann’s organiser in the dorsal side 
while low level of nodal lead the formation of the ventral mesoderm. Thus, Nieuwkoop centre is the 
region of the dorsal endoderm that induces the organiser tissue (Agius et al., 2000; De Robertis et al.,
2000).
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1.1.4 Mesoderm Specification
Mesoderm induction was identified by Nieuwkoop and colleagues using late blastula embryo 
animal cap explants (AC) juxtaposed with explants of the vegetal pole (Nieuwkoop, 1969). 
AC cells are not under the influence of mesoderm-inducing signal and if cultured alone 
generate atypical epidermis. In the presence of the vegetal pole, mesoderm induction occurs 
with the development of a variety of mesoderm cell types such as muscle, notochord and 
blood (Nieuwkoop, 1969). During the blastula stage, vegetal endoderm secretes mesoderm- 
inducing signals conferring dorso-ventral pattern to the mesoderm (fig. 1.4). Dale and Slack, 
1987 demonstrated that the ventral and lateral vegetal pole induces the ventral mesoderm 
(mesenchyme, blood, and small amount of muscle) and dorsal vegetal cells induce dorsal 
mesoderm cell types such as notochord and muscle (Dale and Slack, 1987). An additional 
source of signal (the third signal in 3 signal model) originates from the Spemann’s Organiser 
centre during gastrulation (fig. 1.4). When the dorsal mesoderm has been induced, it dorsalises 
the ventral mesoderm to form the intermediate mesoderm which gives rise to the muscle 
progenitor cells (Dale and Slack, 1987; Kessler and Melton, 1994; Smith, 1989; Smith, 1993). 
The cells in the ventral midline outside the dorsalising activity generate only blood tissue 
(Smith, 1989). During gastrulation, Spemann’s Organiser acts as a signalling centre via the 
release of antagonists of growth factors to the adjacent cells in order to organise the embryonic 
axis (De Robertis et al., 2000). For example, the activity of the BMP antagonists Noggin and 
Chordin is essential for the ventral mesoderm formation where BMP signal is highly 
expressed (Graff, 1997). The third set of signals therefore, antagonises the ventralising action 
of the fourth set of signals (updated as 4 signal model) which comes from the ventral region of 
the embryo (fig. 1.4) (Wolpert et a l ,  2007).
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Figure 1.4 The four signal model in mesoderm induction. Adapted from Wolpert, 2007. Mesoderm induction in Xenopus involves four set of 
signals. The first two signals originate in the vegetal region of the embryo. The first set of signals (1) comes from the ventral region to specify a 
ventral-type mesoderm. The second set of signals (2) comes from the Nieuwkoop centre and specifies the dorsal-most mesoderm that will form the 
Spemann’s organiser. The third set of signals (3) emanates from the Spemann’s organiser and inhibits the ventralising action of the forth set of 
signals (4) which comes from the ventral region (Wolpert et al., 2007).
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The fourth set of signal is secreted to ventralise the mesoderm and interact with the dorsalising 
signal. Thus, the establishment of a pattering in the mesoderm along the D-V axis depends on 
a balance between the dorsaling and the ventralising signals and the capacity of the cells to 
respond differently in relation of their position along the morphogen gradient.
1,1.5 Mesoderm inducing factors
Embryonic induction is regulated by a set of signalling pathways which are evolutionary 
conserved. These signals regulate cell-cell contact, tissue specification and organogenesis. In 
particular, the pathways described below are involved in mesoderm induction, axis 
specification and embryo pattering.
1.1.5.1 TGF-p family members
TGF-p family is composed of a large group of proteins including activin/inhibin family, Bone 
morphogenetic proteins (BMPs), growth/differentiation factors (GDFs) and the TGF-beta 
subfamily. Those members play fundamental roles in the regulation of various biological 
processes such as cell proliferation, lineage determination, differentiation, apoptosis, cell 
migration and adhesion (Massague, 1998). Members of the TGF-beta superfamily interact 
with a conserved family of transmembrane protein serine/threonine-specific kinases referred to 
as the TGF-P receptor family (Massague, 1998). Ligands bind the receptor type II which 
recruits and phosphorylate the receptor type I. Receptor type I phosporylates and activates the 
intracellular Regulatory Smad (RSmad; Smad-1, -2, -3, -5 and -7). RSmad accumulates in the
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nucleus as heteromeric complex with a second class of Smads, the common Smad (coSmad4). 
The complex RSmad/coSmad-4 associates with DNA binding proteins and various 
transcriptional coactivators or corepressors to regulate positively or negatively gene 
expression (Attisano and Wrana, 2002). Vertebrates have seven distinct type I receptors, each 
of which can bind with one of five type II receptor to mediate signals for the TGF-P family 
lingand (Attisano and Wrana, 2002). Activin/nodal signalling is activated via the interaction 
with the Activin receptor-Like Kinase (ALK) 4 and 7 with the following phosphorylation of 
Smad-2 and -3. BMP bind BMPR-IA and IB receptor with the following phosphorylation of 
Smad-1, -5 and -8. Both pathways transduce the signal via coSmad-4 (Attisano and Wrana, 
2002; Massague, 1998).
In Xenopus, after MBT different TGFp members are involved in the process of embryonic 
induction. Those members involve a subfamily functionally related to activin which includes 
activin, derriere, and the Xenopus nodal related genes Xnr-1, -2, -4, -5 and -6 and members of 
the BMP subfamily BMP-2, -4 and -7 (Hill, 2001). Activin/nodal family act in mesoderm 
induction (Wardle and Smith, 2006), endoderm formation and gastrulation movements (Hill,
2001). The involvement of activin as a mesoderm inducer has been shown in animal cap 
explants assay. Explants treated with activin generate a variety of dorsal and ventral mesoderm 
tissues (Ariizumi and Asashima, 2001; Ariizumi et a l , 1991; Asashima et al., 1990; Green et 
al., 1990). The mesodermal inducing activity is dependent from the concentration used in AC 
explants. Low activin concentration induces the formation of ventral type mesoderm such as 
blood-like cells and mesenchyme, while high concentration induce the formation of dorsal- 
type mesoderm such as muscle and notochord (Ariizumi et al., 1991; Green et al., 1992). The 
cells respond to the factor according to predetermined threshold of concentration. Therefore, 
activin can be defined as a morphogen due the ability to induce different cell types. In
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embryos, activin subfamily members are believed to be produced from the vegetal cells and 
their synthesis require the maternal transcription factor VegT (Kofron et al., 1999). The 
Xenopus Nodal-related proteins Xnr-5 and -6 are the first mesoendodermal inducing factors 
expressed before the MBT under the regulation of the p-catenin Tcf complex (Yang et al.,
2002). Xnr-1, -2 and -4 are expressed slightly later in the dorsal side of the embryos 
(Takahashi et al., 2000). Agius and colleagues, suggested a model (fig. 1.3) for the mesoderm 
induction where high level of Nodal in the dorsal side of the embryo induces the formation of 
the Spemann’s organiser, while low level of Nodal in the ventral side induces the formation of 
the ventral mesoderm (fig. 1.3) (Agius et al., 2000).
Bone morphogenic proteins (BMP) exhibit a gradient of distribution in the mesoderm. In the 
prospective ventral mesoderm and ectoderm there are high levels of BMP while in the dorsal 
side there are low levels (Graff, 1997). It has been shown that BMP-4 is a stronger inducer of 
the ventral mesoderm together with BMP-2 and -7 (Graff, 1997; Hill, 2001). The high level of 
BMP activity on the ventral side is modulated by two potent inhibitors Chordin and Noggin 
which are expressed in the dorsal marginal zone during gastrulation. Chordin and Noggin bind 
with high affinity BMP-4 and -2 abolishing BMP activity by inhibiting the binding of the 
ligand to the receptor (Piccolo et al., 1996; Zimmerman et al., 1996). Thus, the dorsal fate is 
promoted from the inhibition of the ventral molecules from the organiser antagonist rather the 
active induction of the dorsal fate.
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1.1.5.2 Fibroblast growth factor family
Fibroblast growth factors (FGF) constitute a large family composed of 22 members in 
mammals. FGFs are involved in a wide range of cellular process including early embryonic 
development, chemotaxis, cell migration, differentiation and apoptosis (Bottcher and Niehrs,
2005). FGF proteins bind the receptor (FGFRs) which belong to a subfamily of the cell surface 
receptor tyrosin kinases. FGF binding causes a dimerisation of the receptor and the 
autophosphorylation of the intracellular domain which is fundamental to recruit the signal 
complex. Signal transduction occurs via Ras/MAPK pathway, but also via the Pl3-kinase/Akt 
or PLCy pathway (Bottcher and Niehrs, 2005). FGF plays an important role as mesoderm 
inducer. FGF was the first purified molecule demonstrated to induce mesoderm in animal cap 
explants (Slack et al., 1987). The high expression of FGF in the lateral and ventral vegetal 
region of Xenopus embryos generates a gradient in the mesoderm along the D-V axis (Smith, 
1993). Thus, FGF proteins induce the ventrolateral mesoderm to form the mesenchyme and 
small amount of muscle. Green and colleagues, proposed a model of orthogonal concentration 
gradients of activin and FGF throughout the marginal zone. This generates a gradient of 
signal, in which cellular responses are bound by tight thresholds of activin concentrations that 
are modified by FGF which in turn patterns the mesoderm during embryonic development 
(Green et al., 1992). FGF mesodermal target is the T-box transcription factor brachyury 
(.Xbra) which is required for the posterior mesoderm and axial development in the mouse, 
zebrafish and Xenopus. In Xenopus Xbra is expressed transiently in the presumptive 
mesoderm and persistently in the notochord and in the posterior tissues. Mesoderm induction 
requires FGF pathway downstream target gene brachyury. Both are components of a 
regulatory loop in which Xbra induce FGF and vice versa. This regulatory loop is required for
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mesoderm inducing activity of Xbra. If FGF activity is disrupted, by interfering with FGF 
signalling, mesoderm formation is blocked (Schulte-Merker and Smith, 1995).
1.1.5.3 Wnt signalling pathway
Wnts are a large family of proteins involved in different cellular mechanisms such as 
embryonic development, tumour progression and stem cell differentiation (Eisenberg and 
Eisenberg, 2007). The canonical Wnt pathway transduces the signal via the binding of the 
frizzled family of transmembrane receptor and the lipoprotein receptor-related (LRP) isoform 
LRP5 and LRP6. The interaction ligand/receptor, relayed via the cytoplasmatic protein 
Dishevelled (Dsh), promotes the inactivation of glycogen synthase kinase 3 (GSK3) with a 
consequent accumulation of p-catenin. P-catenin translocate into the nucleus and forms a 
transcriptional enhancer complex with LEF/TCF DNA binding protein. Wnt signalling plays 
an important role during embryogenesis. In particular, components of the Wnt pathway such 
as P-catenin, GSK and Dsh are enriched dorsally during the first cell cycle to establish 
embryonic D-V axis (reviewed in section 1.1.3). During the early germ layer formation, Wnt 
signal is required for the formation of the ventral mesoderm. Wnt8 is expressed in the ventral 
and lateral mesoderm after MBT but not in the cells of the Spemann’s organiser. The 
repression of Wnt-8 expression in the organiser is important for normal dorsal development 
(Christian and Moon, 1993). Ectopic expression of Wnt-8 after mid-blastula stage promotes 
the differentiation of isolated AC as ventral mesoderm. Thus, Wnt-8 is involved in the 
differentiation of the ventral mesoderm after the MBT (Christian and Moon, 1993). However, 
it has been shown that overexpression of Wnt-8 at cleavage stage embryo does not cause 
autonomous mesodermal differentiation in isolated AC explants (Christian et al., 1992).
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Primary induction of the mesoderm has a maternal origin and start before the onset of the 
zygotic gene expression. Therefore, Wnt-8 does not act as a primary mesoderm inducing 
signal because it is expressed after MBT to direct marginal zone cells to differentiate as 
ventral mesoderm (Christian and Moon, 1993). During gastrula stage dorsoventral pattering 
require two distinct signals. The dorsalising signal from the Spemann’s organiser where Wnt 
antagonist Dkk-1 (Glinka et a l,  1998) and FrzB (Leyns et a l ,  1997) create a zone of low 
levels of Wnt signal to induce the embryo dorsalisation and the development of the head. The 
second signal initiates the ventral mesoderm differentiation via Wnt-8 expression and 
attenuates the response of the cell to the Organiser inducing signals. Therefore, the 
dorsoventral patterning in the embryonic mesoderm is determined by a balance of Wnt signal 
inhibitors from the dorsal side and Wnt expression in the ventral side (Christian and Moon, 
1993).
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1.2 Heart development
During development mesoderm differentiates into chordamesoderm, paraxial mesoderm, 
intermediate mesoderm and lateral mesoderm.
The notochord originates from chordamesoderm, also known as axial mesoderm, which is 
replaced by the vertebral column. The paraxial mesoderm, located along both sides of the 
neural tube, is the precursor of the somites. The intermediate mesoderm, located between the 
paraxial mesoderm and the lateral plate, is the precursor of the urogenital system, kidneys and 
gonads, and lateral plate mesoderm, located in the periphery of the embryo, becomes divided 
horizontally into two layers; the somatic layer (under the ectoderm) that will form the future 
body wall and the splanchnic mesoderm (above the endoderm) that will form the future 
circulatory system, viscera and heart. The space between these two layers is called the coelom. 
The early developing heart is therefore of mesodermal origin. However, late in development 
of amniotes evidence suggests that there are also contributions from cells of neural crest origin 
(Gilbert, 2006).
1.2.1 Early events in heart development
Heart development in mouse, chicken, amphibian and zebrafish arises from cells in the 
anterior lateral plate mesoderm of early embryo which locate in either side of the precordal 
plate and rostral notochord during gastrulation movements. The specification of the heart 
precursors occurs via multiple tissue and cell-cell contact which are temporally and spatially 
regulated by a network of inductive signals. In mammals and birds the bilateral fields of 
cardiogenic mesoderm fuse in the anterior region of the embryos to generate the cardiac
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crescent (Zaffran and Frasch, 2002). In Xenopus, the regions which lead the inducing signal to 
specify cardiac precursor cells have been identified as the dorsal midline mesoderm (Sater and 
Jacobson, 1990b) also known as Spemann’s Organizer (Foley et al., 2006) and anterior 
endoderm (Nascone and Mercola, 1995). Signals responsible for cardiac specification involves 
Wnt antagonism, Bone Morphogenic Protein (BMP), Fibroblast Growth Factor (FGF) and 
TGFp family member Nodal (Foley et a l, 2006; Mohun et al., 2003). These signals interact to 
specify the cardiogenic cell lineage via the expression of a network of cardiogenic 
transcription factors (GATA, Nkx, T-box). Those factors are responsible for the transcription 
of cardiac differentiation markers during the heart morphogenesis. Evidence in chick shows 
that cardiac inducing activity of endoderm occurs via BMP expression (BMP-2, -4 and -7) 
(Schultheiss et a l,  1997) which overlap with the expression of the vertebrate homolog of the 
Drosophila tinman gene, Nkx2.5 (Schultheiss et al., 1997). In fact, it is believed that BMP and 
Nkx2.5 interact synergistically to induce myocardial differentiation (Jamali et al., 2001a). 
BMP activity is necessary but not sufficient to induce cardiogenesis. It has been shown that 
cardiac induction requires additional factors from the anterior endoderm. These factors include 
Wnt-p catenin inhibitors Dkk-1 and Crescent which establish a zone of low Wnt activity 
where cardiogenesis occurs. Thus, it has been proposed that heart formation occurs in the 
anterior lateral mesoderm by the establishment of a region expressing low levels of Wnt signal 
and high level of BMP signal (Marvin et al., 2001; Schneider and Mercola, 2001). However, 
recent evidence shows that the Wnt pathway has no significant effect during cardiac 
specification but its inhibition is required in a period between the end of specification and the 
onset of differentiation (Samuel and Latinkic, 2009). Contrary to the other Wnt family 
members it has been shown that W nt-11 regulates cardiogenesis. Loss- or gain-of function 
experiments in Xenopus have shown that W nt-11 is required for heart formation and it is
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sufficient to induce an ectopic beating heart in embryonic explants (Pandur et al., 2002). An 
additional signal required for heart development in zebrafish and chick is FGF8. FGF8 is 
present, in zebrafish, in the precardiac mesoderm and is required for the ventricular 
morphogenesis (Marques et a l, 2008; Reifers et al., 2000). FGF8 mutant acerebellar (ace) 
lack GATA-4 and Nkx2.5 expression and is defective in the ventricular chamber (Reifers et 
al., 2000). In chick FGF8 cooperates with BMP2 to induce cardiogenesis. BMP2 upregulates 
ectopical FGF8 and therefore FGF8 acts downstream of BMP2 (Alsan and Schultheiss, 2002). 
Evidence in Xenopus shows that FGF and Nodal signalling are required during the first hour 
of cardiac induction at gastrulation (Samuel and Latinkic, 2009).
1.2.2 Heart morphogenesis
Mapping experiments of cardiac progenitor cells in the developing avian and mouse embryo 
shows that specification of the heart takes place in the primitive streak (posterior to the 
Hensen’s node) from which emerges the cranio-lateral mesoderm at gastrula stage 
(Buckingham et al., 2005; Harvey, 2002). The cardiac progenitors originate from the primitive 
streak and migrate to the anterior of the embryo to lie under the head fold forming two groups 
of cells on either side of the midline (mouse E6.5) (Buckingham et al., 2005). The cells 
migrate to the ventral midline to form a crescent shaped epithelium also known as the cardiac 
crescent (mouse E7.5-8) which is the precursor of the atrial and ventricular musculature, the 
valves and Purkinje fibres. The early heart tube is successively formed from cardiac crescent 
(Buckingham et al., 2005) and is composed of and inner endothelial tube covered by a 
myocardial layer (Harvey, 2002). Different analysis showed that the cardiac crescent cells are
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pre-pattemed, in terms of their contribution to the cardiac tube, along the anterior-posterior 
axis (Buckingham et al., 2005). Thus, it was believed that the straight heart tube contains all 
cardiac compartments as circumferential segments (fig. 1.5 A). This theory however, has been 
recently revisited. It is now firmly established that the heart tube cells are fated to become the 
left ventricle only and the remaining myocardium is added during the subsequent development 
(fig. 1.5 A) (van den Berg and Moorman, 2009). The future ventricle cells are positioned more 
anteriorly in the heart tube with respect to their future location (fig. 1.5 A)(Buckingham et al., 
2005). When the elongated heart tube has formed assumes a rightward spiral form, in a 
process known as heart looping (Fig. 1.5 B). The process of looping converts the original 
anterior-posterior patterning of the heart tube into the left-right asymmetry which is finally 
resolved with the chamber formation (fig. 1.5 B) (Fishman and Olson, 1997). The complexity 
of understanding the chamber formation has become more difficult since it has been 
discovered that not all cardiac chambers are present in the myocardium of the early tube 
(section 1.2.3). Besides, the developing chambers do not derive from the entire heart tube 
myocardium (van den Berg and Moorman, 2009). The old idea that the chambers 
differentiated as circumferential segment along the length of the heart tube has been replaced 
by the ballooning model where the cardiac chambers balloon out from the outer curvature of 
the looping heart (fig. 1.5 B) (Moorman and Christoffels, 2003; van den Berg and Moorman, 
2009). The formation of the chamber in the outer curvature of the looped heart is initiated by a 
high regional activation of increase in cell volume followed by an increase in the rate of 
proliferation of the large cells (Soufan et al., 2006).
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presumed fate revised fate
vs
Tubular heart Looping heart
Figure 1.5 Mouse heart development (later view). Modified from den Berg and Moorman, 2009 and 
Boogerd et al., 2009. (A) Recent researches have changed the original view of cardiac development 
where the heart tube contained all prospective cardiac chambers as circumferential segments. Recently 
has been confirmed that in the heart tube are present only the precursor cells of the left ventricle and 
the remaining myocardium is added during subsequent development. (B). Heart tube, generated from 
the fusion of the cardiac crescent in the ventral midline, is composed of inflow and outflow tract. 
During the heart looping the heart undergo to a rightward spiral movement where the ventricular 
component of the heart has moved to the right and balloon out from the outer curvature. The looping 
movement is therefore finally resolved with the formation of the 4-chambered heart, av-canal; 
atrioventricular canal, la; left atrium, lv; left ventricle, ra; right atrium, rv; right ventricle (Boogerd et 
al., 2009; van den Berg and Moorman, 2009).
4-chambered heart
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These regional changes in both size and proliferation occur prior to trabeculation and may 
suggest that the pathway of signals that control cell-size are also important for the regulation 
of the myocyte proliferation and differentiation (van den Berg and Moorman, 2009). The 
contractile apparatus of the future chambers develops in the outer curvature which shows, 
during the myocardium proliferation, an increase in conduction activity. In contrast, the 
myocardium of the inner curvature, the atrioventricular canal and the OFT remains poorly 
differentiated (van den Berg and Moorman, 2009).
Heart structure varies among vertebrates. After heart looping, the heart has two chambers in 
fish in which the atrium is directly connected with the ventricle (fig. 1.6). The evolution from 
aquatic to terrestrial environment has determined the developing of a complex heart structure 
which required the separation of oxygenated from deoxygenated blood. Moreover, the high 
volume-low pressure cardiovascular system present in tunicates (blood volume is equal 40% 
of the body weight) has evolved into a low volume-high pressure cardiovascular system in 
vertebrates (blood volume is equal 6% of the body weight). This change has driven the 
contracting straight tubular heart to transform into the more efficient and powerful 
synchronously contracting looped heart in vertebrates (Moorman and Christoffels, 2003). 
Amphibians heart is composed of two atria and one ventricle while terrestrial species (birds, 
reptile and mammals) show heart composed of two atria and two ventricle in which septae 
separate completely the oxygenated from deoxygenated blood in the pulmonary and systemic 
circulation (fig. 1.6) (Fishman and Olson, 1997; Olson, 2006).
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Fish Reptiles, birds 
and mammals
B ody Gills
L u n g s
Figure 1.6 Anatomy of the heart in vertebrates. Modified from Olson, 2006. The heart in fish is 
composed of one atrium and one ventricle chamber while terrestrial vertebrates have the heart 
composed by two atrial and two ventricular chambers. Frog heart is evolutionary positioned between 
aquatic and terrestrial vertebrates heart. Amphibian heart is composed of two atria and one ventricle. 
Oxygenated blood is showed in red and deoxygenated blood is showed in blue (Olson, 2006).
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1.2.2.1 Gene regulatory network during cardiogenesis
Cardiac development is regulated by evolutionary conserved transcription factors that 
coordinate the specification and differentiation of myocytes. These transcription factors 
(Nkx2.5, MEF2, GATA-4 and Tbx) respond to inductive signals in myocardial development 
and control the cardiac cells fate, the expression of genes encoding contractile proteins and the 
morphogenesis of cardiac structures (Olson, 2006). The Drosophila tinman vertebrate 
homolog Nkx2.5 is homeobox transcription factor. In the mouse Nkx2.5 expression is first 
observed in the precardiac mesoderm and in the pharyngeal endoderm (E7.5) and its 
expression continues at high level in the heart through adulthood (Akazawa and Komuro, 
2005; Jamali et al., 2001b). In Nkx2.5 null mice, the heart tube fails to undergo looping but 
the expression of the main cardiac-specific genes still occurs (Jamali et al., 2001b; Lyons et 
al., 1995). However, ventricular specific marker MLC2v is not expressed while myosin-heavy 
chain |3 and cyclin D2 show normal expression. This indicates that not all ventricle-specific 
genes are regulated by Nkx2.5 (Lyons et al., 1995).
Nkx2.5 has been isolated in Xenopus as well. Its expression domain is similar to Nkx2.5 
expression in mouse and Drosophila (Tonissen et a l, 1994). Nkx2.5 expression starts at 
gastrulation and persist at neurula stages where is present in the presumptive heart mesoderm. 
In the adult heart and later in the myocardium NKx2.5 expression starts to decrease (Tonissen 
et al., 1994). It has been shown that Nkx2.5 synergistically interact with GATA-4 to activate 
transcription of cardiac genes such as ANF (Durocher et al., 1997). It has been shown that the 
synergistic interaction between GATA-4 and Nkx2.5 regulates the expression of ANF 
specifically in the atrium (Small and Krieg, 2003).
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The GATA zinc-finger transcription factor family is comprised of six members, but only three 
(GATA-4, -5, -6) have been shown to be important for heart development. In particular, 
GATA-4 is present in the gut, the gonads, the liver, the visceral endoderm and the parietal 
endoderm (Arceci et al., 1993; Peterkin et al., 2005; Pikkarainen et al., 2004). In the mouse, 
GATA-4 mRNA is present at early developmental stages (E7.0) in the precardiac mesoderm 
and continues to be expressed during heart tube formation in the myocardium and 
endocardium (Kelley et al., 1993). During heart morphogenesis GATA-4 is also required for 
the proper assembly of the heart tube formation (Kuo et al., 1997).
Mef2 (myocyte enhancer factor 2) family of transcription factors comprises four members 
(Mef2-A, -B, -C, -D) which bind a conserved A-T rich DNA sequence. Mef2 family members 
are expressed in cardiogenic precursor cells and in differentiated cardiomyocytes (Lin et al., 
1997). Mef2C regulates cardiac myogenesis and the right ventricular development. It is 
expressed in the cardiac precursors before the heart tube formation and is required for the 
activation of cardiac contractile protein. In Mef2C null mice the heart fails to undergo looping 
and lacks the right ventricle chamber. The ablation of Mef2C prevents the selective activation 
of specific cardiogenic transcription factors such as HAND2 and HAND1. HAND2 transcripts 
were downregulated during the heart looping concomitant with failure of the right ventricular 
region to form. HAND1 expression in the mutants was contiguous throughout the heart tube 
without the gap in expression that normally characterises the future right ventricle. Distortion 
in HAND1 expression and the lack of HAND2 expression in the heart tube are consistent with 
the lacking of right ventricle in mutant embryos (Lin et al., 1997).
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T-box genes family is composed, in vertebrate, of at least 18 members which together play 
important roles in cardiac lineage determination, chamber specification, valve formation, 
epicardial development and formation of the conduction system (Plageman and Yutzey, 2005). 
Mutations of T-box transcription factors lead to congenital heart disease as atrial septal defect 
in Holt-Oram syndrome (Tbx5 mutation) (Basson et al., 1997) and cardiac outflow tract and 
pharyngeal arch abnormalities in DiGeorge or 22 q ll deletion syndrome (Tbxl mutation) 
(Baldini, 2004). Thus, T-box family show an important role as regulator of the heart 
development. For example the interaction between Tbx5, Tbx20, Nkx2.5 and GATA-4 lead 
the atrial chamber differentiation through the regulation of ANF which is suppressed in the 
atrioventricular canal from Tbx2 and Tbx3 expression (Hoogaars et al., 2007). Tbxl is 
specifically expressed in the second heart field (SHF, section 1.2.3) and provides extensive 
contribution to the OFT via the regulation of forkhead (Fox) transcription factors. Tbx20 is 
expressed in the primary heart field (PHF) and plays an important role in the recruitment and 
elongation of the heart tube (Hoogaars et al., 2007). T bxl8 is expressed in a small 
subpopulation of cells located ventrally to the heart tube which gives rise to the proepicardium 
(Jahr et a l,  2008). In Xenopus, T bxl8 is specifically expressed from stage 36 in the right horn 
of the sinus venosus and no expression has been found in the left sinus horn (Jahr et al., 2008). 
Nkx-2.5 and Isl-1 expressing cells contribute to regulate the formation of proepicardium (Zhou 
et al., 2008) suggesting a functional role for Nkx2.5 in proepicardium formation.
The conserved core of transcription factors regulates the specification of two distinct 
progenitor cell populations known as primary and secondary heart field. In amniotes, the 
primary heart field (PHF) forms the left ventricle and portions of the atria, while the secondary 
heart field generates the right ventricle, portions of the atria and outflow tract (Laugwitz et al., 
2008).
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1.2.3 Heart field formation
The heart is generated from muscle and non-muscle cell lineages, including cardiac myocytes, 
conduction system cells, smooth muscle and endothelia cells (Laugwitz et a l, 2008). The 
differentiation of these multiple tissue type is regulated under specific temporal and spatial 
coordinated control in which different tissues become components of the developed heart. 
How these different tissues arise during heart development is a question still under 
investigation. Three major sources of cardiac precursors have been identified in mouse: 
cardiogenic mesoderm, cardiac neural crest and proepicardial organs (Laugwitz et al., 2008). 
Cardiogenic mesoderm gives rise to the heart tube from which atrial and ventricle chambers 
are formed (fig. 1.7 B). Cardiac neural crest migrates to the heart after heart looping to 
generate the vasculature smooth muscles of the aortic arch and ductus arteriosus (fig. 1.7 B). 
the proepicardium generates heart mesenchyme and the epicardial cells (fig. 1.7 B) (Jahr et al.,
2008). Different studies demonstrate that cardiogenic mesoderm consist of two distinct fields 
of cells which contribute to different regions of the heart. It is known that a source of cells 
identified as PHF is generated from cardiac crescent to develop the heart tube containing the 
outline of left ventricle, atrio-ventricle structure and atria (fig. 1.8). The origin of this field has 
been extensively investigated because it was not clear where the outflow tract myocardium 
(OFT) originated from. The question of which progenitor cells contribute to the OFT has been 
unresolved for many years in part because experiments were performed in explanted embryos 
which die before the OFT was completed.
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Figure 1.7 Different cardiac cell types in heart development. Modified from Laugwitz et al., 2008. 
(A) Heart development starts from cardiac crescent which lately generates the heart tube. Heart looping 
involves anticlockwise spiral movement resolved with the formation of a chambered heart. (B) Three 
population of embryonic heart precursor contribute to the heart development. Cardiogenic mesoderm 
gives rise mainly to the atria and ventricular myocytes, cardiac neural crest gives rise to aorta smooth 
muscles and proepicardium gives rise to endothelium. Cranial (Cr)-caudal (Ca), right (R)-left (L), and 
dorsal (D)-ventral (V) axes are indicated. AA, aortic arch; HFs, head folds; IVS, interventricular 
septum; LA, left atrium; LV, left ventricle; ML, midline; PhA, pharyngeal arches; PLA, primitive left 
atrium; PRA, primitive right atrium; RA, right atrium; RV, right ventricle (Laugwitz et al., 2008).
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Figure 1.8 Primary and Second heart field in mouse and chick. Taken from Laugwitz et al., 2008. 
In mouse heart development PHF (showed in red) contributes to generate the left ventricle and portion 
of the atria, while the SHF (showed in green) contribute mainly to generate OFT, right ventricle and 
portion of the atria. Cranial (Cr)-caudal (Ca), right (R)-left (L), and dorsal (D)-ventral (V) axes are 
indicated. LA, left atrium; LV, left ventricle; ML, midline; PhA, pharyngeal arches; OFT, outflow 
tract; RA, right atrium; RV, right ventricle (Laugwitz et al., 2008).
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Initial evidence of distinct cells contributing to the OFT formation came from in vivo labelling 
experiments in chick embryos in which it was shown that the cranial-most outflow region was 
formed by a secondary source of myocardium progenitors (de la Cruz et al., 1977; Dyer and 
Kirby, 2009). More recently three different studies demonstrate the existence of a population 
of cells that contribute to the heart formation after the heart tube has formed. In particular 
Kelly et colleagues, showed through the use of FGFlO-nlacZ reporter in mouse that heart is 
formed from two sources of myocardial precursors which respectively give rise to the heart 
tube and a second population of FGF10 positive cells in the pharyngeal mesoderm where the 
OFT and possibly the right ventricle form (Dyer and Kirby, 2009; Kelly et al., 2001; Laugwitz 
et al., 2008). Labelling studies performed in chick embryo demonstrate that splanchnic 
mesoderm migrate to contribute to the OFT and the right ventricle cell population generating a 
field of population called anterior heart field or secondary heart field (Dyer and Kirby, 2009; 
Laugwitz et al., 2008; Mjaatvedt et al., 2001; Waldo et al., 2001). The precursors cells that 
give rise to the OFT and right ventricle has been variously described as second heart field, 
anterior heart field or secondary heart field. The lack of a proper nomenclature has generated 
controversy but a consensus is emerging that what is referred to as anterior and secondary 
heart field is considered to be a subpopulation of the second heart field (Perez-Pomares et al.,
2009) which give rise to OFT and the right ventricle. However, the confusion in defining this 
field of cells may originate from the use of different techniques in a variety of different 
organism. For this reason the most reliable methods to define the second heart field population 
is via gene expression analysis of specific markers.
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1.2.3.1 Gene expression in the SHF
The LIM-homeodomain transcription factor Isl-1 has been identified as a marker of the second 
heart field. Lineage analysis showed that Isl-1 expression is present in the right ventricle, OFT 
and atria (Cai et a l,  2003). This analysis was confirmed in Isl-1 null mice which completely 
lack the OFT and right ventricle. Morevoer, Isl-1 mutants show reduced Isl-1 expression in 
progenitor cells with a downregulation of FGF and BMP growth factors (Cai et a l, 2003). Isl- 
1 positive progenitor cells generate a distinct second myocardial lineage which supplements 
the myocardium derived from first heart field progenitors. Right ventricle, OFT and part of the 
atrial cells express Isl-1 and proliferate prior to the onset of cardiac differentiation after when 
Isl-1 is downregulated (Cai et a l, 2003; Laugwitz et a l, 2008; Moretti et a l, 2007). It has 
been shown that Isl-1 and Nkx2.5 mark a cell population which gives rise to the myocardial 
cells, a subset of endocardium and aortic endothelium (Cai et a l ,  2003; Moretti et a l, 2006). 
The possibility that Isl-1 marks multipotent primordial cardiovascular progenitors which gives 
rise to distinct cell lineages within the second heart field was confirmed by Moretti and 
colleagues using genetic fate-mapping in mice. The primordial multipotent cardiovascular 
progenitor cells positive to Isl-1 can generate different cell types (endothelial, myocardium 
and smooth muscle) during in vivo embryonic development (Moretti et a l, 2006). This 
demonstrates that the multipotent Isl-1/Nkx2.5 progenitor expressing cells represent a 
common cardiac progenitor which contributes substantially to the embryonic heart. Recent 
studies carried out using both Nkx2.5 and Isl-1 Cre mice showed that both of these genes have 
a similar expression domain throughout the heart field of the lateral plate mesoderm 
demonstrating that the differences between the primary and the second heart field progenitors 
depend entirely on the timing of differentiation during heart development (Dyer and Kirby,
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2009; Ma et al., 2008). This is supported by evidence in Xenopus where Isl-1 and Nkx2.5 are 
co-expressed in the cardiac crescent during neurula stages (Brade et al., 2007). Other studies 
have shown that Isl-1 is partially expressed in the left ventricle (PHF) (Cai et al., 2003; 
Moretti et al., 2006; Prall et al., 2007). Thus, the initial hypothesis that Isl-1 could be used as 
exclusive marker of the second heart field has been revised. The current hypothesis suggests 
that Isl-1 marks a broad range of undifferentiated progenitor cardiac cells which mainly 
contribute to the secondary heart field. It has been suggested that the role of Isl-1 as pan­
cardiac progenitor cell marker mainly expressed in the SHF (Laugwitz et al., 2008; Prall et al., 
2007). Thus, the first and the second myocardial lineages seems to be regulated by the same 
core of cardiac transcription factors (GATA, Nk, SRF) which are expressed under the control 
of BMP and FGF pathways (Buckingham et al., 2005). In particular, in the SHF the forkhead 
box HI DNA binding transcription factor Foxhl is directly expressed under the regulation of 
Isl-1. Foxh 1 regulates the expression of Mef2c in collaboration with Isl-1, GATA factor and 
Nkx2.5 (Dodou et al., 2004; Laugwitz et al., 2008; Perez-Pomares et al., 2009; von Both et 
al., 2004). In the PHF the expression of downstream targets Tbx5 and Handl are regulated by 
the same core of transcription factor including GATA family, Nkx2.5 and SRF (Black, 2007; 
Cai et al., 2003; Perez-Pomares et al., 2009). The main differences between the two fields 
depends entirely on differential regulation of the same transcriptional network (Perez-Pomares 
et al., 2009) and different spatiotemporal contribution to the heart. Nkx2.5 is the main 
regulator of the PHF and Isl-1 whereas GATA4 and Foxhl are the key transcription regulator 
in the SHF (Laugwitz et al., 2008).
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1.2.3.2 Regulation of the SHF by signalling pathways
The development and proliferation of the SHF during heart tube elongation has been shown to 
be regulated by a set of signaling pathways including Wnt, FGF, BMP and retinoic acid (RA). 
The canonical Wnt pathway showed an important role in the regulation of SHF proliferation. 
It regulates the renewal and differentiation of Isl-1 positive cardiac progenitors (Qyang et a l,
2007) and also plays an important role in promoting the expansion of Isl-1 positive cells 
through the activation of FGF ligands (Cohen et a l,  2007). Moreover, the canonical Wnt 
pathway promotes growth and diversification of SHF precursors into right ventricle and 
interventricular myocardium (Ai et a l, 2007; Rochais et a l ,  2009).
FGF 10 was the first gene identified in the SHF (Kelly et a l,  2001). FGF8 loss in mouse was 
shown to be fundamental in the proliferation and survival of the SHF and requirement in the 
OFT septation (Ilagan et a l, 2006; Park et a l,  2006; Rochais et a l,  2009). Moreover, Ilagan 
and colleagues speculated that FGF8 signal increases the cell motility in order to allow the
cells belonging to the SHF to migrate into the heart tube (Ilagan et a l,  2006).
Evidence reveals an important role for BMP during the SHF differentiation and development. 
OFT septation and development of the smooth muscle and endocardial cushion are under the 
control of BMP4, while BMP2 recruits SHF cells to develop the arterial pole. Also, the 
elongation of the OFT is regulated by BMP4 and 7 (Rochais et a l,  2009).
Retinoic acid (RA) has been shown to be involved in the SHF development. The lack of
retinaldehyde dehydrogenase (Raldh2), enzyme involved in the RA synthesis, leads to a strong
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posteriorisation of SHF markers (Isl-1, FGF10, FGF8). In fact, it has been demonstrated that 
RA restricts the number of cardiac progenitor cells in zebrafish (Keegan et al., 2005) and is 
required to limit the expansion of Isl-1 positive cells posteriorly through the reduction of 
FGF8 expression (Sirbu et a l, 2008).
1.2,4 Axial patterning o f the heart
The development of a complex multichambered heart structure is dependent on the correct 
establishment of the anteriorposterior (A-P) and left-right (L-R) polarity in the heart tube. The 
polarity is established through the regional cardiac cell diversification along the A-P axis and 
is resolved with the specification of the atrial and ventricle primordia in a defined anterior and 
posterior order. This determines the correct progression of cardiac morphogenetic events from 
heart tube looping to chamber formation. It is known that heart pattern establishment through 
the A-P and L-R axis is directed by a number of signals such as retinoic acid (RA), Nodal, 
FGF and BMP.
1.2.4.1 Retinoic Acid
Retinoic acid (RA) is the active form of vitamin A. It is formed by two oxidative reactions in 
which retinaldehyde is synthesised from retinol and subsequently retinoic acid is synthesised 
from retinaldehyde. These reactions are catalysed by two different enzymes; alcohol 
dehydrogenase (ADHs) and retinaldehyde dehydrogenase (RALDH2) (Hochgreb et al., 2003).
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RA, after synthesis, binds RA nuclear receptors (RARa, (3, and y) and retinoid X receptor 
(RXRa, p, and y). This complex works as a ligand-activated transcription factor, which 
transmits the signal for the activation of genes that contain the retinoic acid response elements 
(RAREs) (Collop et a l, 2006).
Anterior-posterior polarity is one of the most important decisions during heart development 
and this event happens prior to the synthesis of contractile proteins in vertebrates cardiac cells 
(Xavier-Neto et al., 2001). Multiple studies have confirmed the role of RA in the specification 
of the anterior-posterior polarity in the heart. Excess RA induces a dose- and stage-dependent 
expansion of atrial compartment and consequently a at the expense of the ventricular tissue 
(Xavier-Neto et al., 2001). Chicken embryos treated with RA and analysed by the expression 
of atrial myosin heavy chain 1 (AMHC1) and ventricular myosin heavy chain 1 (VMHC1) 
show strong atrialisation of the heart with concomitant expansion of AMHC1 expression 
domains (Yutzey et al., 1995). Quail embryos deficient in RA have an oversized ventricle and 
lack atrial structures and ophalomesenteric veins (Heine et al., 1985; Xavier-Neto et al., 
2001). It has been shown in chick that cardiomyocytes adopt regional identity along the A-P 
axis soon after gastrulation and the cardiac diversification can be altered throughout RA 
treatment before differentiation. Cardiogenic mesoderm identity is definitively established just 
before contractile protein gene expression and it can no longer be altered by RA treatment 
after differentiation occurs (Yutzey et al., 1995). These and other studies with retinaldehyde 
dehydrogenase (RALDH2) enzyme, which is involved in the synthesis of RA, support the 
model that during heart development RA signaling induces posterior (future sinoatrial) cell 
fate, while the specification of the anterior fate (future ventricules and conotruncus) is induced 
in absence of RA (Xavier-Neto et a l, 2001). Studies performed in the chick embryo analysing 
RALDH2 expression indicate that heart patterning is established in two distinct phases.
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During the first phase, called specification phase (developmental stage HH5-7), there is an 
increase of RALDH2 expression in the posterior mesoderm close to the sino-atrial precursor. 
In the second phase, called determination phase (developmental stage HH7-8), there is a 
strong expression of RALDH2 which encircles the sino-atrial precursor generating a wave of 
expression from the caudal to the rostral region of the lateral plate mesoderm (Hochgreb et al.,
2003). This demonstrates that the A-P axis specification from RA is provided by the posterior 
mesoderm. Studies on zebrafish embryos have demonstrated that RA affects heart patterning 
differently during different developmental stages. Pan-retinoic acid receptor (RAR) antagonist 
experiments have established that RA signaling is required during gastrulation. When RAR 
antagonist is added before gastrulation, there is a consistent myocardial expansion indicating 
that RA restricts the cardiac progenitor pool during cardiac specification creating a balance 
between cardiac and non-cardiac identity. However, if RA antagonists are added in zebrafish 
after gastrulation the number of cardiomyocytes remained the same (Keegan et a l , 2005). 
Thus, RA is required before gastrulation to regulate the cardiomyocytes population size. 
Xenopus embryos which are treated with RA antagonist before gastrulation result in 
overexpression of Nkx2.5 which is consistent with the myocardial expansion phenotype 
described in zebrafish (Collop et a l,  2006; Keegan et a l ,  2005) suggesting that RA maintains 
the balance between cardiac and non cardiac cell identity ensuring that appropriate heart size 
develops (Keegan et a l, 2005). Similar hypothesis has been shown by Drysdale and 
colleagues. If embryos are treated with RA after cardiac specification there is an inhibition of 
myocardial differentiation markers, but the endocardium does not appear to be affected. RA 
treatment after heart differentiation does not show any significant changes. Myocardial 
differentiation is sensitive to RA expression which restricts heart field growth during 
cardiogenesis (Drysdale et a l, 1997). However, Collop and colleagues have demonstrated that
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Xenopus embryos treated with RA antagonist after gastrulation show a failure in the formation 
of the heart tube. In experiments with lower concentration of RA antagonist, cardiac 
development continues but is blocked before the normal morphogenesis is completed (Collop 
et al., 2006). Thus, RA is involved in different stages during heart development in order to 
control the correct proportion of cardiomyocites to generate the final heart structure. It has 
also been established that RA plays an important role in the formation of left and right 
asymmetry. Xenopus embryos treated with a RA antagonist at stage 32-34 and examined at 
later stages presented abnormal hearts with “some left-right asymmetry”, but lacking a 
vascular system connection and circulating blood (Collop et al., 2006). It has been shown that 
RA controls the expression of lefty, Pitx2 and nodal during L-R patterning. RA treatments 
show a randomisation of looping and symmetrical expression of lefty, nodal and Pitx2. 
Therefore, RA may synergise with the expression of the left-restricted factors (Chazaud et al.,
1999).
1.2.4.2 Nodal
During vertebrate embryo development Nodal acts as inducer of mesendoderm. It also 
regulates embryonic axis establishment, nervous system patterning and the left and right 
asymmetry (Schier, 2003). Baker and colleagues, showed a distinct direct and indirect role of 
Nodal during the asymmetric cardiac morphogenesis in zebrafish (Baker et al., 2008). Nodal 
directly influences the conversion of cardiac cone to heart tube (cardiac jogging) whereby the 
atrial cells are repositioned to the anterior-left of the ventricle cells. The cardiac cone rotates 
and changes the original L-R axis to the D-V axis of the linear heart tube. The second 
asymmetry during cardiac looping is not influenced directly by Nodal. Cardiac looping
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rotation establishes ventricle position to the right of the atrium and is directly dependent on the 
direction of the jogging (Baker et al., 2008). Moreover, it has been shown that Nodal has a 
direct role in the establishment of the site of inner ventricular and outer atria curvature (Baker 
et al., 2008). Evidence in zebrafish showed that Nodal regulates left-right asymmetry during 
heart morphogenesis by controlling the speed and direction of cardiomyocites movement. 
BMP asymmetric expression is dependent on regulation by asymmetrically expressed Nodal 
and both regulate the asymmetric behaviour of cardiomyocite movement during heart 
development (de Campos-Baptista et al., 2008).
Nodal and lefty are expressed in the left lateral plate mesoderm (LPM) where Nodal plays an 
important role in the initial asymmetry of the anterior LPM. However, it has been shown in 
Xenopus that these signals are only transiently expressed, while the homeobox gene Pitx2c 
continues to be expressed during the looping of the heart and the gut (Campione et al., 1999). 
The Nodal target Pitx2c is asymmetrically expressed in the LPM and the expression domain is 
conserved in amphibians, fish and mammals (Campione et al., 1999). Pitx2c is expressed from 
stage 26 in Xenopus and is clearly involved in the regulation of the looping movement in the 
heart and in the gut (Campione et al., 1999).
1.2.4.3 FGF
Evidence from chick embryos suggest that FGF8 is expressed in the right side of the Hensen’s 
node and represses the left expression of Nodal and Pitx2c as a right determinant (Boettger et 
al., 1999). Moreover, it has been shown that FGF8 has a direct involvement in the 
establishment of looping direction during heart development. Left-sided application of FGF8 
in the Hensen’s node showed a randomisation of the direction of the heart situs with a
39
1.0 Introduction
predominant left-sided looping phenotype (Boettger et al., 1999). Similar evidence was 
demonstrated in mice where Fgf8 mutants display abnormal looping to the left side when 
analysed at embryonic day 9.5 (Meyers and Martin, 1999). Moreover, Meyers and colleagues 
have shown more detailed cardiovascular role for FGF8 during heart development. FGF8 
mutant mice exhibit strong cardiovascular defects when analysed at E16.5 including a lack of 
OFT septation, abnormal septation with double outlet right ventricle (Tetralogy of Fallot), 
abnormal development of aortic arch arteries and aberrant vasculature structure (Abu-Issa et 
al., 2002). Work in zebrafish showed a specific requirement of Fgf8 during heart 
development. Fgf8 mutant (ace) embryos show a distinct defect in the ventricle chamber 
which is greatly reduced in size. This evidence highlights the possibility that Fgf8 is required 
for induction and patterning of myocardial precursors acting upstream of cardiogenic 
transcription factors Nkx2.5 and GATA-4 (Reifers et al., 2000).
1.2.4.4 BMP
Evidence suggests that BMP acts to regulate the L-R axis establishment. In particular BMP4 
has been shown to play an important role in heart looping morphogenesis via the expression of 
the Xenopus nodal related protein X nrl. BMP4 is expressed in the left side of the heart tube in 
Xenopus and zebrafish from the heart tube stage until the onset of the heart looping 
(Breckenridge et al., 2001). BMP affects the L-R axis but does not interfere with the regional 
specification of the chambers along the A-P body axis. Moreover, Xnr-1 acts upstream of 
BMP4 and induces the asymmetric left-sided expression of BMP4 in the heart tube. In fact, 
ectopic expression of Xnr-1 affects the asymmetric expression of BMP4 in the heart tube. It is 
possible that BMP4 expression is mediated by upstream molecules such as lefty and Pitx2c
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because Nodal expression in the LPM ends before the heart tube has been generated 
(Breckenridge et al., 2001). Similar evidence in zebrafish showed that BMP-4 is expressed in 
the left side of the heart during the jogging stage when the midline of the heart “jog” to the left 
and loops to the right (22-somite stage). BMP4 expression is linked with the direction of the 
jogging and looping of the heart (Chen et al., 1997). If BMP4 expression is symmetric the 
heart does not jog and looping does not occur (Chen et a l, 1997). Recent evidence in 
zebrafish showed that BMP signalling is required to regulate the migration of cardiac 
progenitor cells and rotation during heart looping (Smith et al., 2008) in order to generate 
asymmetric organ development. This evidence agrees with the role of BMP4 in directing the 
jogging and the looping of the future asymmetric heart morphogenesis along the L-R axis 
(Smith et a l,  2008). Rotation of the heart requires Has2 which controls the right migration of 
the cardiac precursors and is finally directed by BMP towards the LPM. Coordination of these 
genes regulate the heart tube formation and the future pattering of the heart (Smith et a l,
2008).
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1.3 Heart development o f  Xenopus laevis
1.3.1 Amphibian as a model fo r vertebrate cardiogenesis
Study of the heart development in mammalian embryos is limited by early lethality of cardiac 
malformations. Heart development is sensitive to genetic perturbations. The limitations in 
using mouse as a model for study heart development can be overcome by the use of Xenopus 
embryos. Xenopus heart development has been clearly elucidated from cardiac induction to 
chamber formation. Frog heart is composed of three chambers, one ventricle and two atria. For 
this reason it is evolutionally located between the two-chambered fish heart and the four- 
chambered amniote heart (Warkman and Krieg, 2007). These morphological differences are 
not restrictive because heart development is governed by a core of transcription factors 
evolutionally conserved between vertebrate and invertebrate species (Olson, 2006). One major 
advantage to use Xenopus to study the heart development is its lack of dependence on 
cardiovascular system (Blitz et al., 2006). Thus, any gene manipulation concerning the heart 
development can be studied at all developmental stages as they are not immediately lethal for 
the embryos. Therefore, Xenopus is highly suitable to study the mechanisms of organogenesis 
in whole embryo and in undifferentiated cells as in the case of in vitro organogenesis.
1.3.2 Heart morphogenesis in Xenopus laevis embryos
Heart mesoderm specification occurs during gastrulation (Sater and Jacobson, 1989) when the 
cardiac progenitors arise from the lateral periphery of both lateral sides of the embryo. During 
neurula stage they move dorsally and laterally to fuse on the ventral midline to form a delta­
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shaped region (fig. 1.9, stage 27) (Kolker et al., 2000). At this stage the heart field expresses 
pan-myocardial markers MLC2 (Latinkic et al., 2004), Nkx2.5 (Tonissen et a l, 1994) and 
MHC-a (Logan and Mohun, 1993; Mohun et al., 2000) and is located along the anteroventral 
region behind the cement gland (Mohun et al., 2000). The expression of MLC2 and MHC-a 
indicate the onset of cardiac differentiation where the future heart is orientated along the A-P 
axis (Mohun et a l,  2000). At stage 29-30 the splanchnic mesoderm (formed from anterior 
mesoderm) is concentrated in the heart-forming region and develops as a ventral trough 
formed from myocardial tissue. The endocardial tube, which starts to develop from the 
anterior end of the splanchninc mesoderm, is encompassed by the myocardial ventral trough. 
At the same time, the somatic mesoderm, consisting of a single cell layer, localises under the 
ventral ectoderm to form the ventral and lateral walls of the pericardial cavity (Mohun et a l,
2000). At stage 31-32 (fig. 1.9) the myocardial trough surrounds the dorsal endocardial tissue 
to generate the heart tube. The anterior end of the myocardial trough does not completely 
surround the endocardial tissue, which bulges to generate a sinus (aortic sac). This develops 
into the ventral aorta and bilaterally into the left and right first aortic arch. At the posterior end 
the endocardium generate the sinus venosus which bifurcates and extends caudally towards the 
liver primordium. The myocardium encompasses the sinus venosus dorsally and laterally as 
far as the bifurcation point. The dorsal mesocardium, generated from the myocardium and the 
splanchnic mesoderm, extends posteriorly to generate the major vessels of the venous system. 
At this point the linear heart tube is completed and retains this linear structure for several 
hours until heart looping occurs.
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Figure 1.9 Major steps of Xenopus heart development. Taken from Kolker et al., 2000. Heart 
development is described throughout the major developmental steps in which the fusion in the ventral 
midline of the cardiac precursor generate the heart tube (stage 31). At stage 33-35 the heart tube loops 
in a rightward spiral movement in which the final heart structure is completed with the formation of 
one ventricle and two atrial chambers (stage 46) (Kolker et al., 2000).
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At stage 35 (Fig. 1.9, stage 33 and stage 35) the linear heart tube changes its anterior-posterior 
axis direction because the posterior side (presumptive atrium and sinus venous) moves 
dorsally, more closely to the anterior region and the heart tube moves anticlockwise in a spiral 
motion in the process known as heart looping. Consequently, the OFT (positioned anteriorly) 
moves medially and the conus (positioned posteriorly) relocates to the right side of the 
embryo. During heart chamber formation (fig. 1.9, stage 39-40) the looped heart is located 
along the A-P axis. The atrium is located dorsally compared to the ventricle and at the same 
time the development of trabeculae (generated from ventriculae myocardia) and valve occurs. 
The atrioventricular valve and valves into the OFT will be clearly resolved at stage 45-46 
(Mohun et al., 2000) when the heart chamber are completely formed (fig 1.9, stage 46). Atrial 
septation is the last process to occur during heart formation. The septum develops from the 
dorsal region of the atrium and divides the atrium in two distinct and unequal chambers with 
the right atrium being larger than the left. When septation is complete the left and right atria 
are connected respectively with the pulmonary vein and sinus venosus respectively. Therefore, 
at the end of tadpole development, the heart is composed of septated atria, a single atrio­
ventricular valve, and one not septated ventricle which is highly trabeculated (Mohun et al., 
2000). Oxygenated and deoxygenated blood converges into the single ventricle from the left 
and right atrial chambers respectively. The incomplete outflow tract has two valves in series 
which direct the blood into either the pulmonary arteries or systemic arteries (Lohr and Yost, 
2000).
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1.3.2.1 Heart growth
Mouhun and colleagues compared the change in cell number during heart tube and looping 
movement. Nuclei counting in successive pairs of sections showed twice the number of 
myocardial cells in the central looped portion of the myocardium compared with linear heart 
tube. The most anterior and the most posterior regions of the looped heart show a smaller 
increase (Mohun et a l ,  2000). Different evidence shows that heart size regulation is related to 
signals secreted from the dorsal side during gastrulation and prior to neural tube closure 
(Garriock and Drysdale, 2003). Embryos lacking all dorsal structures showed an increase of 
heart size with thicker myocardium and increased expression of GATA-4 and Nkx2.5 
(Garriock and Drysdale, 2003). The heart field is spatially restricted during post-neurula stages 
(Sater and Jacobson, 1990a) and it corresponds with the domain of expression of Nkx2.5. 
Nkx2.5 is expressed also in the lateral portion of the heart field which is initially specified to 
form myocardium but later is respecified to become dorsal mesocardium and the roof of the 
epicardium (Raffin et al., 2000). Thus, during the heart development a redirection of the cell 
fate occurs in which the mesocardium and pericardium are generated from the myocardium. 
The loss of heart-forming region is correlated with a decrease of Nkx2.5 and GATA-4 close to 
the dorsal tissue suggesting that heart restriction occurs prior the subdivision of the myogenic 
and non-myogenic compartments (Garriock and Drysdale, 2003). Another interesting aspect of 
heart development concerns the inverse relationship between the proliferation and 
differentiation of cardiac cells. Molecules that induce cell cycle exit promote cell 
differentiation. Movassagh and Philpott showed that cycline-dependent kinase inhibitor 
p27Xic is required for cardiac differentiation in Xenopus heart development (Movassagh and 
Philpott, 2008). Identification of molecules that regulate the differentiation or proliferation of
46
1.0 Introduction
myocytes is crucial for understanding the regulation of cardiac differentiation. It has been 
shown that by stage 29-30 the majority of the cells have left the cell-cycle and only a small 
portion of differentiated cardiomyocytes still proliferate until stage 41. This demonstrates that 
cardiac differentiation occurs normally when cell cycle is inhibited. In fact, inhibition of the 
cell cycle from post-gastrula stage does not effect cardiac differentiation but lack of Xic leads 
to a substantial reduction of the differentiation markers with a consequent reduction of the 
heart size. It may be possible that Xic binds the transcription factors which lead cardiac 
differentiation to promote cardiogenesis (Movassagh and Philpott, 2008).
1.3.3 Heart tissue composition
Vertebrate heart is composed of tissues divided into three layers: epicardium, myocardium and 
endocardium. The epicardium is the outside layer and surrounds the myocardium tube. The 
endocardium is the innermost cell layer in the heart tube.
1.3.3.1 Epicardium
Epicardium originates from the proepicardium which develops in the posterior limits of the 
heart between the sinus venosus and the liver (Manner et al., 2001). Epicardium is the outer 
layer of the vertebrate heart. Mesenchymal cells delaminate from epicardium and invade the 
myocardium and subepicardial spaces to provide the cardiac vessel and the connective tissue. 
Moreover, epicardium is involved in the differentiation of the embryonic myocardium 
(Manner et a l, 2001; Perez-Pomares et al., 2009; Smith and Bader, 2007). The epicardium is
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characterised by the expression of transcription factors as Wilm’s tumor (WT-1), Pod- 
1/epicardin (Perez-Pomares et al., 2009; Ratajska et al., 2008) and Tbxl8 (Cai et al., 2008; 
Jahr et al., 2008). It has been shown in zebrafish that BMP4 is required for the proepicardial 
specification via the expression of Tbx5 which confers to the anterior lateral plate mesoderm 
the capacity to respond to the BMP signal (Liu and Stainier, 2010).
1.3.3.2 Myocardium
Myocardial cells are believed to originate once endocardial progenitors delaminate from the 
polarized ephithelium which forms the visceral layer of the lateral plate mesoderm (LPM) 
(Perez-Pomares et al., 2009). LPM is linked with the pharyngeal endoderm which is 
fundamental in the cardiac muscle development (Lough and Sugi, 2000). Myocardium can be 
divided into primitive myocardium and chamber myocardium (Perez-Pomares et al., 2009). 
Primitive myocardium is located in the inflow tract, the AV region and the inner curvature of 
the heart tube. Unlike the chamber myocardium, the region which constitute the primitive 
myocardium show a low mitotic activity (Sedmera et al., 2003) and is directly correlated with 
the development of the conduction system. The chamber myocardium corresponds to that of 
the heart tube and atrial and ventricle chambers. It has been shown that it is generated from a 
pool of rapidly proliferating cardiac precursor cells. The proliferation slows as they 
differentiate to cardiomyocytes but increase in size. The largest cells are found in the ventricle 
demonstrating that the increase in size of cardiomyocytes is chamber dependent (Soufan et al., 
2006). Chamber myocardium and primitive myocardium are regulated by T-box family 
members. It has been shown that Tbx2 is expressed in the inflow tract, atrioventricular canal, 
inner curvature and outflow tract. It represses the chamber differentiation via atrial natriuretic
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factor (ANF) (Christoffels et al., 2004). In fact, Tbx-2 expression domain is complementary to 
ANF, connexin Cx40, Cx43 and Chisel. Therefore, chamber myocardium development is 
regulated by the inihibitory activity of Tbx2 and the expression of ANF (Christoffels et a l, 
2004). Tbx3 is expressed in the developing conduction system, in the sinoatrial node, 
atrioventricular region, intemodal region and atrioventricular region (Hoogaars et al., 2004). 
Tbx3 represses chamber-specific program gene expression to allow the formation of the 
conduction system (Hoogaars et al., 2004). Tbx3 is also involved in the specification and 
formation of the sinoatrial node and regulates the pacemaker gene expression program 
(Hoogaars et al., 2007). Tbx20 and Tbx5 collaborate with Nkx2.5 and GATA-4 to regulate the 
chamber specification programm (Hoogaars et al., 2007).
1.3.3.3 Endocardium
Endocardium is the endothelial innermost cell layer in the heart tube and is evolutionary 
present only in vertebrates (Perez-Pomares et al., 2009) endothelium and therefore 
endocardium are vertebrate-specific. Endocardium plays an important role in the heart 
development. In particular, it is involved in the formation of the cardiac valves and septa, the 
division of the truncus into the aortic and pulmonary trunks, the development of Purkinje 
fibers and the formation of trabecular myocardium (Harris and Black, 2010). A group of cells 
from specific region of the endocardium undergoes a endocardial-mesenchymal 
transformation (EMT) to form the endocardial cushions which grow in multiple locations 
during of the heart to form the valvular structure and the membranous septan (Harris and 
Black, 2010; Person et al., 2005). The Xenopus Smad3 is of interest as within the heart it is 
only expressed in the endocardium from stage 27 to 33 (Howell et al., 2001).
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1.3.4 Cardiac differentiation factors
The heart differentiation is characterised by the regional expression of genes such as MLC2, 
cTnl, MLClv, Irx4 and ANF which are specifically expressed in the atrial and ventricles 
chambers. MLC2 expression in Xenopus starts at late tail bud stages (stage 26) when the 
cardiac precursors fuse in the ventral midline and continues to be expressed in the adult heart 
(Latinkic et a l, 2004). Therefore, MLC2 is a pan-myocardial marker. In mammals MLC2 
shows a different expression. MLC2a and MLC2v are expressed in the atrial and ventricle 
chambers respectively (Latinkic et al., 2004; Small and Krieg, 2004). It has been shown in 
Xenopus that MLC2 is homolog of MLC2a in mammals and no equivalent of MLC2v has 
been found in Xenopus (Latinkic et al., 2004).
Cardiac Troponin I (cTnl) is a heart specific marker. Its expression is restricted to the heart in 
all developmental stages. It is first expressed in the heart at tailbub stage (stage 26) and 
continues to be expressed after late developmental stages (stage 40) (Drysdale et a l, 1994).
M LClv is a regionalised myocardial marker which is expressed at tailbud stage in the somitic 
mesoderm. During heart tube formation is expressed in the anterior half of the prospective 
myocardium, in the bilateral lymph heart and in the precursors of the interhyoid muscles of the 
jaw (Smith et a l, 2005). After heart looping (stage 36) M LClv is expressed in the jaw muscle 
and in the heart becomes specifically expressed in the ventricle chamber. MLClv is highly 
expressed in the proximal outflow tract and in the single ventricle but expression is not found 
in the atria (Smith et a l, 2005).
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Iroquois (Irx4) homeodomain transcription factor is detected at stage 20 in a small cluster of 
cells in the hindbrain and at stage 26 is highly expressed in the hindbrain above the otic 
vesicle. At stage 28 is expressed also in the retina and only at stage 36 is expressed at low 
levels in the heart in particular in the lateral sub-region of ventricular myocardium. At late 
developmental stages (stage 39) it becomes specifically expressed in the ventricle chamber 
(Garriock et al., 2001; Smith et al., 2005)
Atrial natriuretic factor (ANF) is expressed in the developing myocardium at stage 32 and in 
both atria and ventricle chambers until stage 45. At stage 47-49, ANF expression becomes 
specifically restricted in the atria while a decreased expression is observed in the ventricle. At 
stage 49 ANF is expressed exclusively in the atrium (Small and Krieg, 2000).
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1.4 Study o f heart development through in vitro and in vivo organogenesis
The heart development is regulated by a core of evolutionary conserved transcription factor in 
all vertebrate organisms (Olson, 2006). This evolutionary conservation allowed the use of 
different model organisms to study the multiple aspects that regulate heart development. In our 
study we wanted to investigate the regulation of different aspects after cardiac specification 
such as cardiac cell fate diversification and morphogenesis. In order to achieve these goals we 
used Xenopus embryos as a model organism. One of the major advantages of using Xenopus to 
study the heart development is the availability of explant assays such as animal cap assay. The 
animal cap is pluripotent as under specific induction conditions they can generate numerous 
cell types. For example, treatment of the animal cap explants with different concentration of 
activin induces the formation of different mesodermal tissues in a dose dependent manner 
(Ariizumi et al., 1991; Asashima et al., 1990; Green et al., 1990). Recent evidence suggests 
that this simple assay can also be used for in vitro organogenesis studies. Latinkic and 
colleagues, demonstrated that injection of GATA-4 mRNA in animal cap explants induces the 
expression of cardiac differentiation marker MLC2 and the development of a beating tissue 
(Latinkic et al., 2003). In this work, using GATA-4 injection in animal cap explants we have 
proved the possibility to investigate the cardiac patterning and cell diversification 
establishment in cultured ectodermal explants. However, animal cap assay does not provide a 
reproducible method to investigate the mechanism of cardiac morphogenesis, as their capacity 
to beat in culture is poor. In addition, the beating explants only show a very limited degree of 
morphogenesis. Thus, in order to investigate the mechanisms that regulate heart 
morphogenesis a reliable assay was needed in which it was possible to obtain a heart-like 
structure with high degree of morphogenesis and beating capacity. For this reason we
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combined and modified the animal cap assay and the secondary heart formation assay 
(Ariizumi et al., 2003) where injected explants were transplanted into host embryo. Using in 
vivo heart formation assay, we have proved the possibility to investigate different aspects 
involved during heart morphogenesis through the generation of a secondary beating structure 
with features resembling the heart proper.
1,4.1 Thesis aims
We aimed to study the mechanism involved in the cardiac cell diversification establishment 
using animal cap explants previously injected with GATA-4. We wanted to verify if, under the 
inducing activity of GATA-4, we could find in the same explants the expression of ventricular 
versus atria markers and if those genes showed a patterning of expression. Moreover, we also 
aimed to study the different aspects concerning the heart morphogenesis. In order to achieve 
that, we combined an in vivo and an in vitro assay, in which GATA-4 injected dissociated and 
reaggregated AC explants were transplanted into a host embryo at specific developmental 
stages. The aim to use this second assay, heart formation assay, was to combine our study on 
cardiac cell diversification establishment with the mechanism involved during the heart 
morphogenesis. We also tried to study different aspects of the heart morphogenesis using 
Xenopus whole embryos. We aimed to use specific inhibitors of pathway of signals in whole 
embryo at developmental stages corresponding to the end of the cardiac specification. Using 
treated whole embryos we aimed to verify which pathway of signals are involved during the 
different steps of the heart morphogenesis.
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Chemicals, salts, buffer and equipments were obtained from Bio-Rad (California, USA), 
Roche Diagnostic (Mannheim, Germany), Fisher Scientific (Loughborough, UK), Invitrogen 
(Paisley, UK), Ambion (Cambridgeshire, UK), Promega (Madison, USA), Sigma-Aldrich 
(Dorset, UK), GE Healthcare (Buckinghamshire, UK) and New England BioLabs (Ipswich, 
UK).
2.1 Xenopus laevis embryos manipulation
2.1.1 Obtaining Xenopus laevis embryos
Xenopus embryos were obtained as previously described (Sive et a l , 2000) either by natural 
mating or manual eggs collection. Adult frogs were injected with Human Chorionic 
Gonadrotopine hormone (HcG, Sigma-Aldrigh) via the dorsal lymph sac. The concentration 
was dependent upon the frog size, generally between 700-800U for female and 200U for male. 
Male and female were allowed to mate naturally in a tank over night at 19°C after hormone 
injection, and the embryos were collected manually with a plastic pipette. Before 
manipulations embryos were treated with 2% cysteine (pH 7.9-8.0, Sigma-Aldrigh) for 5-10 
minutes (min) to completely remove the protective jelly. After de-jellying, embryos were 
washed in 10% Normal Amphibian Media (NAM; 1 lOmM NaCl, 2mM KC1, ImM Ca(N03)2, 
ImM MgS0 4 , O.lmM EDTA, ImM NaHC03) and stored at 14°C until required.
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For in-vitro fertilisation, female frogs were injected with HcG and eggs were obtained by 
manual release into a Petri dish. The male frog was sacrificed and the testes was surgically 
isolated from the abdomen using forceps and kept in Leiboviz’s L I5 media (Sigma-Aldrigh) at 
4°C for up to 5 days. Small explants of testes was sliced and eggs coated, and left for 5 min for 
fertilisation to take place which is indicated by contraction of pigmentation. Embryos were left 
for 20 min in 10% NAM to rotate and after fertilisation were de-jellied in cysteine (2%, pH 
7.9-8.0, Sigma-Aldrigh) as previously described.
2.1.2 Xenopus strain
Experiments were carried out using two Xenopus transgenic lines carrying a cardiac actin-GFP 
reporter (Latinkic et al., 2002) or an MLClv-GFP reporter (Smith et al., 2005). Green 
Fluorescent Protein (GFP) presence was detected using a Leica MZ16F Fluorescence 
Stereomicroscope (Milton Keynes, UK) with a GFP filter (GFP2: excitation 480/40 nm, 
emission 510 nm). GFP protein emits fluorescence at wavelength of 510nm.
2.1.3 Staging o f embryos
Embryos were staged according to the Normal table of Xenopus laevis stage development 
(Nieuwkoop and Faber, 1994). Developmental stages of cultivated explants were assessed 
according to stages of development reached by siblings control embryos.
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2.1.4 Injection o f Xenopus laevis embryos with mRNA
Embryos were kept in 10% NAM at 16°C until the required embryonic stages. Embryo 
injections were performed in Petri dishes containing 75% NAM, 3% Ficoll PM 400 (Sigma- 
Aldrigh). Needles were pulled from capillary (Harvard Apparatus) using a Kopf 720 Neddie 
Puller (Kopf Instruments, CA, USA). Samples were filled into the needle using IM 300 
microinjector machine (NARISHIGE). After needle calibration for each embryo was injected 
lOnl of mRNA solution using 10mm graticule (Tonbridge Kent, England). Together with the 
mRNA, a final concentration of 10%, rodamine-dextran (20mg/ml) and dextran-biotin 
(25mg/ml) (Molecular probes) was co-injected as lineage tracer (table 2.2).
Embryos were injected at 1-2 cell-stage and kept in 75% NAM, 3% Ficoll PM 400 until stage 
9 in order to be processed for animal cap isolation. Embryos injected for phenotypic analysis 
were transferred to 10% NAM four hours after injection in order to avoid defective
gastrulation due to high the salt content of 75% NAM.
2.1.5 Animal cap isolation
Animal caps were cut as described by Sive and colleagues at stage 9 in agarose-coated dishes
(1% agarose in dHiO) containing 75% NAM (Sive et al., 2000).
Briefly, embryos at stage 9 show a distinct morphology composed of two defined poles, the 
animal pole, in which the mRNA was previously injected, and the vegetative pole at the 
opposite extremity. The animal pole is composed of a group of pigmented undifferentiated 
cells which cover a cavity called blastocoel. The vegetal pole is the region containing the yolk 
which provides the nutrients for the growing embryo. Cutting animal caps first involved
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removing the chorion membrane which surrounds the whole embryo. Animal pole explants 
were excised from the embryo and incubated in 75% NAM with gentamicin (25mg/ml, Sigma- 
Aldrigh) and also a mix of streptomycin-penicillin (50X, Sigma Aldrich) at 19-21°C. Due the 
use of an inducible form of GATA-4 mRNA dexamethasone hormone (Dex, Sigma-Aldrich) 
was added over night to the explants (2pM) to activate GATA-4-GR (Latinkic et al., 2003). 
Control embryos were kept in 10% NAM and gentamicin (25mg/ml, Sigma-Aldrich) at the 
same temperature as animal caps until the required developmental stage.
2.1.6 Dissociation and reaggregation o f animal cap explants
Animal cap explants were cut at stage 9 in agarose-coated dishes (1% agarose in dL^O) 
containing 95% Ca2+/Mg2+- free saline solution (CMFM; 88mM NaCl, ImM KC1, 2.4mM 
NaH0 3 , 7.5mM Tris-HCl pH 7.6) and 75%NAM. Twenty five explants were transferred to a 
1.5ml tube and dissociated in CMFM, 0.1% Bovine Serum Albovine (BSA 99%, Sigma- 
Aldrige). The dissociated cells were centrifuged at 1000 rpm for 1 minute and CMFM, 0.1% 
BSA was replaced with CMFM, 0.5mM CaC^ (fig. 2.1 A) Dex was added to the dissociated 
cells injected with GATA-4 mRNA. The cells were left for 3 hours at 19-21°C. The 
reaggregate cells (reaggregates) were transferred to agarose-coated dishes containing 
75%NAM and gentamicine (25mg/ml, Sigma-Aldrich) and left over-night at 19-21°C (fig. 2.1 
A) (Kuroda et al., 2005; Sive et al., 2000).
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2.1.7 Transplants o f reaggregates in Xenopus host embryos
Transplants were originally carried out according to Ariizumi and colleagues (Ariizumi et a l, 
2003). Reaggregates at stage 20 were transplanted into host embryos at the same stage. 
Embryos were transferred to agarose-coated dishes (1% agarose in dH^O) containing 
75%NAM with gentamicine (25mg/ml, Sigma-Aldrich). The chorion was removed from the 
embryos using a pair of forceps. The reaggregates were transferred to the same agarose dish 
and using a syringe needle and a forceps were cut to 0.03 mm in size using a 10mm graticule 
(Tonbridge Kent, England) placed under the agarose dish as a guide. In the ventral region of 
the host was created a wound where the reaggregate was transplanted. Transplanted host 
embryos remained in the agarose dish at least for one hour in order to allow the wound to 
repair and minimising the possibility of rejection (fig 2.1 B).
2.1.8 Morphogenic analysis o f reaggregates by confocal microscope
Confocal analysis was carried out on reaggregates transplanted into host embryos using a 
fluorescent microscope (Leica DM6000B). All images were analysed with the same 
magnification using objective lense HC PL FLUOTAR 40X. Leica Confocal Software 2.0 was 
used in order to process the images during secondary heart (SH) scanning.
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ReaggregationDissociation
Animal cap explants St. 9 CMFM CMFM + CaCh St.20
A
Transplantation
Reaggregate St. 20 Host embryo St. 20 St. 43
Figure 2.1 Dissociation and reaggregation of explants transplanted in host embryos. (A) Animal 
cap explants previously injected were excised from the animal pole and dissociated in CMFM and after 
reaggregation were cultivated until stage 20. (B) Transplantations were performed on the ventral side 
of the host embryos at stage 20 with reaggregates at the same stage. Transplants were analysed at stage 
43.
59
2.0 Material and Methods
2.1.9 Axis perturbation by UV-treatment
Axis perturbation of the embryo by UV exposure is a procedure which needs to be carried out 
soon after fertilisation of the egg. For this reason embryos were obtained through in vitro 
fertilisation as previously described. In order to obtain a complete axis perturbation, embryos 
need to be irradiated before the cortical cytoplasm rotation (CCR) is completed i.e. during the 
first 60% of the first cell cycle (Sive et al., 2000). Immediately after, embryos were transferred 
to a 50ml plastic tube (Anachem) containing 45ml 10% NAM. The tube was covered with a 
transparent cling film and inverted upside down over a UVGL-25 lamp. Embryos were 
exposed for 30 seconds to short wave (254nm) UV-light. Five min after irradiation treatment, 
embryos were transferred to Petri dishes containing 10%NAM. Good quality ventral embryos 
develop a blastopore lip that appears simultaneously around their entire circumference, 
coincident with the development of the ventral lip in control embryos. An accurate method to 
scoring UV-treated embryos involves the use of the dorsoanterior index (DAI) (Sive et al., 
2000). DAI is given as a whole number. Irradiated embryos with DAI inferior to 2 were 
chosen for further experiments (Sive et al., 2000). UV-treated embryos were used as host at 
stage 20 for the transplantation of GATA-4 injected reaggregates at the same stage.
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2.1,10 Heart field precursor excision and dissociation
Embryos at stage 21 were transferred to an agarose coated dish (1% agarose in dH20) with 
75% NAM and the chorion was removed using of a pair of sharp forceps. Heart Fields (HF) 
were dissected from the embryo using a syringe needle and a sharp forceps (fig. 2.2 A). The 
HFs were transferred to an agarose coated dish (1% agarose in dHiO) with 75% NAM and 
analysed at St. 40.
HFs dissociation was carried out in an agarose coated dish (1% agarose in dH20) with 95% 
Trypsin (Sigma-Aldrigh) and 5% of 75% NAM (fig. 2.2 B). HFs were left 10-15 min in order 
to allow the cell to dissociate completely and transferred in 1.5ml tube. The dissociated cells 
were centrifuged at lOOOrpm for 30 seconds and trypsin was replaced with 75% NAM and 
0.5mM CaCl2. The dissociated cells were centrifuged at lOOOrpm for 30 seconds and left at 
least three hours to reaggregates before transferring to an agarose coated dish (1% agarose in 
dH20) containing 75% NAM.
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St. 20 St. 40
B eat ing  HF
Dissociation
Tripsin
Reaggreagation
NAM 75%NAM 75% + CaCI2
Figure 2.2 HF dissection, dissociation and reaggregation. (A) The HF was excised from embryos 
with two transverse sections (1 and 2) and a further longitudinal section (3) and cultivated until beating 
activity was detected. (B) The HF at stage 21 were dissociated using trypsin and reaggregated in 75% 
NAM and CaCl2 and cultivated in agarose coated dishes (1% agarose in dH20 )  with 75% NAM.
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2.1.11 Media inhibitor treatment
Inhibition of specified signal pathways was carried out using embryos at specific 
developmental stages incubated in 75% NAM with the appropriated inhibitor. Each inhibitor 
was previously diluted in DMSO and the final concentration used in each treatment is 
described in table 2.1. Inhibitor activity was confirmed by phenotypic analysis compared with 
control embryos in DMSO.
Inhibitor Concentration Mode of Action M anufacturer References
A-83-01 75|iM ALK4/5/7 inhibitor Sigma-Aldrigh (Tojo et al. , 2005)
SU-5402 50|xM RTK inhibitor of FGFR1- 
4
Calbiochem (Mohammadi et al., 
1997)
Table 2.1 Inh ib ito rs of signaling pathw ay.
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2,2 RNA synthesis
2,2,1 Linearisation ofDNA template
Constructs of different DNAs were linearised using the appropriate restriction enzyme as 
described in Table 2.2. DNA constructs (5pl) were incubated with the restriction enzyme and 
enzyme specific buffer at the appropriate temperature according to the manufacture 
specifications. Construct linearisation was confirmed using agarose gel electrophoresis made 
with TBE buffer (45mM Tris Base, 45mM Boric Acid, ImM EDTA ph 8.0, 0.1% Acetic 
Acid) and ethidium bromide incorporation (6pi for 100ml of agarose, Fisher) run at 75V for 
30 min. DNA linearisation was visualised putting agarose gel under UV light (Gel Doc-It 
Immage System, Biorad). DNA molecular weight was verified using a 1Kb marker 
(Invitrogen). The enzyme reaction was inactivated by incubation of the mix at 65°C for 20 
min.
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Plasmid Construct Linearisation RNA
polymerase
mRNA
injection
References
GATA-4-GR pCS2 Sail Sp6 lng/10nl (Afouda et al., 
2005)
Dkk-1 pCS2 Notl Sp6 lng/lOnl (Glinka et al., 
1998)
tBr pSP64T EcoRI Sp6 lng/lOnl (Graff e ta l ,  
1994)
XWNT8 pCSKA BamHI Sp6 800pg/10nl (Christian and 
Moon, 1993)
Table 2.2 DNA used for RNA synthesis. Plasmid construct with their restriction sites and polymerase 
used to generate mRNA are described.
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2.2.2 mRNA synthesis
Capped RNA was synthetised from linearised templates and the Sp6 promoter was used to 
drive the transcription reaction (table 2.2). The reaction was performed using the 7mG(ppp)G 
RNA Cap Structure Analogue (NEB). Briefly, DNA (2pl) was incubated with transcription 
buffer (400mM Tris pH 7.5, 60mM MgCE, 20mM spermidine HC1, 50mM NaCl, 2pl), 12.5 
mM DTT, ImM dNTPs, RNAse Inhibitor (RNasin, Promega) and 40 units of Sp6 (Ambion) 
and incubated for 2 hours at 37 °C. This was followed by addition of RQ1 RNAse-free DNase 
(Ambion) and incubation for 15 min at 37 °C. Transcribed RNA was purified using 
ProbeQuant™ G-50 Micro Columns (GE Healthcare) and run on agarose gel (1%) stained 
with ethidium bromide to check its integrity. The concentration of the RNA was determined 
using a spectrophotometer (Bio-Rad Smart Spec 3000).
2.2.3 Dexamethasone inducible construct activity
Glucocorticoid receptor (GR) fusions provide stable constructs which can be used to create 
sense RNA which can be injected into Xenopus embryos. Fusion to the receptor renders the 
protein inactive due to its interaction with Heat Shock Protein 90 (HSP 90) complex. Fused 
proteins accumulate in the nucleus until its ligand dexamethasone (Dex) is added. Dex causes 
a conformational change that release HSP90 from the protein which is thereby activated 
(Mattioni et al., 1994).
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2.3 RT-PCR analysis
2.3.1 mRNA extraction
RNA extraction was carried out using acid guanidium thiocyanate-phenol-chloroform 
extraction (Chomczynski and Sacchi, 1987). Twenty five animal cap explants, 3 reaggregates, 
5 HF explants or 5 control embryos were used per sample. Briefly, denaturing solution 
(Solution D; 4M guanidinium thiocynate, 25mM sodium citrate, pH7.0) containing 0.1M (3- 
Mercaptoethanol (98%; Sigma-Aldrigh) was added to each sample. Sequentially, 2M sodium 
acetate (pH 4, 50pl), water saturated phenol (500pl, Fisher Scientific) and chloroform (lOOpl, 
Fisher Scientific) were added to the samples homogenate and mixed, followed by incubation 
on ice for 15min. Samples were centrifuge at 14,000 rpm for 20 min at 4°C. Ice-cold 
isopropanol (500pl, Fisher Scientific) was added to the subsequent solution and incubated for 
1 hour at -70 ° C. Following centrifugation at 14,000 rpm for 20 min at 4° C, the solution was 
removed and cold 70% ethanol (500pl, Fisher Scientific) added and centrifuged as before. 
Pellets were air-dried and resuspended in ddH20 (0.5pl for each animal cap) and stored at - 
20° .
2.3.2 Reverse transcription
Reverse transcription polymearase chain reaction was carried out using M-MLV Reverse 
transcriptase kit (Invitrogen) according to the manufactures specifications. Briefly, 2pg of 
RNA, 1.25(4.1 dNTPs (lOmM, Promega) and lpl random primers (0.5pg/pl, Invitrogen) were 
added to a volume of 15 pi. To denature the RNA, samples were incubated at 65°C for 5 min
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and then quickly cooled on ice. The following mix was then added to each sample and 
incubated for 2 min at 37°C.
5 pi 5X First Strand Buffer (250mM Tris-HCl pH 8.3, 375 mM KC1, 15mM
MgCl2)
2.5pl DTT (lOOmM)
1.25pl RiboLock RNase Inhibitor (40U/pl, Fermentas)
1.25pl M-MLV RT (200 units, Invitrogen) was added to each sample and incubated for 10 min 
at 25°C followed by an incubation of 50 min at 37°C. The reaction was heat inactivated for 15 
min at 70°C and the cDNA stored at -20°C.
2.3.3 RT-PCR
The expression of the genes of interest in treated animal cap explants, reaggregates or whole 
embryos was analysed using RT-PCR. RT-PCR was performed using the primers described in 
table 2.3 at concentration of 0.1 pM. Primers (0.1 pM) were designed using Primer3 software 
(http://frodo.wi.mit.edu/primer3/). PCR conditions and primers sequence are described in table 
2.3. Cycle number and reaction condition were scrutinised such that production amplification 
was determined to be in the linear range of specific PCR product. Reactions were set up in 
duplicate for each cap sample using the following mix:
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5(xl 5X GoTaq Flexi Buffer (Promega)
0 .5 j l i 1 dNTPs (lOmM)
2pl MgCh (2mM, Promega)
1 pi Forward primer (2.5mM, Invitrogen)
lpl Reverse primers (2.5mM, Invitrogen)
0.25pl GoTaq DNA Polymerase (5U/pl, Promega)
to 24 pi ddH20
PCR was carried out using MJMini PCR Machine (Bio-Rad) with the following cycling 
conditions:
95°C for 3 min 
95°C for 30 seconds 
Tm for 30 seconds x cycles
72°C for 30 seconds 
72°C for 10 min
Specific cycle numbers were performed for each gene analysed as described in Table 2.3. 
Following PCR, products were analysed using agarose elecrophoresis gel (2%) with ethidium 
bromide staining visualised under UV. Samples were normalised relative to Ornithine 
Decarboxylase (ODC) levels as a loding control.
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Primers Sequence Accessionnumber
Tm
(°C)
Product
Size (bp)
Cycle
Number
IRX4 (+) 
IRX4(-)
tgcagctttgggtgtctatg
atggccagcatgatcttctc
NM_001096735.1 58 336 38
MLClv (+) 
MLClv (-)
tgggacagaatccaaccaat
tgaatggtgttcctgtgcat
AY289206 58 491 38
MLC2 (+) 
MLC2(-)
tgtatcgaccaaaaccgtga
attggggtcacagcaaacat
AY219706 58 329 32
ODC (+) 
ODC (-)
gccattgtgaagactctctccatt
ttcgggtgattccttgccac
NM_001086698 58 220 28
Tbxl8 (+) 
Tbxl8 (-)
tgtttccagccatgagagtg
gagagatggctccaaaatgc
EB736397 58 553 39
Table 2.3 P rim ers used in RT-PCR.
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2,3.4 QRT-PCR
Quantitative RT-PCR analysis was performed using cDNA prepared as described previously. 
Primers (0.1 pM) were designed using Primer3 software (http://frodo.wi.mit.edu/primer3/). 
PCR conditions and primers sequence are described in table 2.4. The following mix was used 
for each PCR reaction with a final volume of 25pi:
5pi 5X GoTaq Flexi Buffer (Promega)
0.5pl dNTPs (lOmM)
2pl MgCh (2mM, Promega)
1 pi Forward primer (2.5mM Invitrogen)
1 pi Reverse primers (2.5mM Invitrogen)
1.25pl SYBR Green (2X SYBER Green Supermix, BioRad)
0.25pl GoTaq DNA Polymerase (5U/pl, Promega)
to 24pl ddH20
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PCR was carried out using a MiniOpticon PCR Machine (Bio-Rad) with the following cycling 
conditions:
95°C for 3 min
95°C for 30 seconds ^
Tm for 30 seconds
72°C for 30 seconds >  X cycles 
75°C for 15 seconds 
Plate Read y
Melting curve from 55°C to 95°C
Data was analysed using MJ Opticon Monitor 2.0 software (BioRad). The fold difference in 
gene expression levels between samples was calculated with the following formula:
Amount of target = 2'AACt (Livak and Schmittgen, 2001)
Ct correspond to the threshold cycle for target amplification
AACt Correspond to Ct target gene Ct control
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Primers Sequence Accession num ber Tm(°C)
Product
Size
(bp)
Cycle
Number
IRX4 (+) 
IRX4(-)
acctctggacaccaccaatc
cgcaacaggttgaaagtgaa
NM_001096735.1 58 184 45
MLClv (+) 
MLClv (-)
tgctccaacacatttccaag
actcttcttgcccatgcagt
AY289206 58 186 45
MLC2 (+) 
MLC2(-)
tgtatcgaccaaaaccgtga
cttctgggtccgttccatta
AY219706 58 189 45
ODC (+) 
ODC (-)
gccattgtgaagactctctccatt
ttcgggtgattccttgccac
NM_001086698 58 220 45
Table 2.4 Primers used in QRT-PCR. Primers used for QRT-PCR required a product size not longer 
than 250bp. For this reason primers sequence for Irx4, M LClv and MLC2 were specifically designed 
for QRT-PCR accordingly.
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2.4 Gene expression analysis
2.4.1 Antisense probe preparation
Standard antisense probe synthesis was performed according to the method of Sive (Sive et 
al., 2000), transcribed from linear DNA. Riboprobes were labelled with digoxygenin- or 
fluorescin- UTP (Dig or Flu respectively, Roche). DNA templates used were linearised at 
appropriate promoter site for antisense direction using T7 polymerase (Promega) (table 2.5). 
Briefly, the reaction mix for each sample (40pl of final volume) contained:
8  pi 5X transcription buffer (Promega)
4pl 1M DTT (Promega)
2 pl 10X Dig/Flu RNA labelling mix (Roche)
0.5 pi RiboLock RNase inhibitor (40U/pl, Fermentas)
2  pi RNA polymerase (Tab.2.3)
1 Pg DNA
to 40pl ddH20
The mix was incubated for 2 hour at 37 °C and then 2pl of RQ1 RNAse-free DNase lU/pl 
(Promega) was added for 15 min at 37 °C. Probes were purified using ProbeQuant™ G-50 
Micro Columns (GE Healthcare) and RNA integrity was checked using agarose gel 
electrophoresis ( 1  %) with ethidium bromide staining.
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Gene Plasmid Polymerase
Restriction
enzyme
References
MLC2 pGemTeasy T7 Sail (Chambers etal., 1994)
MLClv pSPORT T7 Sail (Smith etal., 2005)
Tbxl8 pGemTeasy T7 Sail (Jahr etal., 2008)
Cardiac
Troponin
Bluescript SK T7 Sail
(Drysdale etal., 1994)
Table 2.5 Antisense probe used in whole m ount in situ hybridisation. Each probe was labelled with 
either digoxygenin or fluorescein.
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2.4.2 Whole mount in situ hybridisation
Animal cap explants and embryos were fixed in MEMFA (0.1M MOPS pH7.4, 2mM EDTA, 
ImM M gS04i O.lx Formaldehyde) at the required stage (Sive et a l , 2000), dehydrated in 
100% ethanol (Fisher Scientific) and stored at -20°C until required.
Samples were gradually rehydrated in a TBS ethanol series, washed in TBS-Tween 20 (TTw, 
20mM NaCl, 5mM Tris-Cl pH 7.4, 0.1% Tween-20 [Fisher Scientific]) and permeabilised 
with Proteinase K in TBS (lOpg/ml, Roche) for 15 min. After three washes in TTw, samples 
were fixed in MEMFA for 20 min. Prehybridisation was carried out by incubation in 
hybridisation buffer (50% Formamide [Fisher Scientific], 5X SSC [SSC, 0.1M NaCl, 15mM 
Sodium Citrate], 5mM EDTA pH8.0, 10%CHAPS [Fisher Scientific], IX Denharf s solution 
[0.02% BSA, 0.02% polyvinylpyrrolidone], 0.02% Ficoll 400, Heparine Sulphate [lmg/ml, 
Sigma-Aldrigh], Torula RNA Type DC [lmg/ml, Sigma]) at 60-65°C for at least 4 hours. 
Samples were rinsed with fresh hybridisation buffer (500pl) containing digoxigenin or 
fluorescin anti sense probe and incubated at 60-65°C over night.
The samples were then washed once in 25% Formamide, 2X SSC, 0.1% Chaps for 10 min at 
60-65°C, followed by two washes in 2XSSC, 0.1% Chaps at 60-65°C for 15 min and several 
washes in 0.2X SSC, 0.1% Chaps at 60-65°C each one for 30 min. Samples were then washed 
twice in MAB-T (0.1 M maleic acid [Sigma], 0.15 M NaCl, 0.1 triton [Fisher Scientific]). 
Blocking was carried out by incubation for at least 1 hour at room temperature in MAB-T 
containing 2% BMB blocking Reagent (Roche) and 10% Heat Inhactivated Sheep Serum
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(HSS, Sigma). Samples were left over night at 4°C in MAB-T, 2% BMB and 10% HSS with 
either antidigoxigenine antibody (Roche) 1:2500 or antifluorescine antibody (Roche) 1:10000.
Samples were washed several times in MAB-T and incubated for 15 min in Alkaline 
Phosphatase Buffer (APB; lOOmM Tris pH9.5, 50mM MgCb, lOOmM NaCl, 0.1% Tween-20, 
2mM Levamisole [Sigma]). Colour detection was achieved using the following substrates:
5-Bromo-4-chloro-3-indolyl phosphate (BCIP, Roche). This substrate stains turquoise 
when used alone. After AP buffer incubation samples were transferred into AP buffer 
containing BCIP (3.5pl/ml) and left in dark to allow the staining to develop. BCIP can 
be used also for colour development in double in situ hybridisation. Overlapping 
colour development between BCIP and the secondary substrate generate a strong blue 
colouration.
BMpurple (Roche). This substrate develops a strong blue colour after the embryos 
were previously incubated in AP buffer. BMpurple was used only in double in situ 
hybridisation when there is not overlapping expression between two transcripts.
Magenta-Phosphate (Sigma). This reagent stains magenta. Develop very slowly but it 
produces low background. It is generally used in double in situ hybridisation in 
combination with BCIP. Overlapping expression generate a violet colour clearly 
distinguishable from magenta and turquoise. In order to obtain a stronger stain it is 
generally used in combination with Tetrazolium Red (TTZ, Sigma). Stock of Magenta-
77
2.0 Material and Methods
Phosphate (25mg/ml) and TTZ are made in Dimethylformamide and used at 9pl/ml in 
AP buffer.
Once colour development was complete, samples were dehydratated and then rehydratated in 
an ethanol series in order to remove unbound stain and stop the colour reaction. After washing 
in MAB-T for 10 min, samples were stored in TBS at 4°C or bleached with 1 %H2 0 2 , 5% 
Formammide, 0.5XSSC. Benzyl alcohol;Benzyl benzoate (BB/BA) was used to clear the 
embryos and animal cap explants.
Double in situ hybridisation was carried out for the analysis of two different RNA transcripts. 
During hybridisation fluorescine and digoxigenine probes were added together. After the 
development of the first transcript samples were fixed in MEMFA for 20 minute and gradual 
hydration-dehydration ethanol series was carried out. Samples were washed in MAB-T and 
blocked for lh  at RT in MAB-T, 2% BMB, 10% HSS. The secondary antibody was 
subsequently added over night at 4°C and developed as described above.
2,4,3 Immunohystochemistry
Transplant embryos were analysed for the presence of cardiac tissue in reaggregates using 
mouse anti-chicken tropomyosin monoclonal antibody (CH-1) (Kolker et al., 2000). 
Transplants were fixed in Dent’s fixative (80% Methanol [Fisher Scientific], 20% dimethyl 
sulfoxide [DMSO]) for 2 hours at RT and bleached using 5% hydrogen peroxidase (in Dent’s
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fixative) for 4-5 hours at RT. Transplanted embryos were rehydrated with PBS (137mM NaCl, 
2.7 mM KC1, lOmM Na2HPC>4 , 2mM KH2PO4 , 1%BSA) in a methanol-PBS series with 1% 
DMSO. Transplants were incubated 30-45 min in 50mM acetate buffer containing bovine 
testicular hyaluronidase (lmg/ml, Sigma-Aldrigh) and rinsed in PBS-T (PBS, 0.1% Triton-X) 
three times. Transplants were incubated in PBS-T containing 2% BMB blocking Reagent 
(Roche) and 5% Heat Inhactivated Sheep Serum (HSS, Sigma) for 4 hours at RT. The primary 
antibody CH-1 was diluted 1:50 in PBS-T, 2% BMB, 5% HSS and left over night at 4°C. The 
samples were then washed five times in PBS-T and incubated over night at 4°C in PBS-T, 2% 
BMB, 5% HSS containing 1:500 dilution of Goat a-mouse Alexa Fluo 488 (Invitrogen) 
(Kolker et al., 2000). The samples were then washed in PBS-T and fluorescence detection was 
carried out using a Leica M216 fluorescent microscope (Milton Keynes, UK) with a GFP 
filter.
For confocal analysis samples were dehydrated in methanol (MEOH), and cleared with benzyl 
alcohol/benzyl benzoate (BABB). Following this treatment, the tissues were transparent. 
Samples were transferred to slides coated with 1% agarose in which wells were cut and filled 
with BABB solution. The embryos were covered with a cover slip in order to prevent 
evaporation.
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3.0 Heart cell fate diversification in an animal cap assay
3.1 Introduction
Vertebrate heart development involves a series of morphogenetic steps in which a relatively 
simple layer of cardiac precursors generates a complex structure composed of atrial and 
ventricular chambers. This complexity presents a challenge for in vivo study of heart 
development, an essential organ, as very often experimental manipulations cause early 
lethality. As one alternative, in order to understand how cardiac cell diversification of 
ventricular versus atrial cells is established during embryogenesis, we used a simple animal 
cap (AC) assay. AC explants excised from the animal pole of the embryo and cultivated in a 
simple saline solution express epidermal genes. However, under specific induction with 
certain molecules they can be induced to differentiate into specific cell types. Latinkic and 
colleagues showed that injection of GATA-4 is sufficient to induce cardiac differentiation. In 
these explants the pan-myocardial marker MLC2 is expressed and when cultivated longer also 
show beating activity (Latinkic et al., 2003). AC explants therefore, provide a simple in vitro 
to study the mechanisms of heart development.
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3,1.1 Chapter Aim
Using the cardiogenesis assay, we aimed to:
1. Investigate the establishment of regionally restricted cardiac fates in intact animal pole 
explants.
2. Investigate the mechanisms that lead to the establishment of regionally restricted 
cardiac genes.
3.2 Results
3.2.1 Gata-4 injection induces regionally restricted cardiac fates in animal cap 
explants
It has been previously established that isolated parts (explants) of Xenopus embryos are able to 
grow and differentiate when cultivated in a simple saline solution. It has also been shown that 
the explants injected with GATA-4 express pan-myocardial markers such as MLC2 but no 
muscle differentiation markers (Latinkic et al., 2003).
Animal cap (AC) explants cultivated until stage 33 showed the expression of MLC2 when 
analysed by whole mount in situ hybridisation (WMISH) and RT-PCR analysis (fig. 3.1 A). 
Further analysis has been carried out on explants injected with GATA-4 in order to verify the 
existence of ventricular markers M LClv and Irx4. During embryonic development, M LClv 
and Irx4 become ventricular specific markers after stage 37 and therefore the explants were 
cultivated until stage 39. In situ hybridisation analysis (fig. 3.1 G-H) showed that 75% of the
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explants express M LClv indicating that ventricular cell fate has been induced. This was 
confirmed by RT-PCR analysis (fig. 3.1 A) which also showed the expression of Irx-4.
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Figure 3.1 GATA-4 injected animal caps express specific ventricular markers (A) GATA-4 injected animal caps cultivated until stage 40 
showed the expression of MLC2, M LClv, Irx4 and Tbxl8 when analysed using RT-PCR at stage 40. (B) Control embryo at stage 33 analysed by 
WMISH for the expression of MLC2 (C-D). 50% of AC explants expressed MLC2 (n=25) when analysed by WMISH. (E-F) Control embryo at 
stage 40 analysed in WMISH for the expression of M LClv. (G-H) 75% of AC explants cultivated until stage 40 express M LClv (n=50) when 
analysed by WMISH (arrows), ih; interhyoid muscles of the jaw; lh; lymph heart, v; ventricle, AC; animal caps control, G4; GATA-4, WE; whole 
embryos.
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GATA-4 AC explants were also analysed by double WMISH for the expression of pan- 
myocardial markers and a ventricular marker (fig. 3.2). The lacking of suitable atrial markers 
in Xenopus directed us to use the ventricular and panmyocardial markers together as an 
indirect method to observe also the establishment of atrial cell fate. Double WMISH 
performed in whole embryos showed overlapping expression between the panmyocardial and 
ventricular markers which corresponds to the ventricular region, while the region of MLC2 
expression only correspond to the atria (fig. 3.2 A1 and B l). 36% of AC explants analysed for 
the expression of panmyocardial marker cTnl and ventricular marker M LClv showed a region 
of overlapping expression between these markers and a region in which cTnl was expressed 
alone (fig. 3.2 A2-A4). 13% of GATA-4 AC explants express only cTnl. Similarly, 41% of 
GATA-4 AC analysed for the expression of MLC2 and M LClv showed a region of 
overlapping expression between these markers and regions where MLC2 was expressed alone 
(fig. 3.2 B2-B4). 30% of GATA-4 AC explants expressed MLC2 only. Additional 
investigation has been carried out in GATA-4 injected explants in order to check for the 
presence of non-myocardial cell types. RT-PCR analysis demonstrated that GATA-4 AC 
explants express the proepicardial marker T bxl8  (fig. 3.1 A). These results demonstrate that 
GATA-4 injected animal cap explants express myocardial and non-myocardial markers. 
Moreover, in the same explants pan-myocardial markers and ventricular marker showed 
patterned expression when analysed by double WMISH. The overlapping expression found 
between the panmyocardial markers and the ventricular marker corresponds to the ventricle 
region while the expression of the panmyocardial markers alone corresponds to the atrial 
region. Animal cap explants therefore demonstrate a reproducible model that allows us to 
investigate the establishment of cardiac ventricular versus atrial cell fate diversification during 
cardiac differentiation and organogenesis.
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Figure 3.2 Regional gene expression in GATA-4 AC. (A l) Control embryo at stage 39 analysed by 
WMISH for the expression of cTnl and 1LC1 v. (A2-A4) 36% of GATA-4 AC (n=55) showed region 
of overlapping expression between cTnl and MLClv (arrow) and region of cTnl expression alone 
(head arrow). (B l) Control embryo at stage 39 analysed by WMISH for the expression of MLC2 and 
MLClv. (B2-B4) 41% of GATA-4 AC (n=41) treated by BB/BA showed region of overlapping 
expression between MLC2 and ILCL (arrow) and region of MLC2 expression alone (head arrow), 
ih; interhyoid muscles of the jaw, v; ventricle.
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3.2.2 Dkk-1 enhances cardiogenesis but has only a small specific effect on 
M LClv
Latinkic and colleagues showed that cardiogenic activity of GATA-4 in animal caps explants 
can be enhanced by co-injection with Dkk-1 (Latinkic et al., 2003). Dkk-1 is a Wnt/p-catenin 
antagonist (Semenov et al., 2001) which acts as a head inducer via the anteriosation of the 
body during embryonic development (Glinka et al., 1998). AC explants were co-injected with 
Dkk-1 and GATA-4 and analysed using WMISH and RT-PCR to verify if cardiac cell 
diversification has occurred. Co-injected animal cap explants analysed by WMISH (fig. 3.3 D- 
E) and RT-PCR (fig. 3.3 D-E) showed the expression of pan-myocardial marker MLC2. qRT- 
PCR analysis showed that, in co-injected explants, MLC2 expression was enhanced when 
compared with the expression in GATA-4 injected explants (fig. 3.3 B). Furthermore animal 
cap explants cultivated until stage 40 showed the expression of ventricular specific markers 
when analysed by RT-PCR (fig 3.3 A). M LClv expression was also confirmed using WMISH 
in which 50% of the explants analysed showed the expression of this gene (fig. 3.3 G-H). 
qRT-PCR analysis demonstrated also an increase of M LClv expression in co-injected AC 
explants compared with GATA-4 injected AC (fig. 3.3 B). Thus, in co-injected explants there 
is an overall increase in cardiac tissue (MLC2) caused by Dkk-1 that most likely accounts for 
the increase of M LClv. GATA-4 and Dkk-1 co-injected explants were also analysed for the 
expression of Tbx 18 in order to verify the presence of non-myocardial cell types. Co-injected 
explants analysed by RT-PCR do not show the expression of Tbx 18 (fig. 3.3 A).
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Figure 3.3 Dkk-1 enhances cardiogenic activity of GATA-4 in animal cap explants. (A) Co-injected AC explants show the expression of 
MLC2, M LClv and Irx4 when analysed using RT-PCR. (B) Co-injected AC explants analysed using qRT-PCR showed a fold increase of 
expression of MLC2 and M LClv when compared to GATA-4 injected explants. (C) Control embryo analysed by WMISH for the expression of 
MLC2. (D-E) 72% of co-injected AC explants expressed MLC2 (n=33) in WMISH analysis (arrow). (F) Control embryo analysed by WMISH 
for the expression of MLClv. (G-H) 50% of co-injected AC explants expressed M LClv (n=25) when analysed by WMISH (arrow), ih; 
interhyoid muscles of the jaw; lh; lymph heart, v; ventricle, AC; animal caps control, G4; GATA-4, WE; whole embryos.
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3.2.3 Dissociation abolishes ventricular cell fate in GATA-4 injected explants
Expression of pan-myocardial, ventricular and proepicardial markers in AC explants injected 
with GATA-4 or co-injected with GATA-4 and Dkk-1 demonstrates that cell diversification 
has occurred in the explants. Expression of a pan-myocardial marker depends directly on the 
injection of GATA-4 mRNA which triggers cardiac induction in the explants. However, 
cardiac cell diversification in the explants may also depend on the embryonic dorso-ventral 
axis (D-V) which has been established before the excision of the animal caps from the embryo 
(De Robertis and Kuroda, 2004; Sokol and Melton, 1991). It has been shown that the capacity 
of the animal cap explants cells to differentiate into a specific tissue type is related to the 
inducer activity and also to the differential competence of the cells in the responding tissue 
(Sokol and Melton, 1991). To test if the pre-patteming in animal cap explants injected with 
GATA-4 determines the expression of ventricular and proepicardial markers, we dissociated 
and subsequentially reaggregated them. Uninjected animal cap explants dissociated and 
reaggregated express endodermal markers (Kuroda et al., 2005) but when the same explants 
are injected with GATA-4 they express the pan-myocardial marker MLC2 (fig. 3.4). However, 
the same explants lack expression of ventricular and proepicardial markers when analysed by 
RT-PCR with respect to injected intact caps (fig. 3.4). Dissociation leads to disruption of the 
cell-cell contact and upon reaggregation any embryonic patterning established before the 
dissociation is lost. This result demonstrates that the expression of the pan-myocardial marker 
MLC2 is directly dependent on the injection of GATA-4 but this is not sufficient to establish 
ventricular and proepicardial cell fates.
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Figure 3.4 Loss of regionally restricted marker expression in dissociated explants. Animal cap 
explants were dissociated and reaggregated and cultivated until stage 39. Reaggregated explants 
analysed using RT-PCR showed the expression MLC2 but not the expression of ventricular and 
proepicardial markers. GATA-4 AC explants express MLC2, M LClv, Irx4 and Tbx 18 when analysed 
by RT-PCR at the same stage. AC; animal caps control, G4 AC; GATA-4 injected AC explants, G4 R; 
GATA-4 reaggregated explants, R C; control reaggregated explants, WE; whole embryos.
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3.2.4 Dissociated heart field  precursors lack ventricular and proepicardial 
gene expression
The absence of the expression of regionally restricted heart genes in dissociated and 
reaggregated animal cap explants demonstrate the importance of the embryonic patterning 
established in the embryo by stage 9. In contrast, pan-myocardial genes such as MLC2 are not 
affected by dissociation in GATA-4 injected explants (fig. 3.4). An additional method to 
investigate the mechanism of cardiac gene expression diversification is using heart field (HF) 
explants. The HFs are able to grow and differentiate autonomously in culture and for this 
reason can be classified as a morphogenetic field (Raffin et al., 2000). In cultivation they 
demonstrated the capacity to generate a looped beating structure (Raffin et al., 2000) with a 
low degree of morphogenesis. Endodermal tissues allow cardiac differentiation to occur in HF 
explants but it is not sufficient to generate obvious atrium and ventricle chambers (Mohun et 
al., 2003). The HF was excised from the embryo at stage 21 (fig. 3.5 A), cultivated until stage 
40 and analysed by double WMISH for the expression of MLC2 and M LClv (fig. 3.5 C-F). 
Double WMISH in the HFs showed a region in which the expression of MLC2 and MLClv 
overlapped indicating the position of the ventricle (fig. 3.5 C-F) while the regions that are 
MLC2 positive only presumably correspond to the atrium (fig. 3.5 C-F). In HF explants 
ventricular and atrial cell fates exists but the degree of morphogenesis is very low compared to 
the normal heart. RT-PCR analysis of HFs and HF without endoderm at stage 40 also 
confirmed the expression of Irx4 and Tbx 18. Tbx 18 expression is very weak in heart field 
explants and is almost lost in HF lacking endoderm (fig. 3.5 B). RT-PCR analysis was also 
carried out in dissociate and reaggregated HFs at stage 40. Those explants showed the 
expression of MLC2 but not the expression of the ventricular and proepicardial markers (fig.
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3.5 B). Expression of MLC2 was lower with respect to the other samples. The HF precursors 
are probably more dependent on cell-cell contact for the maintenance of cardiac fate compared 
to GATA-4 reaggregates, in which this is largely a cell-autonomous process.
These results demonstrate that chamber cell fate diversification occurs later than cardiac 
specification and it requires specific cell-cell contacts to occur. In addition, the results showed 
that gene expression found in GATA-4 reaggregates closely resembles gene expression found 
in HF reaggregates as an in vivo source of cardiac precursors. Thus, the lacking of ventricular 
and proepicardial gene expression found in GATA-4 reaggregates is not peculiar but represent 
a physiologically relevant result.
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Figure 3.5 Heart field loose ventricular gene expression when dissociated and reaggregated. (A)
Heart Field (HF) were excided from embryo at stage 21 and cultivated until stage 40 and (B) analysed 
by RT-PCR together with HF without endoderm and HF reaggregated at the same stage. (C-F) HF 
were also analysed at stage 40 by double-WMISH for the expression of MLC2 and LCI . WMISH 
analysis showed regions of overlapping expression between MLC2 and [LCF corresponding to the 
ventricle (arrows) and regions MLC2 positive only corresponding to the atrium (head arrows). (G-H) 
Control embryos at stage 40 were analysed by WMISH for the expression of MLC2 and MLClv. a; 
atria, ih; interhyoid muscles of the jaw; r; reaggregate, v; ventricle, HF; heart field, HF no end.; HF 
without endoderm, HF R; heart field reaggregated, WE; whole embryos.
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3.2.5 Ventricular cell fate establishment can be rescued in reaggregated cells
The absence of ventricular and proepicardial gene expression in dissociated explants injected 
with GATA-4 demonstrates the importance of embryonic pre-patteming in establishing 
cardiogenesis. Figure 3.1 A shows that intact explants injected with GATA-4 express 
ventricular and proepicardial markers. In order to re-establish the expression of ventricular and 
proepicardial markers in dissociated animal cap explants we used molecules known to be 
involved in patterning the heart.
3.2.5.1 Dkk-1
Dkk-1 enhances cardiogenic activity of GATA-4 in AC explants which show the expression of 
ventricular and proepicardial markers (fig. 3.3 A-B). In order to verify if it is possible to re­
establish cell diversification in dissociated explants, GATA-4 reaggregates were treated with 
Dkk-1 or XWnt- 8  mRNA. We co-injected the reaggreagate with GATA-4 and Dkk-1 to 
compare the results obtained with the reaggregates injected with GATA-4 (fig. 3.4). 
Moreover, we combine Dkk-1 injected AC explants at stage 9 with GATA-4 injected 
reaggregates at the same stage. The aim of this experimental design was to verify if the source 
of signal provided by Dkk-1 is capable to re-establish the polarity lost in GATA-4 
reaggregates by the dissociation process. We also combined XWnt- 8  injected AC explants at 
stage 9 with GATA-4 reaggregates at the same stage. For the same reason using Wnt- 8  
injected AC (as a source of signal) we aimed to change the A-P polarity in GATA-4 
reaggregates and verify if it was possible to re-establish cardiac cell fate diversification.
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RT-PCR analysis of the samples at stage 39 showed that MLClv expression was re­
established in GATA-4 and Dkk-1 co-injected reaggregates in contrast to GATA-4 injected 
reaggregates. The same expression was also found in GATA-4 reaggregates combined with 
Dkk-1 AC explants (fig. 3.6). GATA-4 reaggregates did not express MLClv when combined 
with XWnt- 8  injected explants. The same sample showed a low level of MLC2 expression 
with respect to the other samples (fig. 3.6) confirming that the source of signal provided by 
XWnt- 8  did not re-establish the cardiac cell fate but partially inhibited cardiogenesis. Irx4 
expression found in GATA-4 reaggregates combined with Wnt- 8  reflects its expression in the 
head region (Garriock et a l,  2001). Therefore, XWnt- 8  has most likely neuralised GATA-4 
reaggregates.
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Figure 3.6 Ventricular cell fate can be rescued with Dkk-1 in reaggregates. (A) RT-PCR analysis 
was performed in explants at stage 39 for the expression of ventricular and proepicardial markers. 
M L C lv was expressed in GATA-4 reaggregates co-injected with Dkk-1 or combined with Dkk-1 AC. 
Irx4 was expressed in GATA-4 reaggregates combined with Dkk-1 AC and in GATA-4 reaggregates 
combined with XWnt-8 AC explants. Tbx 18 expression was not rescued. AC; animal caps, R C; 
reaggregates control, R; reaggregates, WE; whole embryos.
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3.2.5.2 BMP
In order to examine the effect of BMP signalling during cardiac cell diversification, GATA-4 
reaggregates and AC explants were co-injected with the mutant dominant-negative form of the 
type I BMP specific receptor, tBr mRNA (Graff et al., 1994). AC explants and reaggregates 
were cultivated until stage 40 and analysed by RT-PCR for the expression of ventricular and 
proepicardial markers. Reaggregates co-injected with both GATA-4 and tBr mRNA showed 
the expression of the ventricular marker M LClv (fig. 3.7). Irx4 expression was not found in 
co-injected reaggregates. Tbx-18 expression was only partially rescued in reaggregates co- 
injected with GATA-4 and tBr mRNA (fig. 3.7).
These results demonstrate that cardiac cell diversification can be restored in GATA-4 
reaggregates via the inhibition of BMP pathway or via Dkk-1. Dkk-1 can only rescue the 
expression of the ventricular markers M LClv and Irx4 while the inhibition of BMP allows the 
expression of ventricular and proepicardial genes in reaggregated explants. Thus, ventricular 
cell fate might be specified by anterior signals (as shown in Dkk-1 and tBr results) while 
proepicardial cell fate require Wnt signalling, as Dkk-1 inhibits it in intact AC explants.
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Figure 3.7 Co-injection of GATA-4 with tBr mRNA rescues the ventricular and proepicardial 
gene expression in reaggregates. GATA-4 reaggregates co-injected with tBr show ventricular and 
weak proepicardial gene expression with respect to GATA-4 injected reaggregates. Similar expression 
was found in injected and co-injected intact caps. Expression of Irx4 is lost in co-injected intact caps 
but no further analysis has been done to explain this result.
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3.3 Discussion
3.3.1 GATA-4 induces cardiogenesis but is not sufficient for cardiac cell 
diversification
Cardiogenesis assay is a simple method to induce cardiac differentiation using animal cap 
(AC) explants. Cardiac tissue in AC is induced by GATA-4 mRNA, as shown by expression 
of pan-myocardial markers MLC2 (Latinkic et al., 2003) and cTnl (Drysdale et al., 1994). In 
this thesis it was shown that GATA4-injected AC explants express ventricular and 
proepicardial markers when cultivated until stage 40 (fig. 3.1). Moreover, AC explants 
analysed by double WMISH showed gene expression patterning between the pan-myocardial 
markers MLC2 and the ventricular marker MLClv. MLC2 and MLClv showed overlapping 
expression in the explants in the region corresponding to the ventricle, while the region where 
MLC2 was expressed alone is presumed to correspond to the atria (fig. 3.2). The atrial specific 
marker ANF was not used in WMISH and RT-PCR analysis as it becomes atrial-specific 
marker only at stage 49 (Small and Krieg, 2000). We found that AC explants do not survive if 
cultivated until stage 49 and for this reason, and since there are no other suitable atrial markers 
available in Xenopus that we are aware of, we decided to use for RT-PCR and WMISH 
analysis pan-myocardial, ventricular and proepicardial markers. Expression of MLC2, 
MLClv, Irx4 and Tbx 18 in AC explants demonstrated that cardiac cell diversification has 
occurred (fig. 3.1). We have shown that GATA-4 mRNA injection is necessary but not 
sufficient to allow the AC cells to differentiate in diverse heart cell types. When GATA-4 
injected explants were dissociated and reaggregated and analysed at stage 39-40 they 
expressed MLC2 but not ventricular and proepicardial markers (fig. 3.4). Grunz and Tacke, 
showed that when uninjected explants were dissociated they lost cell-cell contacts and the
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intercellular signals which lead the cells to autonomous neuralisation, when kept dispersed in 
cultivation for up to 5 h (Grunz and Tacke, 1989). Importantly, the explant cells loose any 
embryonic pre-patteming (regional differences) previously established. It has been shown that 
cells in intact AC explants are not uniform but have a dorsoventral polarity. In fact, when the 
prospective dorsal and ventral regions of AC explants were dissected and treated with activin 
they differentiated into dorsoanterior and ventrolateral structures respectively (Sokol and 
Melton, 1991). This demonstrated that the capacity of the explants to express ventricular and 
proepicardial markers depends on GATA-4, but also on a pre-existing pattern in the explants. 
Thus, the lack of cardiac cell diversification in dissociated GATA4-injected AC explants 
results from the loss of cell-cell contact and the loss of embryonic pre-patterning. Similarly to 
GATA-4 reaggregated explants, heart field explants (HF) dissociated and reaggregated 
express MLC2 but lack of ventricular and proepicardial markers (fig. 3.5). The loss of cell-cell 
contact during neurula stage (stage 20) demonstrated that the cardiac cell diversification 
occurs later that this developmental stage. Intact HF cultivated until stage 39 express 
ventricular and proepicardial markers and when analysed in WMISH showed patterning of 
expression between MLC2 and M LClv (fig. 3.5 C-F).
3.3.2 Dkk-1 enhances cardiogenesis in AC explants
It has been shown that Dkk-1 is a Wnt/p-catenin antagonist (Semenov et al., 2001) and acts as 
head inducer via the anteriosation of the body structure during embryo development (Glinka et 
a l, 1998). When Dkk-1 is co-injected with GATA-4 mRNA it enhances cardiogenesis in AC 
explants (Latinkic et al., 2003). Co-injected AC explants showed the expression of pan-
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myocardial marker MLC2 and also the expression of ventricular markers MLClv and Irx4 
(fig. 3.3). Quantitative analysis (qRT-PCR, fig. 3.3 B) demonstrated that the co-injection of 
GATA-4 with Dkk-1 enhances the expression of MLC2, M LClv and Irx4 when compared 
with the expression of the same markers in GATA-4 injected explants. Thus, in AC explants 
Dkk-1 increases the expression of MLC2 that most likely accounts for the increase of MLClv. 
Moreover, we believe that the enhancement of M LClv can be also related with the capacity of 
Dkk-1 to anteriorise the body structure during embryos development (Glinka et al., 1998). 
During the heart tube stage the cell diversification has already occurred along the A-P axis and 
the ventricle cells are specified more anteriorly compared to the future posterior location in 
adult heart. We showed that M LClv is expressed at high levels in co-injected AC explants 
compared to Irx4 expression (fig. 3.3). This is related with the embryonic expression of Irx4 in 
the ventricle which is lower that M LClv (Garriock et a l ,  2001; Smith et al., 2005). GATA-4 
injected AC explants showed the expression of Tbx 18 which is a proepicardial marker (Jahr et 
al., 2008). The expression of Tbx 18 is a good indicator of cardiac cell diversification because 
it demonstrated that GATA4-injected AC explants are composed of myocardial and non- 
myocardial cardiac cells. It has been shown that cardiac progenitors positive for expression of 
Nkx 2.5 and Isl-1 contribute to the development of the proepicardium (Zhou et al., 2008). In 
fact, cells expressing the proepicardium marker Wt-1 (Perez-Pomares et al., 2009) are 
descendent from the cardiac precursors which express both Nkx 2.5 and Isl-1 (Zhou et al.,
2008). In AC explants co-injected with GATA4 and Dkk-1 the expression of Tbx 18 is absent 
(fig. 3.3), leading us to conclude that Dkk-1 expression in AC inhibits Tbx-18 during the 
development of the epicardium. The role of Dkk-1 in epicardium differentiation has been 
investigated in mutant mice null for Dkk-1 and Dkk-2 (Phillips et al., 2010). Inhibition of 
Dkk-1 generates a multilayered epicardium which is due to an over-specification of
100
3.0 Heart cell fate diversification
proepicardial cells rather that increased proliferation of the mature epicardium. Thus, it is 
believed that Wnt signalling plays a positive role in specifying the proepicardium (Phillips et 
al.).
3.3.3 Ventricular expression can be rescued in reaggregated explants
GATA-4 dissociated and reaggregated AC explants do not express ventricular markers as in 
intact AC explants. This expression however can be rescued by manipulating the explants with 
signalling pathways known to be involved in heart development. In particular, Dkk-1 showed 
the capacity to restore the ventricular gene expression in those reaggregates. GATA-4 and 
Dkk-1 co-injected reaggregates showed the expression of M LClv in contrast to GATA-4 
reaggregates. M LClv expression was also found in GATA-4 reaggregates combined with 
Dkk-1 AC (fig. 3.6). Therefore, we believe that the re-establishment of the ventricular gene 
expression in these reaggregates depends directly with the anterior signal provided by Dkk-1. 
Irx4 expression was found in GATA-4 reaggregates combined with Dkk-1 AC and also in 
GATA-4 reaggregates combined with Wnt-8 AC (fig. 3.6). We believe that the expression 
found in reaggregates combined with Dkk-1 is related to the ventricular expression, while the 
expression found in GATA-4 reaggregates combined with Wnt-8 AC is related with the 
expression of this marker in the head regions of the embryo (Garriock et al., 2001). Thus, we 
believe that XWnt-8 AC has neuralised GATA-4 reaggregates. This may also explain the low 
level of MLC2 expression found in the same reaggregates. Tbx 18 was not expressed in these 
samples. This is probably dependent on the direct negative effect of Dkk-1 on the epicardium 
specification (Phillips et a l). Similarly to Dkk-1 also BMP plays an important role during
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cardiogenesis. We have shown that inhibition of BMP via co-injection of tBr, mutant form of 
the type I BMP specific receptor which inhibits BMP signalling, with GATA-4 in reaggregates 
can restore the expression of M LClv, Irx4 and unlike Dkk-1, also Tbxl8 (fig. 3.7). During 
early Xenopus embryo development the inhibition of BMP-4 generates the conversion of the 
ventral mesoderm to the dorsal mesoderm (Graff et al., 1994). During gastrulation ventricular 
myocardial progenitor cells show a dorsal location along the embryonic dorsoventral axis 
(Keegan et al., 2004) corresponding with the level of FGF (Marques and Yelon, 2009). 
Inhibition of BMP and the conversion of ventral mesoderm to dorsal mesoderm (Graff et al., 
1994) may lead to an increase of ventricular cell fate in the reaggregated explants. As 
described in zebrafish, BMP regulates the cardiac chamber proportion (Marques and Yelon,
2009). Overexpression of BMP signalling generates ventralised embryos which displayed an 
enlarged atrium and an increased number of atrial cardiomyocites (Marques and Yelon, 2009). 
This evidence opens an opportunity to study the role of this signalling pathway in the 
regulation of the cell fate diversification during cardiac differentiation. In addition, Glinka and 
colleagues, showed that the inhibition of BMP and Wnt leads in whole embryos the induction 
of the head structure during gastrula stage in the endomesoderm (Glinka et al., 1997). We 
believe therefore that the inhibition of BMP may share the mechanism with Dkk-1 in inducing 
ventricular expression in reaggregated explants. Both Dkk-1 and tBr probably enhance 
anterior identity in the reaggregated GATA4-expressing explants, thereby specify ventricular 
cell fate. Co-injection of tBr and GATA-4 in reaggregates partially rescues the expression of 
the proepicardial marker Tbx 18 (fig. 3.7). Schlueter and colleagues, showed in chick that both 
BMP2 and BMP4, which are expressed in the sinus venus myocardium, may contribute to the 
recruitment of the LPM cells to the proepicardium cell lineage. When proepicardium explants 
were treated with BMP2 or BMP antagonist Noggin they both resulted in a loss of
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proepicardium markers Tbx 18, W tl and Cfc. Moreover, the same explants showed an 
upregulation of myocardial markers (Schlueter et al., 2006). In contrast to the results obtained 
in chick, recent evidence in zebrafish showed that BMP together with Tbx5 are essential for 
proepicardium specification (Liu and Stainier, 2010). Mutant zebrafish lacking of BMP4 had 
reduced level of Tbx 18 and tcf21 proepicardial markers. Moreover, BMP2 overexpression 
induced an ectopic overexpression of Tbx 18 but not tcf21 indicating that BMP signalling 
alone is not sufficient to completely commit cells to the proepicardial fate (Liu and Stainier,
2010). Recent evidence showed also that GATA-4 play an important role in proepicardial 
specification. In mice GATA-4 is highly expressed in the proepicardium and GATA-4 null 
mice lacked completely the proepicardium cells (Watt et al., 2004). Furthermore, evidence 
showed that GATA-4 acts as downstream target of BMP4 in lateral mesoderm (Rojas et al., 
2005). These results together with the results of Liu and Stainier are consistent with a model in 
which BMP4 regulates the proepicardium specification via the expression of GATA-4 
(Svensson). The results found in GATA-4 and tBr co-injected rearregates and AC explants 
(fig. 3.7) are more consistent with those found in zebrafish (Liu and Stainier, 2010). The low 
level of expression of Tbx 18 may be directly related with the inhibition of BMP signalling. 
However, we are not capable to explain the lack of Irx-4 expression in co-injected AC 
explants in which we expected the expression of this marker as inhibition of BMP causes 
dorsalised embryos (Graff et al., 1994). Further investigation is required to understand how 
Dkk-1 and BMP regulate cardiac cell fate diversification in these explants.
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3.3.4 Ventricular cell fate specification occurs after neurula stage
In parallel to AC explants assay we used also heart field (HF) precursors excised from whole 
embryos. HFs are very useful to understand how the cardiac cell diversification is established 
during heart development. HFs can be considered as morphogenic field for the capacity to 
grow a beating structure when excised from the embryo and cultivated until late 
developmental stages (Raffin et al., 2000). HFs in isolation expressed pan-myocardial marker 
MLC2, ventricular markers M LClv and Irx4 and also proepicardial marker Tbxl8 (fig. 3.5). 
Moreover, they beat but the heart tube shows an incomplete looping. In contrast, HFs 
dissociated and reaggregated at stage 21 and cultivated until stage 40 expressed MLC2 but 
lacked MLClv, Irx4 and Tbx 18 gene expression (fig. 3.5 A). Thus, they behave as GATA-4 
reaggregates which do not show ventricular and proepicardial cells diversification. The 
inducing activity to specify the cardiac precursor has occurred as the reaggregated HFs 
express MLC2 but the dissociation and reaggregation during neurula stage showed that the 
cell diversification has not yet been determined and occurs prior the beginning of the heart 
differentiation.
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4.0 Analysis of morphogenesis in explants transplanted into 
Xenopus host embryo
4.1 Introduction
In the previous chapter we have shown that in animal cap explants GATA-4 induces the 
expression of pan-myocardial gene MLC2, the ventricular markers M LClv and IRX4 and 
the proepicardial marker Tbx 18. This gene expression depends on the injection of the 
cardiac inducer GATA-4 and also on intact AC tissue integrity, possibly reflecting the 
requirement for pre-patteming in the explants. This confers to the caps the capacity to 
generate a simple structure which at late developmental stages is capable of beating. 
However, the beating activity is rare and is usually associated with morphologically non- 
distinct tissue.
To understand how rudimentary heart morphogenesis is established we required a reliable 
and simple assay. This was provided by modifying and combining two assays: 1) GATA4- 
injected animal caps (described in Ch. 3) and 2) secondary heart formation assay (Ariizumi 
et al., 2003). As described previously, when animal cap explants were dissociated, 
reaggregated and cultivated they express pan-myocardial marker MLC2 but completely 
lack ventricular marker expression. It is likely that the absence of ventricular and 
proepicardial markers is caused by the dissociation process which disrupts the cell-cell 
contact and the embryonic patterning previously established. Ariizumi and colleagues 
obtained a secondary heart inside a Xenopus host embryos using activin induced 
reaggregated animal caps. W hen transplanted in host embryos, reaggregated cells are able 
to generate a complex structure capable of beating (Ariizumi et al., 2003). We found that 
the use of GATA-4 injected reaggregates was more reliable that the use of reaggregates 
treated with activin. For this reason, we performed our experiments using GATA-4
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mRNA. We confirmed the ability to generate a secondary beating heart-like structure from 
GATA-4 reaggregates transplanted into Xenopus host embryos. The in vivo heart formation 
assay is a useful method of re-establishing the gene expression lost in cultivated 
reaggregate explants and is also a functional assay to study the emergence of basic heart 
morphogenesis, growth and physiology.
4.1.1 Chapter Aim
Using GATA-4 injected explants, we aimed to study:
1. The generation of a simple and reliable assay to study heart patterning and 
morphogenesis after cardiac specification.
2. The role of the host in the generation of a secondary heart-like structure.
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4.2 Results
4.2,1 GATA-4 injected reaggreagates generate a secondary beating heart 
when transplanted into a host embryo
Heart development involves a complex series of steps including specification of regionally 
restricted cell types, growth and looping which ultimately results in emergence of 
embryonic heart composed from two atria, one ventricle and OFT. Whilst the animal cap 
assay is powerful for the investigation of cardiac specification, in our experience it does 
not support more advanced steps of cardiogenesis. To study these, we have developed a 
heart formation assay (HFA). In the HFA, dissociated and reaggregated GATA-4 injected 
animal cap explants (instead of activin treated ACs used by Ariizumi et al., 2003) were 
transplanted into host embryos at stage 20 (Ariizumi et al., 2003). The transplants were 
performed as described in the methods by making a small incision in the ventral side the 
host where the reaggregate was placed. The use of CAG-GFP transgenic reaggregates and 
host embryos facilitated the detection of cardiac induction and morphogenesis in the same 
transplants.
46% of the reaggregates transplanted into host embryos showed beating activity when 
analysed at stage 40 (fig. 4.1; movie 1). Co-injection of GATA-4 with Rhodamine- and 
Biotin-dextran helped to confirm the presence of the reaggregate inside the host embryo 
(fig. 4.1 D). When transplants were carried out using uninjected reaggregates (fig. 4.1 H-I) 
or reaggregates not treated with dexamethasone (fig. 4.1 J-K) no cardiac induction or 
beating activity were detected in the transplants.
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Figure 4.1 46% of GATA-4 injected reaggregates beat when transplanted in host embryos.
(A-G) 46% of regaggregates transplanted in host embryos (arrows) showed beating activity in 
(n=220) when analysed at stage 40. (D) Co-injection with lineage tracer helped to locate the 
reaggregate inside the host during fluorescent microscope analysis (arrows). (H-I) Reaggregates not 
treated with Dexam etasone (arrows) or (J-K) not injected with GATA-4 mRNA (arrows) did not 
show any GFP or beating activity.
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4.2.1.1 Patterning analysis of the secondary heart
A useful method to detect ventricle-restricted gene expression in reaggregates involves the 
use of transgenic embryos containing the M LClv-GFP reporter gene (Smith et al., 2005). 
Reaggregates (M LClv-GFP) transplanted at stage 20 into the host embryos at the same 
stage were positive for GFP expression and showed beating activity when analysed at stage 
40 (fig. 4.2). We investigated then the regional distribution of gene expression within the 
transplanted reaggregates using WMISH analysis. Double-WMISH was performed in 
transplants at developmental stage 42 for the expression of the pan-myocardial marker 
MLC2 and the ventricular marker M LC lv (fig. 4.3 A-D). The region of overlapping 
expression between MLC2 and M L C lv correspond to the ventricle region while the region 
positive to MLC2 expression alone correspond to the atria (fig. 4.3 A l-C l). 48% of the 
reaggregates showed distinct ventricle and atria gene expression (fig. 4.3 A l-C l). 17% of 
reaggregates show only an overlapping expression and 30% of reaggregates exclusively 
show the expression of MLC2 only suggesting that in those cases incomplete or aberrant 
development occurred. Reaggregates which showed both clear atrial and ventricle regional 
gene expression did not show any evidence of alignment with the anterior-posterior (A-P) 
gene expression patterning of those gene in the heart of the host embryos (fig 4.3 A-C). 
This result suggests that ventricular and atrial cell fates are not specified by a mechanism 
that is directly related to A-P axis of the embryo.
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Figure 4.2 GATA-4 reaggregates express M L C lv when transplanted in host embryos. (A-E) M LClv-GFP transgenic reaggregates (arrows) were 
previously injected with GATA-4 and transplanted into M LC lv transgenic hosts at stage 20. Reaggregates analysed at stage 40 were positive for GFP 
expression and showed beating activity.
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Figure 4.3 48% of transplanted reaggregates show distinct atrial and ventricular gene expression. (A-C) Transplants were analysed using WMISH 
for the expression of MLC2 and M LClv at developm enta l stage 40. (A l-C l)  Reaggregates show overlapping expression of MLC2 and M LC lv (48% 
n=45) (arrow) in the region corresponding to the ventricle and MLC2 expression alone (head arrow) in the atrial region. (D) Double WMISH in heart 
shows the overlapping expression between M LClv and MLC2 in the ventricle and expression of MLC2 alone in the atria. M LC lv is also expressed in the 
jaw  muscle, ih; interhyoid muscles of the jaw; r; reaggregate, v; ventricle.
I l l
4.0 Transplanted explants morphogenesis
Our analysis of patterning in the secondary heart was extended by WMISH for the 
expression of the proepicardial marker Tbxl8  (fig. 4.4 F). 25 % of the reaggregates 
analysed using double WMISH (fig. 4.4; n=30) showed an apparent overlapping 
expression between MLC2 and T bxl8  (fig 4.4 A2) while 40% of the reaggregates showed 
distinct regions of expression between MLC2 and Tbxl8 (fig. 4.4 B l). The transplants 
therefore developed a completed structure composed of myocardial and non-myocardial 
cells which express a distinct regional gene distribution capable to proceed toward the 
physiological step of beating.
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Figure 4.4 Transplanted reaggregates show the expression of proepicardial marker T bxl8. (A-B) Reaggregates transplanted at stage 20 in host 
embryos at the same stage were analysed by WMISH at stage 40 for the expression of MLC2 and Tbx 18 (n=30). (A l) The host heart express Tbx 18 in the 
proepicardium and MLC2 in the heart (arrows). (A2) 25% of the reaggregates show an apparent overlapping expression between MLC2 and Tbx 18 
(arrow). (B l) 40% of the reaggregates show distinct expression between MLC2 (head arrow) and Tbx 18 (arrow). (C) T bx-18 is proepicardial marker and is 
localised in the right sinus horn of the heart and it does not have overlapping expression in the heart when is co-analysed with the pan-myocardial marker 
MLC2.a; atrium, pe; proepicardium, r; reaggregate, v; ventricle.
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4.2.1.2 Morphogenic analysis of the secondary heart
Transgenic embryos usage has been very helpful in the detection of cardiac induction in 
reaggregates and also in the classification of the structure of the beating reaggregates. 
However, better characterisation o f the morphogenesis in the SH required a method 
capable of higher resolution and this was provided by confocal microscopy. Reaggregates 
transplanted at stage 20 into host embryos at the same stage were analysed by whole mount 
immunohystochemestry at stage 42 using a monoclonal antibody raised against cardiac 
troponin T (Ch-1) (Kolker et al., 2000). The reaggregates (n=43) were excised from the 
host embryos and analysed by confocal microscopy. Confocal analysis showed two 
different types of morphogenesis. The first, a tubular structure (34% of reaggregates) in 
which the degree of morphogenesis indicates a shape bearing a degree of similarity to the 
heart (fig. 4.5 A). The second type of reaggregates showed (65%) no obvious sign of 
morphogenesis (fig. 4.5 B-D). Transplanted reaggregates had an apparent synchronised 
beating activity in which the cells generated a wave. However, beating activity observed in 
the transplants was not documented using physiological methods.
Taken together these results demonstrate the possibility of obtaining a SH from a group of 
cells previously injected with GATA-4 mRNA. The SH have distinct cell diversification 
with regional expression of ventricular and proepicardial markers and beating activity. 
These findings therefore raised the question of the nature of the host-transplant interactions 
that are required for SH development.
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Figure 4.5 Reaggregates show the developm ent o f different types of m orphogenesis. (A-F) 
Reaggregates transplanted at stage 20 into host at the same stage were analysed by IMHC. 
Reaggregates show different degrees of morphogenesis which include (A) a simple tubular 
structure or (B-F) rudimental group of cell without any significance morphogenesis. The scale bar 
corresponds to 100pm.
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4.2.2 Secondary heart development is lost in UV treated hosts
To further our understanding of SH formation we altered the nature of the transplant-host 
interactions using UV treatment of host embryos.
UV-treated embryos lack the dorsoventral axis because the exposure to the UV irradiation 
disrupts microtubule movement and the migration of the dorsal determinants. Therefore, 
the embryos are completely ventralised. Embryos transgenic for the CAG-GFP reporter 
were exposed to the UV-light for 30 seconds (Sive et al., 2000) and used as hosts for 
transplantation at stage 20 with GATA-4 injected reaggregates (CAG-GFP) at the same 
stage (fig. 4.6 C). Reaggregates transplanted into UV-treated host showed the existence of 
cardiac induction when analysed at stage 35 (fig. 4.6 D-E). This was confirmed using 
WMISH analysis for the expression of MLC2 showing that cardiac induction triggered by 
GATA-4 injection was not affected by UV-ventralisation of the host (fig. 4.6 G-I as 
indicated by the arrows). Significantly, reaggregates transplanted into UV-treated hosts did 
not show beating activity and also failed to express ventricular marker M L C lv when 
analysed at stage 39 using double W M ISH for the expression of MLC2 and M LC lv (fig. 
4.7 F-G).
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Figure 4.6 Cardiac induction is m aintained in reaggregates transplanted into UV-treated  
host. (A-B) Reaggregates transplanted at stage 20 (arrows) into hosts at the same stage were 
positive for GFP expression when analysed at stage 35. (C-E) Reaggregates (CAG-GFP) (arrows) 
were transplanted at stage 20 into UV-treated host at the same stage. GFP expression analysis 
confirmed cardiac induction. (F-Fl) Control transplants at stage 35 were analysed by WMISH for 
the expression of MLC2 (arrow). (G-I) Reaggregates transplanted into UV-treated hosts (50% 
n=30) showed the expression of MLC2 (arrows) by WMISH analysis, h; heart, r; reaggregate.
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Figure 4.7 M L C lv  expression is lost in reaggregates transplanted into a UV-treated host. (A-
B) Reaggregates (CAG-GFP) transplanted at stage 20 into hosts at the same stage were positive for 
GFP expression (arrows) when analysed at stage 39. (C-D) Reaggregates (CAG-GFP) transplanted 
at stage 20 into UV-treated host at the same stage were positive for GFP expression when analysed 
at stage 39 (arrows). (E-El) Control transplants analysed by WMISH showed overlapping regions 
between MLC2 and M LC lv (arrow) and regions positive for M LC2 only (head arrow). (F-G) 
Reaggregates transplanted into UV-treated host (35% n=65) showed the expression of M LC2 only 
when analysed by double WMISH. ih; interhyoid muscles of the jaw; r; reaggregate, v; ventricle. 
Anterior (A)-posterior (P) axis is indicated.
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In addition, UV-treated hosts also failed to support the growth of the reaggregates. UV- 
treated transplants and control transplants were analysed using fluorescent microscopy for 
the expression of cardiac actin gene. The 2D analysis suggests that reaggregates 
transplanted into ventralised UV-hosts (80% n=40) were 40% smaller with respect to 
reaggregates transplanted into control hosts (fig. 4.8 A l-B l).
These results demonstrate that secondary heart formation (beating, restricted gene 
expression and growth) requires the host embryonic axes (A-P, D-V). This requirement is 
unlikely to be direct or instructive because SH polarity is independent from A-P host axis 
and in addition a wide range of host locations support SH formation (section 4.2.3). For 
these reasons it is more likely that the signal from the host is permissive for the formation 
of SH.
119
4.0 Transplanted explants morphogenesis
Control transplant St. 39 UV-treated 
transplant St. 39
Figure 4.8 UV-treated host does not support the grow th of the reaggregate. (A) Control 
transplants (n=40) and (B) UV-treated transplants (n=40) were analysed at stage 39 by the 
fluorescent microscope. Reaggregates (CAG-GFP) were positive for GFP expression. (A l-B l) The 
2D analysis showed that UV-treated host embryos (80%) does not support the growth of the 
transplanted reaggregate which has a smaller size when compared with reaggregate transplanted 
into control host embryo. The bar corresponds to 100pm.
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4.2,3 A wide range o f  permissive regions in the host supports secondary 
heart formation
Previous results demonstrate the ability to generate a SH from a group of GATA-4 injected 
reaggregates transplanted into host embryos. As the generation of a functional SH depends 
on the host, we wanted to identify the region or regions in the host capable of supporting 
the development of a SH. Reaggregates (CAG-GFP) injected with GATA-4 mRNA were 
transplanted at stage 20 in different locations of the host (CAG-GFP) at the same stage 
(fig. 4.9 A). 51% of reaggregates transplanted in the head region of the hosts (n=20) 
showed cardiac induction but not any beating activity (fig. 4.9 B-C). Transplants in the 
ventral, lateral and caudal region of the host showed cardiac induction and beating activity 
(fig. 4.9 D-F) similarly to reaggregates transplanted in the ventral region of the host (fig. 
4.1).
GATA-4 injected (CAG-GFP) transplants in the dorsal side of the host lacked cardiac 
induction when analysed at stage 37 (100% n=20) with respect to control transplants at the 
same stage (fig. 4.10 C-D and A-B). W hen the same transplants were analysed at stage 42 
they showed cardiac induction (50% n=20) but did not show any beating activity (4.10 E- 
F). Transplants were also analysed using double WMISH for the expression of MLC2 and 
M LClv (fig 4.10 G-Gl). The heart of the host showed an overlapping expression in the 
ventricle region given by the expression of both the markers (fig. 4.10 G). However, 20% 
of reaggregates in the dorsal region (n=94) express MLC2 and a small region of 
overlapping expression between MLC2 and M LC lv (fig. 4.10 G l) in contrast to 
expression pattern found in control reaggregates.
Delay in the expression of GFP in reaggregates transplanted into the dorsal region of the 
host may be influenced by Wnt/p-catenin signal which is known to be a negative regulator 
of cardiogenesis (Tzahor and Lassar, 2001). A simple way to verify this hypothesis
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involves the use of the Wnt- (3 catenin pathway inhibitor Dkk-1. Reaggregates (CAG-GFP) 
co-injected with GATA-4 and Dkk-1 mRNA were transplanted at stage 20 in the dorsal 
side of host (CAG-GFP) at the same stage (fig. 4.11 C-D) and in the ventral side o f the 
host as control transplants (fig. 4.11 A-B). W hen dorsal transplants were analysed at stage 
37 cardiac induction was found (90% n=20) as indicated by the expression of GFP (fig. 
4.11 C-D). Transplants were also analysed by double WMISH at stage 40 for the 
expression of MLC2 and M LC lv (fig. 4.11 G -G l). 35% of reaggregates transplanted in the 
dorsal region of the host (n=-84) showed regional gene expression distribution which 
included a region of overlapping expression between MLC2 and M LC lv and a region 
positive to MLC2 only (fig. 4.11 G l). Reaggregates co-injected with GATA-4 and Dkk-1 
or injected with GATA-4 alone did not show any beating activity when transplanted in the 
dorsal side of the host embryos as in the case of reaggregates transplanted in the head of 
the host embryos (fig. 4.9). These regions in the host allow cardiac gene expression but are 
not permissive to the development of a secondary beating structure.
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Reaggregates at St. 20 transplanted  in host a t St. 20
-► A
Figure 4.9 Secondary heart develops in a broad range of regions in the host. (A) Reaggregates 
at stage 20 were transplanted into host em bryos at the same stage in a num ber o f different regions 
rostrally, ventrally, laterally, caudally and dorsally, as indicated by the number. (B-C) 51% of 
reaggregates (CAG-GFP, n=20) (arrows) showed cardiac induction when transplanted into the head 
of the hosts but lost the ability to beat. (D-G) Reaggregates transplanted in the ventral region, 
lateral region or caudal region o f the host were positive for GFP and showed beating activity 
(arrows).
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C ontrol transplant St. 37 C ontrol transplant St. 37
Dorsal transplant St. 37
▼
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D orsal transplant St. 37
wm'P?'
R eaggregatc transplanted dorsally St. 40
100(im
Figure 4.10 Delay in cardiac induction response in GATA-4 reaggregates transplanted close
to the neural tube. (A-B) CA G-G FP reaggregates transplanted at stage 20 into hosts at the same 
stage (control transplant) were positive for GFP expression when analysed at stage 37 (arrows). (C- 
D) Reaggregates (CAG-GFP) were transplanted at stage 20 into the neural tube of hosts at the same 
stage (dorsal transplants). They did not show GFP activity (100%  n=20) when analysed at stage 37 
(arrows) but (E-F) showed cardiac gene expression when analysed at stage 40 (50% n=20; arrows). 
(G -G l) Gene expression was also confirm ed by W M ISH analysis for MLC2 and M LC1\ 
expression. 20% of reaggregates (n=94) expressed M LC2 (head arrow) and only a small region of 
cells displayed an overlapping expression between MLC2 and M L C 1 v (arrow). Dorsal transplants 
did not show any beating activity, a; atria, ih; interhyoid m uscles o f the jaw ; r; reaggregate, v; 
ventricle.
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D orsal transp lant St. 40 D orsal transplant St. 40
ited dorsaily St. 40
Figure 4.11 Co-injection with Dkk-1 prevents cardiac induction delay in neural tube 
transplant. (A-B) Reaggreagates (CAG-GFP) transplanted at stage 20 into hosts at the same stage 
showed cardiac gene expression when analysed at stage 37 (arrows) (C-D) Reaggregates (CAG- 
GFP) transplanted at stage 20 close into the neural tube in host at the same stage (dorsal 
transplants) showed GFP activity when analysed at stage 37 (90% n=20; arrows) and (E-F) when 
analysed at stage 40 (90% n=20; arrows). (G -G l) Gene expression was also confirmed by W M ISH 
analysis for M LC2 and M LClv expression. 35% o f reaggregates (n=84) showed overlapping 
expression between MLC2 and M L C lv  (arrow) and a region positive to MLC2 alone (head arrow). 
Dorsal transplants did not show any beating activity, a; atria, ih; interhyoid muscles o f the jaw ; r; 
reaggregate, v; ventricle. Anterior (A)-posterior (P) and left (L)-right (R) axes are indicated.
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4.2.4 Competence to generate a beating secondary heart is lost by stage 28
Reaggregates at stage 20 showed the capacity to generate a SH when transplanted into host 
embryos at the same stage (46% of reaggregates showed beating activity n=220; fig. 4.1). 
We wanted to investigate if the reaggregates maintain the ability to generate a SH when 
transplanted at different developmental stage in host embryos at stage 20. For this reason a 
series of different transplants were performed using reaggregates at stage 13, 24, 26 and 28 
(fig. 4.12 A). Reaggregates (CAG-GFP) transplanted at stage 13, 24 and 26 and analysed 
by fluorescent microscope at stage 40 were positive for GFP expression (fig. 4.12 C-E). 
The same set of transplants also showed beating activity (fig. 4.12 B). When reaggregates 
at stage 28 where transplanted into hosts at stage 20 and analysed at stage 40 they 
displayed weak cardiac induction and no beating activity (fig. 4.12 I-J). Moreover, those 
reaggregates had a different morphology when compared to the other transplants. The 
reaggregates had not developed a compacted structure but showed a layer of cells (some of 
them positive to cardiac markers) with clear cell migration into the host embryo (fig. 4.12
I-J).
Competence of reaggregates to generate a secondary heart occurs before stage 20 and is 
maintained until stage 26. The competence to generate a secondary structure in 
reaggregates transplanted at stage 24 and 26 is lower with respect to reaggregates 
transplanted at stage 13 and stage 20 (fig. 4.12 B). Therefore the competence is directly 
related with the developmental stage and is lost by stage 28 (fig. 4.12 B and I-J).
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Reaggregates transplanted at St. 13 Reaggregates transplanted at St. 24
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Transplants in host at St. 20
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Proportion of beating SH of a 
total num ber of transplanted reapsregates
Rcaggregates transplanted at St. 26 Reaggregates transplanted at St. 28
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Figure 4.12 Competence to generate beating structure is maintained until St. 26 in reaggregates. (A) Reaggregates were transplanted at different 
developmental stages into host at stage 20. (C-E) Competence to generate a beating SH is maintained in reaggregates transplanted at stage 13, 24 and 26 but is 
lost at stage 28. Reaggregates (CAG-GFP) were positive for GFP expression in all transplant experiments (arrows). (B) Summary of frenquency with which 
the SH were positive to the GFP expression and showed beating activity. Capacity to generate a beating structure declines with the increasing age of the 
reaggregates. R; reaggregate, H; host.
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4,2,5 There is no cellular contribution from  the host in the generation o f  the 
secondary heart
In order to understand if the secondary heart is generated exclusively from the transplanted 
cells, or, if the host has cellular contribution we transplanted GATA-4 injected reaggregates at 
stage 20 into host embryos at the same stage. The hosts were uniformly injected with 
Rhodamine-dextran lineage tracer (fig. 4.13 A). This experimental design allowed any red 
host cell to be detected in dark reaggregate under the fluorescent microscopy using a DSR 
filter. Transplanted host embryos were analysed at stage 40. The 2D analysis performed 
showed that no host cells were found in the reaggregates (fig. 4.13 B-E). However, we can not 
exclude that there is cell contribution of the host in the regions of the reaggregates which were 
not visible in the surface of the host (fig. 4 .1 3 B 1 ,C 1 ,D 1  and E l; n=20). No further analysis 
has been carried out in order to obtain confirmatory results but from this preliminary finding 
it seems that the host influences the reaggregate to generate a SH non-cell-autonomously.
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Figure 4.13 The reaggregate develops a secondary structure without any apparent cell contr hution from the host. (A) CAG reaggregates were 
transplanted into host embryos previously injected with lineage tracer at stage 20 and analysed at stage 40. (B-E) Reaggregates generate SH without host 
cells contribution (arrows).
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4.3 Discussion
4.3.1 Reaggregate generates a secondary heart-like structure when 
transplanted into host embryo
Heart formation assay involves the transplantation of GATA-4 injected reaggregate at 
stage 20 into host embryo at the same stage. This assay is a modification of the assay 
described by Ariizumi and colleagues, in which dissociated and reaggregated cells were 
treated with activin and transplanted into host embryo at stage 20 (Ariizumi et al., 2003). It 
has already been showed that activin is a mesoderm inducer (Asashima et a l , 1990; Green 
et a l ,  1990; Smith et a l ,  1990) and that its inducing activity is dose-dependent (Ariizumi 
et a l ,  1991; Green et a l ,  1992; Okabayashi and Asashima, 2003). Reaggregates treated 
with activin and transplanted into host embryos develop a beating structure with properties 
similar to a normal heart. Ariizumi and colleagues examined the histological section of the 
secondary heart showing that it can be divided into two chambers (atrium and ventricle) 
based on the thickness o f the myocardium (Ariizumi et a l ,  2003). In our experiments we 
showed that it is possible to generate a secondary heart (SH) using GATA-4 injected 
reaggregate explants. We have found that the use of GATA-4 generate a reliable assay in 
which 46% of the transplanted host embryos displayed beating SH (fig. 4.1). Moreover, 
using W MISH analysis for the expression of MLC2 and M LClv we demonstrated that the 
SH showed a patterning of expression in which the cardiac markers are regionally 
distributed in the transplant (fig. 4.3). The SH also expressed proepicardial marker Tbx 18 
demonstrating that a further heart cell diversification has occurred (fig. 4.4). The gene 
expression patterning relative to the position of M LClv and Tbx 18 cells in reaggregates 
did not show alignment with the A-P expression patterning of the same genes in the heart 
of the host embryos. Thus, GATA-4-injected reaggregates transplanted into the host
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embryos express pan-myocardial marker MLC2 and show a distinct cell diversification 
with the expression of myocardial and non-myocardial genes.
4.3.2 Host embryo is the key regulator o f  the SH development
Experiments performed using transplanted reaggregates demonstrated that host embryos 
are fundamental during the development of the SH. W e showed that host embryos provide 
broad permissive regions, ventrolateral and caudal, where the beating SH can develop (fig. 
4.9). When the reaggregates were transplanted in the head region of the hosts they were 
positive for cardiac actin gene expression but they did not show any beating activity. It has 
been suggested that GATA-4 induces the development of cardiac ectopic tissue in the head 
region without disruption of the heart development (Jiang and Evans, 1996). We believe 
that, as in the case of ectopic cardiac tissue development, the head region allows the 
reaggregates to express cardiac gene but does not support the development of beating 
structure (fig. 4.9). The systematic exploration of permissive regions into the host embryo 
directed us to transplant GATA-4 reaggregates into the dorsal region of the host. When 
GATA-4 reaggregates were analysed at stage 37 they showed a delay in expressing cardiac 
markers with respect to reaggregates transplanted in the ventral region of the host at the 
same developmental stage. The reaggregates transplanted in the dorsal region showed 
cardiac gene expression only later than stage 39 and did not show any beating activity. 
Moreover, W M ISH analysis showed low degree of cardiac cell diversification. 20% of 
reaggregates showed a small number of cells with overlapping expression between MLC2 
and M L C lv (fig. 4.10). We believe that the delay to respond to the inductive signal 
depends from the inhibitory activity of Wnt pathway. Dorsal region is regulated by the 
expression of W nt signal which it has been shown to acting as repressor of cardiogenesis in
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the chick neural tube (Tzahor and Lassar, 2001). In frogs, Samuel and Latinkic, showed 
that activation of Wnt/p-catenin pathway during gastrulation has no effect on 
cardiogenesis, while the same pathway blocks cardiogenesis during a period after cardiac 
specification and the onset of cardiac differentiation (Samuel and Latinkic, 2009). 
However, they did not examine cardiac gene expression after stage 34 in explants with 
elevated Wnt signalling. This evidence is comparable with our finding in which Wnt/p- 
catenin pathway suppresses the cardiac inducing activity of GATA-4 reaggregates 
transplanted at stage 20 into dorsal side of the host embryos. However, we found difficult 
to explain the cardiac gene expression showed in the reaggregates analysed at stage 40. 
Gessert and Kuhl reviewed that during the different steps of cardiogenesis exists a 
condition in which there are high or low levels of Wnt/p-catenin signalling. In particular, 
the cardiac terminal differentiation is regulated by low levels of Wnt/p-catenin signal and 
high level of non-canonical W nt signal in which W nt-11 is the prime candidate (Gessert 
and Kuhl, 2010). W e believe that W nt-11 may be one candidate which allows the cardiac 
gene expression in reaggregates transplanted in the dorsal side at stage 40. Concordant to 
our finding, it has been showed in Xenopus that W n tllr , homolog to W n tll ,  is highly 
expressed in the neural tube from stage 17 and is required for the neural crest cell 
migration (Matthews et al., 2008). In order to verify if  Wnt/p-catenin signal is involved in 
the regulation of cardiac diversification in reaggregates transplanted into the dorsal side of 
host embryos we decide to use the Wnt/p-catenin antagonist Dkk-1. It has been shown that 
Dkk-1 is capable to enhance cardiac induction in the noncardiogenic ventral marginal zone 
by inhibiting the W nt signalling pathway, in particular Wnt3a and Wnt8 (Schneider and 
Mercola, 2001). During embryo development, Dkk-1 is expressed in the Spemann’s 
organiser and cardiogenesis begins in the immediately adjacent mesoderm where there is a 
low level o f W nt-3a and Wnt-8 (Schneider and Mercola, 2001). For this reason, we
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decided to co-inject reaggregates with GATA-4 and Dkk-1, and transplant them in the 
dorsal region of the host embryo. In contrast to the result found with GATA-4 
reaggregates, co-injected reaggregates showed cardiac gene expression from stage 37 as in 
control transplants. Moreover, 35% of the reaggregates showed a pattern of gene 
expression in which MLC2 overlapped with the expression of M LC lv (fig 4.11). Thus, we 
believe that Dkk-1, as well as W nt 11 in GATA-4 reaggregates, may promote cardiac 
differentiation protecting the reaggregates from the inhibitory activity of Wnt pathway. 
The co-injected reaggregates transplanted in the dorsal region however, did not show any 
beating activity (fig. 4.11). These transplanted reaggregates act as the reaggregates 
transplanted in the head region of the host embryos. In both of the experiments 
reaggregates expressed cardiac markers but did not show beating activity. We believe that 
the signals involved in the growth and beating activity are regionally restricted and are not 
present in the dorsal side of the host embryo.
4.3.3 Embryonic axes o f  the host are important to the secondary heart 
development
WMISH analysis in the reaggregates transplanted into host embryos showed that gene 
expression patterning has been established via the regional expression of MLC2 and 
M LClv or Tbxl8. The regional expression of MLC2 and M LC lv or T bxl8  in reaggregates 
is not aligned with the A-P gene expression of the same gene in the heart of the host 
embryos. Despite this evidence we believe that the mechanism by which the host 
influences the SH development involves also the presence of embryonic axes. Transplants 
placed in ventralised UV-treated host express pan-myocardial marker MLC2 (fig. 4.6) but 
not ventricular marker M LC lv (fig. 4.7). MLC2 expression is directly related to the
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injection of GATA-4 but cardiac cell diversification observed in the control transplants is 
dependent on the action of the host. Thus, reaggregates transplanted into ventralised UV- 
treated hosts act as GATA-4 reaggregates in isolation which express MLC2 but lack 
ventricular and proepicardial gene expression (fig. 3.4). The lack of cell diversification in 
the reaggregates is correlated with the lack of proper signalling from the host. The 
asymmetric structure of the heart develops under the influence of the three body axis (D-V, 
A-P and L-R) which confer the polarity to the heart structure (Brand, 2003). Thus, we 
believe that the embryonic axes are not directly instructive because the SH (transplanted 
into the ventral side of the host) showed a gene expression polarity independent from the 
A-P body axis, but provide signals that are permissive to the formation of the SH. 
Moreover, we believe that the host contribute also to the growth of the reaggregate. We 
compared the size of reaggregates transplanted into UV-treated hosts to the size of 
reaggregates transplanted in control hosts. The fluorescent microscopy analysis confirmed 
that reaggreates transplanted into UV-treated host was 40% smaller when compared to 
reaggregates transplanted into the control host (fig. 4.8). The microscopy analysis, 
however, requires further elucidation. The reaggregates were verified only in 2D analysis 
because they were not excised from the host embryos. Thus, we do not know the real 
dimensional structure o f the reaggregates transplanted into the control and UV-host 
embryos. However, WMISH analysis confirmed the analysis performed using fluorescent 
microscopy. Reaggregate transplanted UV-treated host showed a small number of cell 
positive for MLC2 expression (fig. 4.7), while the control reaggregates showed in the host 
surface a wide number of cell positive for MLC2 and for the overlapping expression 
between MLC2 and M L C lv (fig. 4.7). This validates the hypothesis that UV-treated hosts 
do not support the cell diversification and growth of the reaggregates.
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4.3.4 Capacity to generate a SH is lost by stage 28
The capacity o f the reaggregates to develop a SH is extended after the end of gastrulation 
to the postneurula stages (fig. 4.12). However, it decreases at the beginning of the cardiac 
differentiation and it is lost just before the heart tube stage (fig. 4.12). Heart forming 
potency of the reaggregates to generate a SH is present until stage 26 and is completely lost 
at stage 28. The reaggregates transplanted at stage 28 did not beat when analysed at stage 
40, and the structure was not as compact as reaggregates transplanted at different 
developmental stages with evidence o f extensive cell migration into the host embryo (fig. 
4.12 F). We believe that reaggregates have responded initially to the inductive signal of 
GATA-4 to express cardiac genes but with the increasing age they are not capable to 
respond to the signal provided by the hosts. Sater and Jacobson have shown that the heart 
field is composed at post neurula stage of lateral and ventral mesoderm (Sater and 
Jacobson, 1990a). However, they have shown that the lateral mesoderm lost the capacity to 
generate the heart at stage 28 in a process called heart field restriction. When they 
combined the lateral mesoderm at stage 28 to the anterior lateral endoderm at stage 20 they 
discovered that the anterior endoderm inducing activity was not sufficient to restore the 
heart forming potency in the lateral mesoderm. In contrast, the control performed with the 
lateral mesoderm at stage 20 and the anterior endoderm at the same stage formed a beating 
heart. Thus, the reaggregates transplanted at stage 28, as the lateral mesoderm, have lost 
the heart-forming potency even under the influence of a potent signal source as the host or 
the anterior endoderm respectively. For this reason we believe that the reaggregates have 
lost the heart forming capacity before the transplantation occurred. In the future it will be 
interesting to analyse if  the capacity to generate the SH is also related with the age of the 
host. For this reason we aim to transplant reaggregates at stage 20 in host at different 
developmental stages.
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5.0 Requirement for signalling in the heart development after 
cardiac specification
5.1 Introduction
In previous work we described that GATA-4 injected reaggregates are capable of generating a 
secondary beating heart (SH) when transplanted into host embryos. The host plays an essential 
role in the SH development. We demonstrated that a wide range of permissive regions into the 
host allow the reaggregates to generate a SH. However, the host cells do not become a part of 
the SH (fig. 4.13) suggesting that the role of the host is to provide signals to allow the 
development of the SH. Since our results point to cell-cell communication between the host 
and the reaggregate as being very important in the SH development, we turned our attention to 
identification of the key signalling pathways that mediate these interactions. Little is known 
about the pathways involved in chamber specification and morphogenesis in Xenopus. For this 
reason we relied on the work performed in other vertebrate models and in particular zebrafish. 
It has been shown that FGF signalling is involved in the establishment of the size and the 
proportion of the zebrafish ventricle chamber (Marques et a l, 2008; Reifers et al., 2000). 
Moreover, evidence in mouse and chick supports the idea that FGF is also involved in heart 
looping along the L-R axis (Boettger et a l , 1999; Meyers and Martin, 1999). Similarly, it has 
been shown that Nodal plays an important role in the L-R asymmetry establishment of the 
heart in zebrafish. In particular evidence in zebrafish shows an involvement of Nodal during 
the heart looping movements (Baker et a l,  2008). We have investigated the role of these 
signalling pathways in Xenopus embryos after cardiac specification and compared the results
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obtained to the findings in other vertebrate models. These preliminary experiments are 
essential to understand the involvement of specific signal pathways during cardiac chamber 
formation. Moreover, they direct us to understand which signals are provided from the host to 
the reaggregates and how they are important in the development of the beating SH.
5.1.1 Chapter Aim
Using specific inhibitors of signalling pathways in Xenopus whole embryos, we aimed to:
1. Investigate the phenotypes obtained in the heart by inhibition of signalling pathways 
after cardiac specification.
2. Determine the time of action of these pathways during the main steps of cardiac 
morphogenesis.
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5.2 Results
5.2.1 FGF signal is involved in heart looping and chamber growth during 
cardiac differentiation
To investigate the role of FGF, we treated Xenopus embryos with SU5402 after cardiac 
specification. SU5402 is a potent inhibitor of FGFR1 tyrosine kinase activity preventing the 
autophoshorylation of the intracellular domain, which occurs upon the binding of the receptor 
with FGF molecules. SU5402 is composed of an oxindole core which occupies the binding 
site of the ATP preventing the nucleotide binding (Mohammadi et a l, 1997).
Embryos were treated with SU5402 in three different time intervals starting from stage 20 (fig.
5.1 A). Embryos were then collected at stage 39-40 to be analysed by WMISH for the 
expression of MLC2 and M LClv. Phenotypes obtained in the heart of treated embryos were 
classified as Al and A2. 75% of the embryos treated from stage 22 to 30 (n= 20) showed 
completed looping and the ventricle partially located on the left side of the body. Of these, the 
jaw muscles fused in the midline (50%) or were partially fused (fig 5.1 D2 and D4, Al; table
5.1). 25% of the embryos showed the ventricle completely located on the left side of the body 
(fig. 5.1 D3, A2; table 5.1). 50% of the embryos treated from stage 22 to 39 (n=22) showed a 
small ventricle with respect to control embryos, a fusion of the jaw muscles and a visible short 
body trunk (fig. 5.1 E2-E3, A l; table 5.1). The rest of the embryos (50%) showed ventricle 
anteriorisation and fusion of the jaw muscles (fig. 5.1 E4, A2, table 5.1). In both treatments the 
hearts showed defects in looping. In the last treatment performed (stage 30-39, n=21) embryos 
displayed defects in the ventricle location. In particular, 50% of the hearts showed a partial 
looping and the ventricle located anteriorly to fuse with the jaw muscle (fig. 5.1 F3, A2; table
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5.1). The rest of the embryos showed completed looping with visible ventricle anteriorisation 
and fusion with the jaw muscle (fig. 5.1 F2 and F4, A l; table 5.1).
These experiments were informative in highlighting the later roles of FGF in heart formation. 
Inhibition of FGF between stage 20 and 39 causes two phenotypes:
1. Reduction of the ventricle size (fig. 5.1 E2-E3 Al; table 5.1)
2. Looping defects and the ventricle located on the left side of the embryo (fig. 5.1 D3 
A2; table 5.1).
These results focused our attention on a short range of developmental stages which include 
stages 20 to 26.
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Figure 5.1 FGF pathway is involved in heart looping and chamber size growth. (A) Embryos were 
treated with SU5402 at different time periods and collected at stage 39. (B) Control embryos (CAG- 
GFP) were treated with DMSO from stage 22 to 39 and analysed by WMISH for the expression of 
MLC2 and M L C lv and (C) by the fluorescent microscopy. (D-F) Embryos treated with SU5402 were 
analysed at stage 40 using WMISH for the expression of MLC2 and M LClv. (D) 75% of the embryos 
treated from stage 22 to 30 (n=20) showed correct looping (Al, arrow) while 25% of the embryos 
showed the ventricle located on the left side of the body (A2, arrow). (E) 50% of the embryos treated 
(n=22) from stage 22 to 39 showed a reduction in size of the ventricle (Al, arrow), while 50% of the 
embryos showed ventricle anteriorisation (A2, arrow). (F) 50% of the embryos treated from stage 30 to 
39 (n=21) showed the ventricle fused with the jaw muscle and incorrect looping (A2, arrow), a; atria, 
ih; interhyoid muscle of the jaw, v; ventricle. St.; stage.
B
DMSO St. 22-39
Ventral
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L'(miv
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5.2,2 Loss o f  FGF from stage 23 interferes with cardiac looping
Previous treatments demonstrated that FGF regulates different aspects of heart morphogenesis. 
For this reason we refined the time of requirement for FGF by using short SU5402 treatment 
windows from stage 21 to 26. 36% of the embryos treated from stage 21 to 24 (n=38) showed 
incorrect looping. The ventricle was positioned on the left side of the body (fig. 5.2 D2 and 
D4, A2; table 5.1). 47% of embryos showed ventricle posteriorisation along the A-P body axis 
(fig. 5.2 D3, A l; table 5.1). 74% of the embryos treated from stage 21 to 26 (n=62) showed a 
unique phenotype in which the ventricle protruded posteriorly. The heart showed a strong 
defect in looping with a complete absence of a right-ward spiral movement. The OFT 
therefore, was repositioned ventrally (fig. 5.2 E1-E4, A l; table 5.1). 100% of the embryos 
treated from stage 23 to 26 (n=20) showed partial looping with the ventricle and the OFT lying 
perpendicularly to the A-P body axis (fig. 5.2 FI and F3-F4, A 2; table 5.1). Moreover, 20% of 
these embryos displayed the ventricle located on the left side of the body (fig. 5.2 F2, Al; 
table 5.1). In both phenotypes the embryos had fusion of the jaw muscle in the ventral midline. 
60% of the embryos treated from stage 24 to 26 (n=30) displayed defects in heart looping and 
small ventricle compared to embryos treated in DMSO (fig. 5.2 G1 and G3, A l; table 5.1). 
40% of the embryos lacked of looping. The heart was located perpendicularly to the A-P body 
axis and the ventricle was smaller compared to control embryos. 30% of these embryos had 
the ventricle located on the left side of the body (fig. 5.2 G2 and G4, A2; table 5.1).
The experiment described showed that:
1. FGF likely regulates the looping of the heart and location of the ventricle along the A- 
P and L-R body axes (fig. 5.2 D-G; table 5.1).
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2. FGF appears to regulate the ventricle chamber size (fig. 5.1 F, Al; fig. 5.2 G, Al; table
5.1).
These preliminary results suggest that FGF is important during the establishment of looping 
and possibly regulates the ventricle growth.
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Figure 5.2 Inhibition of FGF interferes with heart looping and chamber development. (A)
Embryos were treated with SU5402 at different time periods and collected at stage 40. (B) Control 
embryos (MLClv-GFP) were treated with DMSO from stage 21 to 26 and analysed by WMISH for the 
expression of MLC2 and M L C h  and (C) by fluorescent microscopy. (D-G) SU5402 treated embryos 
(MLClv-GFP) were analysed at stage 39 by fluorescent microscopy and by WMISH for the expression 
of MLC2 and M L C 1\. (D) 36% of the embryos treated from stage 21 to 24 (n=38) had ventricle 
located on the left and incorrect looping (A2, arrow). (E) 74% of the embryos (n=62) treated from stage 
21 to 26 showed OFT posteriorisation and lack of looping (Al, arrows). (F) 20% of the embryos 
(n=20) treated from stage 23 to 26 showed the ventricle located on the left side of the body (Al, 
arrow). The rest of the embryos showed the ventricle located on the right (A2, arrow). (G) 60% of the 
embryos (n=30) treated from stage 24 to 26 showed an unstructured heart with a low degree of looping 
(Al, arrow). 30% of the embryos had the ventricle located on the left (A2, arrow), a; atria, ih; 
interhyoid muscle of the jaw, v; ventricle, St. ; stage.
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SU5402 TREATMENT
Looping phenotypes Cham ber phenotypes
Normal
(% )
Straight
tube
(% )
Reversed
looping
(% )
O ther
(% )
Normal
(% )
Distribution
(% )
Size
reduction
(% )
St.22-30
(n=20) 75 0 25 0 100 0 0
St. 22-39 
(n=22) 0 0 100 0 0 50 50
St. 30-39 
(n=21) 50 0 0 50 0 100 0
St. 21-24 
(n=38) 53 0 36 11 53 47 0
St. 21-26 
(n=62) 26 0 0 74 26
74 0
St. 23-26 
(n=20) 0 0 20
80 100 0 0
St. 24-26 
(n=30) 0 0 30 70 0
0 100
Table 5.1 SU5402 treatm ents. Embryos treated with SU5402 showed defect in looping and chamber 
development. Looping phenotypes included embryos with normal looping, embryos with straight heart 
tube, embryos with ventricle positioned on the left side of the body (reversed looping) and embryos in 
which looping has occurred but was incomplete (other). Chamber phenotypes included embryos with 
normal chamber, irregular chamber position along the A-P body axis (distribution) and embryos with 
small chamber size with respect to control embryos. Each defect is showed in percentage of total 
number of embryos analysed.
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5.2.3 A-83-01 treated embryos have defective heart looping
In order to investigate the role of Nodal during cardiac morphogenesis we used the soluble 
inhibitor A-83-01. A-83-01 is a potent inhibitor of Activin, TGF0 and Nodal pathways via the 
inhibition of the transcriptional activity of Alk4 (activin type IB receptor), Alk5 (TGF(3 type I 
receptor) and Alk7 (nodal type I receptor) receptors (Tojo et al., 2005).
Embryos were treated after stage 21 in order to compare the phenotypes obtained with 
embryos treated with SU5402. Embryos treated with A-83-01 from stage 19 to 22 (n=20) 
showed defects in looping. The heart tube was positioned perpendicular to the A-P body axis 
generating a semi circular shape (fig. 5.3 D, table 5.2). 70% of the embryos showed the 
ventricle located on the left side of the body (fig. 5.3 D2 and D4, A l; table 5.2). The rest of the 
embryos had the ventricle on the right (fig. 5.3 D3, Al; arrow). 50% of the embryos treated 
from stage 21 to 24 (n=40) lacked looping. The ventricles of these embryos were located on 
the right side of the body and the OFTs were more visible compared to control embryos (fig.
5.3 E1-E4, A l; table 5.2). Embryos treated from stage 21 to 26 (n=60) showed a 
randomisation of looping. 50% of the embryos had the ventricle positioned on the right side of 
the body (fig. 5.3 F1-F3, A l; table 5.2) while the rest of the embryos showed the ventricle 
located on the left (fig. 5.3 F4, A2; table 5.2). In embryos treated from stage 24 to 26 (n=32) 
two distinct morphological defects occurred (fig. 5.3 G; table 5.2). 30% of the embryos show a 
straight heart tube completely unlooped which lie along the A-P body axis (fig. 5.3 G1-G2 and 
G4, A l; table 5.2). The OFT and the ventricle were completely visible after WMISH analysis 
(fig. 5.3 G1-G2 and G4, A l; table 5.2). 50% of the embryos had ventricle located posteriorly 
and the distribution of the OFT and the atria is completely uncoordinated (fig. 5.3 G3, A2; 
table 5.2). As previously described A-83-01 inhibits TGF0, activin and Nodal pathways. The
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results found in A-83-01 treated embryos resemble the phenotypes described in embryos 
lacking of Nodal expression. However, we do not exclude that the defects in the heart showed 
in our results come also from the inhibition of TGFp and/or activin. The phenotypes obtained 
in the embryos treated with A-83-01 showed:
1. Defect in L-R asymmetry establishment (fig. 5.3 D, A l)
2. Defects in heart looping (fig. 5.3 E-F and G3).
146
5.0 Signalling after cardiac specification
DMSO St. 19-26 Treatment St. 19-22
Ventral
St. 21-24
Inhibitor added: ACulture time: Treatment time:
Treatment St. 21-24 Treatment St. 21-26 Treatment St. 24-26
Figure 5.3 A-83-01 tre a ted  em bryos show ed defect in  h e a r t  looping. (A) Embryos were treated with 
A-83-01 at different time periods and collected at stage 40. (B) Control embryos (M LClv-GFP) were 
treated with DM SO from stage 21 to 26 and analysed by W M ISH for the expression of MLC2 and 
M LClv and (C) by fluorescent microscopy. (D-G) Embryos (M LClv-GFP) were analysed at stage 39 
by fluorescent microscopy and by W M ISH for the expression of MLC2 and MLC1 \. (D) 70% of the 
embryos treated from stage 19 to 22 (n= 20) showed the ventricle located on the left side of the body 
(A l, arrow). (E) 50% o f the em bryos treated from stage 21 to 24 (n=40) lacked looping of the heart and 
the ventricle was positioned on the right (A l, arrows). (F) 50% of the embryos treated from stage 21 to 
26 (n=60) had the ventricle located on the right (A l, arrow) and 50% of the embryos had left-sided 
ventrcile (A2, arrow). (G) 30% o f the embryos treated from stage 24 to 26 (n=32) lacked looping and 
the heart remained as a straight tube along the A-P axis (A l, arrows). 50% of the embryos showed 
uncoordinated looping and incorrect positioning of the OFT (A2, arrows), a; atria, ih; interhyoid 
muscle of the jaw , v; ventricle, St.; stage.
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A-83-01 TREATM ENT
Looping phenotypes C ham ber phenotypes
Normal
(% )
I
Straight
tube
( % )
Reversed
looping
( % )
Other
( % )
Normal
(% )
Distribution
( % )
Size
reduction
(% )
St. 19- 
22 
(n=20)
0 0 70 30 100 0 0
St. 21- 
24 
(n=40)
50 0 0 50 100 0 0
St. 21- 
26 
(n=60)
0 0 50 50 100 0 0
St. 24- 
26 
(n=32)
20 30 0 50 50 50 0
Table 5.2 A-83-01 treatments. Em bryos treated with A-83-01 showed defect in looping and 
chamber developm ent. Looping phenotypes included embryos with normal looping, embryos with 
straight heart tube, em bryos w ith ventricle positioned on the left side o f the body (reversed looping) 
and em bryos in w hich looping has occurred but was incomplete (other). Chamber phenotypes 
included em bryos with normal cham ber, irregular cham ber distribution and embryos with small 
cham ber size with respect to control embryos. Each defect is showed in percentage o f total number 
o f em bryos analysed.
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5.2.4 Comparison between SU5402 and A-83-01 treatment
Different group of embryos treated with SU5402 or A-83-01 showed similar phenotypes in 
the heart. In particular, SU5402 treatments performed at stage 21-24, stage 23-26 and stage 
24-26 showed a common defect in the heart with embryos treated with A-83-01 at stage 
19-22 and stage 21-26. The hearts displayed defects in looping movement and the 
ventricles were located on the left side of the body. A-83-01 treated embryos from stage 19 
to 22 showed the highest percentage of left-sided ventricle (fig. 5.4). Thus, both treatments 
caused the same defect in heart looping. This work however, requires further investigation 
using alternative methods for manipulation of FGF and Nodal pathways.
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Common phenotype obtained in  embryos treated with 
SU5402 and A-83-01
*0" /..
70* /..
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je% .
20%.
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0% .
St. 21-24 St. 23-26 St. 24-26 St. 19-22 St. 21-26
SU5402 SU5402 SU5402 A-83-01 A-83-01
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Figure 5.4 FGF and Nodal inhibitory treatments showed a common defect in the heart.
Summary o f frenquency w ith w hich SU5402 treatments at stage 21-24, stage 23-26 and stage 24- 
26 showed a com m on defect in the heart with A-83-01 treated embryos at stage 19-22 and stage 
21-26. The reversed looping caused the ventricle to be located on the left side of the body. The 
highest percentage o f left sided ventricle was found in embryos treated with A-83-01 from stage 19 
to 22. St; stage.
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5.3 Discussion
5.3.1 FGF is involved in looping and chamber size regulation
The experiments performed in whole embryos using SU5402 (FGFR inhibitor) elucidated 
a role of FGF in different aspects o f cardiac morphogenesis. Embryos were treated with 
SU5402 in a period between the end of cardiac specification and the beginning of cardiac 
differentiation. Previous work has shown in mouse and chicken a specific role for FGF in 
the regulation of the L-R axis. In particular, FGF8 mutant mice showed abnormal heart 
looping with 50% of the ventricle located on the left side of the body (Meyers and Martin, 
1999). Similar results have been shown in chicken treated with FGF8 beads placed on the 
left side of the Hensen’s node in which the expression of FGF is absent (Boettger et al., 
1999). In these embryos the heart looping resulted randomised and the 20% of the ventricle 
were located on the left. The usage of SU5402 in Xenopus embryos from stage 23 to 26 
(fig. 5.2) showed similar results to mouse and chick embryos. The heart looping was 
reversed and 20% of the embryos show the ventricle located on the left side of the body. 
The heart, therefore, lacked the L-R axis and often lay perpendicularly to the A-P body 
axis. The reversed looping was also found in embryos treated from stage 21 to 24 and from 
stage 24 to 26 confirming that FGF regulated heart looping after cardiac specification and 
before the onset of cardiac differentiation. The embryos treated from stage 21-26, stage 24- 
26 and stage 21-24 (fig. 5.2) showed also defects in the OFT which was posteriorised if 
compared to control embryos. OFT anomalies were described in FGF8 mutant mice in 
which malpositioned or transposed aortic and pulmonary arteries arising from the right 
ventricle (outlet right ventricle, tetralogy of Fallot). The mutant mice showed also failure 
in the OFT septation or persistent truncus arteriosus (Abu-Issa et a l , 2002). Different 
evidence demonstrated that FGF is also important in the regulation of the ventricle
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chamber development. These results were described in zebrafish where the ace/FGF8 
mutants showed a small ventricle (Reifers et al., 2000). Moreover, Marques and colleagues 
showed that FGF regulates the heart chamber development through the establishment of 
the correct number of cardiomyocytes from cardiac specification to heart tube formation. 
FGF inhibition reduced the number of cardomyocites in particular in the ventricle 
(Marques et al., 2008). De Pater and colleagues showed that FGF is required for the 
addition of cardiomyocites in the arterial pole which are reduced in fg f8 -MO injected 
zebrafish embryos. They suggested that the reduction of the ventricle size found in FGF 
mutant embryos (Reifers et al., 2000) or in embryos where FGF was blocked (Marques et 
al., 2008) is explained by the reduction of cardiomyocites differentiation in the arterial 
pole (de Pater et al., 2009). In treated Xenopus embryos we found a reduction of the 
ventricle size in 50% of the embryos treated from stage 22 to 39 and also a small reduction 
in embryos treated from stage 24 to 26. The treatment from stage 22 to 39 covers a time 
period of 48 hours but the treatment performed from stage 24 to 26 covers a time period of 
few hours relative to the onset of the heart tube formation as showed in zebrafish. 
However, at present we do not know if the requirement for FGF in the regulation of the 
heart chamber size corresponds to the same found in zebrafish. For this reason, additional 
experiments need to be performed to confirm these initial results.
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5.3,2 A-83-01 treated embryos showed defect in the L-R axis establishment 
in the heart
Xenopus whole embryos were treated with A-83-01 in the same time period as the embryos 
treated with FGFR inhibitor SU5402. A-83-01 is a potent inhibitor of ALK4, 5 and 7. 
Therefore, it inhibits TGFp, actin and Nodal pathways. The phenotypic analysis performed 
in embryos treated with A-83-01 showed defects in the heart similar to that described in 
other model organism which lacked of Nodal expression. For this reason we believe that 
the effects obtained in embryos treated with A-83-01 were related to the lack of Nodal 
expression. However, we do not exclude that the same defects were caused by the 
inhibition of TGF (3 and activin pathways. We have found that embryos treated from stage 
19 to 22 (fig. 5.3) generates a reversed looping in which 70% of the embryos showed the 
ventricle located on the left side of the body. The original position of the heart is altered so 
that the ventricle is located perpendicularly to the A-P body axis. Similarly 50% of the 
embryos treated from stage 21 to 26 showed a reversed looping but also defects in the 
OFT. We believe that the phenotype obtained in these embryos it may be related with the 
inhibition of Nodal which during early embryonic development is believed to initiate organ 
lateralization (Schier, 2003). Nodal is expressed in the LPM and activate the asymmetric 
expression of downstream gene lefty2 (lft2). In the absent of Nodal signalling organ 
laterality is randomised or disrupted (Schier and Shen, 2000). The first organ to exhibit 
asymmetry in vertebrates is the heart (Ramsdell, 2005). In zebrafish it has been 
demonstrated that Nodal regulates directly the cardiac jogging via the asymmetric gene 
expression and indirectly the cardiac looping (Baker et al., 2008). Chamg and colleagues 
showed that a constitutive mutation of the Alk5 receptor leads to defects in heart looping 
and morphogenesis in mouse embryos. The unlooped hearts of these embryos, however, 
expressed cardiogenic factors such as MF20, dHAND and MLC2V. Thus, the constitutive
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activation of Alk5 does not prevent cardiac myocyte differentiation (Chamg et al., 1998). 
This evidence demonstrates that either inhibition or overexpression of Alk5 generates 
defects in the heart looping and morphogenesis. A-83-01 treated embryos from stage 21 to 
24 and from stage 21 to 26 (fig. 5.3) showed a posteriorised OFT which was misaligned 
with the ventricle. This type of phenotype has been extensively described in embryos 
lacking of the expression of the downstream Nodal target Pitx2. Inactivation of Pitx2 in the 
SHF of mice embryos showed severe defect in the artero-ventricular alignment of the OFT 
and in the proliferation of a subpopulation of the proximal OFT myocardium (Ai et a l,  
2006). Comparison between the SU5402 and A-83-01 treated embryos (fig. 5.4) showed 
that both regulate the looping probably at different developmental stages. Embryos treated 
with SU5402 from stage 23 to 26, from stage 21 to 24 and from stage 24 to 26 showed left 
side embryos as well as in the embryos treated with A-83-01 from stage 19 to 22 and from 
stage 21 to 26 (fig. 5.4). W e can not speculate if Nodal/activin/TGFp regulates heart 
looping before FGF or if they interact at the same time. Moreover, we have not showed the 
effect of SU5402 and A-83-01 in embryos treated from stage 19 to 22 and from stage 23 to 
26 respectively. In both of the treatments we did not obtained a clear data and for this 
reason they were not displayed together with the other treatments. Evidence showed that 
FGF and Nodal act differently in mouse and chick to regulate the L-R asymmetry. Meyers 
and Martin showed a schematic diagram summarising the interaction of Nodal and FGF8 
during the embryo development in chick and mouse. In chick FGF8 is expressed in the 
right side of the Hensen’s node and acts as right determinant inhibiting the expression of 
Nodal which is expressed in the left side. In contrast, in mouse FGF8 is required in the 
node for the left side expression of Nodal during the early phase and in the LPM during the 
late phase (Meyers and Martin, 1999). It is not known if in Xenopus FGF and Nodal 
collaborate in the establishment of L-R asymmetry during heart looping. Our preliminary
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results require further investigation to clarify if the phenotypes described in A-83-01 
treated embryos are related to the inhibition of Nodal or can also be attributed to the 
inhibition of TGFp and/or activin.
6.
Discussion
6.0 Discussion
6.0 Discussion
In this study we have developed a novel model to investigate cardiac cell diversification 
and morphogenesis. The cardiogenesis assay has been used to study the regulation of 
cardiac cell diversification during the heart development. More complex events that 
constitute heart morphogenesis have been studied using the heart formation assay. In this 
assay we generated a secondary heart-like structure that showed growth, beating and 
rudimentary morphogenesis, all features of heart development that do not occur in cultured 
animal cap explants injected with GATA4. Compared to in vivo study of heart function, 
one advantage of the model is that the process of morphogenesis can be observed and 
precisely manipulated in a non-essential secondary heart. Together these assays provide 
new information concerning the mechanisms that regulate heart development.
6.1 Study o f  cardiac cell fate diversification in AC explants
Animal cap (AC) explants assay is a simple method to study the establishment of cardiac 
cell diversification through the injection of GATA-4 mRNA. AC explants analysed at 
stage 39 showed the expression of ventricular markers M LC lv and Irx4 and also the 
expression of pro-epicardial marker T bx l8  (fig. 3.1). The expression of these genes 
demonstrated that cardiac cell diversification has occurred in the explants which were 
composed of myocardial and non-myocardial tissue types. Moreover, using double-whole 
mount in situ hybridization in the same explants for the expression of MLC2 and M LClv 
or cTnl and M L C lv (fig. 3.2) it has been found a gene expression patterning in which there 
were regions of overlapping expression between MLC2 or cTnl and M LC lv and regions in 
which there were no M L C lv  expression. The manipulation of the explants in this assay has 
been useful to understand the mechanism involved in the establishment of the cardiac cell
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diversification. Using dissociated and reaggregated GATA-4 injected explants we showed 
that the cardiac cell diversification was lost due to the lacking of M LClv, Irx4 and Tbxl8 
gene expression (fig. 3.4). The dissociation and reaggregation in GATA-4 injected explants 
involved the lost of any cell-cell contact (Grunz and Tacke, 1989) and more importantly 
the lost of any embryonic pre-patterning established before the dissociation (Sokol and 
Melton, 1991). The expression of MLC2 in reaggregated explants is given by the injection 
of GATA-4 but the lack of any embryonic pre-patteming does not allow the cardiac 
diversification to happen. Using molecules known to be involved in the heart development 
as Dkk-1 we showed that is possible to rescue partially the expression of ventricular 
marker M L C lv (fig. 3.6). Dissociated and reaggregated explants previously co-injected 
with GATA-4 and Dkk-1 showed the expression of M LC lv when analysed at stage 39. 
However, despite the expression of M LC lv, the same explants did not show the expression 
of Irx4 and T bx l8  (fig. 3.6). Thus, we believe that the expression of M LClv only in 
GATA-4 and Dkk-1 co-injected reaggregates is dependent entirely from the capacity of 
Dkk-1 to anteriorise the body structure during the embryo development (Glinka et al., 
1998). Similarly to Dkk-1 treated explants, we have found that the inhibition of BMP 
signalling through the co-injection of tBr mRNA, mutant form of the type I BMP specific 
receptor, with GATA-4 mRNA rescued the expression of M LClv, Irx4 and Tbxl8 in 
reaggregated explants (fig. 3.7). The usage of GATA-4 reaggregates or GATA-4 AC 
explants showed how is possible to study the cardiac cell diversification using a simple 
assay. In particular, co-injected reaggregates or GATA-4 reaggregates combined with Dkk- 
1 injected AC explants demonstrated that these explants can be easily manipulated and 
cultivated until required stage to detect the expression of specific genes. For this reason we 
believe that the usage of Xenopus ectodermal explants is a valid method to study the 
establishment of the cardiac cell diversification. We have shown that the ventricular and
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proepicardial cell fate specification occurs after neurula stage. We achieved this conclusion 
through the use of dissociated and reaggregated heart field explants (fig. 3.5). These 
explants were cut from the embryos, dissociated and reaggregated at stage 20 and 
cultivated until stage 39. RT-PCR analysis showed that they express pan-myocardial 
marker MLC2 but not ventricular and proepicardial gene expression has been found (fig. 
3.5 A). Using AC explants and heart field explants we showed that cardiac cell 
diversification occurs through the presence of embryonic pre-patteming, involves the 
expression of specific genes as GATA-4 (Latinkic et al., 2003) and Dkk-1 (Schneider and 
Mercola, 2001) and probably occurs prior the beginning of heart differentiation. These 
results showed how the in vitro assay is suitable to study the mechanism of the heart 
organogenesis. The use of embryonic tissue that does not normally contribute to heart 
development was useful to understand how specific factors activate cardiac differentiation. 
Moreover, the same explants treated in vitro are not under the influences of the many cell- 
to-cell interaction and cell signalling events that occurs in the embryo during gastrulation 
(Latinkic et al., 2003). Thus, in vitro Xenopus explants are suitable to study the mechanism 
involved in embryo organogenesis, the identification of many genes involved in the heart 
development and also it can be a valid method for advancing regenerative medicine 
(Asashima et al., 2009). Despite the suitability o f AC explants in vitro assay to study the 
cardiac cell diversification, we have to report that this method showed some limitations. 
AC explants and reaggregates explants did not survive in cultivation for more than five 
days. We could not, therefore, verify the expression of the atria specific marker ANF 
(Small and Krieg, 2000) which in Xenopus is expressed specifically in the atrium only at 
stage 49 (5 day pf). Moreover, we also wanted to study the different steps invoiced in the 
heart morphogenesis. Despite the capacity of GATA-4 injected AC explants to beat 
spontaneously in culture, we found that the same explants showed a low degree of
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morphogenesis. GATA-4 injected reaggregates explants express the differentiation marker 
MLC2 but they never formed beating tissue in culture. Although, cardiogenesis assay is a 
simple method to study the heart patterning and cell diversification establishment but is not 
suitable to study heart morphogenesis. W e required an assay which showed a high 
percentage of reproducibility and also the possibility to create a structure resembling the 
characteristic of an ordinary beating heart. In order to achieve that, we combined an in 
vitro and an in vivo assay to generate the heart formation assay.
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6.2 Study o f  cardiac cells diversification and morphogenesis using GATA-4 
reazzregates transplanted in host embryos
Studying the heart morphogenesis required the use of a different assay in which it was 
possible to generate a structure similar to the heart where the regional identity of different 
genes has occurred and the degree of morphogenesis was higher compared to AC explants. 
These requirements were met in the heart formation assay, which allows direct 
manipulation of all phases o f cardiac patterning and morphogenesis in a non-essential 
embryonic structure. We used GATA-4 injected reaggregates at stage 20 and we 
transplanted them into host embryos at the same developmental stages. We found that 
transplanted embryos showed 46% of secondary beating structure when analysed at stage 
39-40. The secondary structure resembled an ordinary heart. We found that the 34% of the 
secondary beating heart (n=43) showed morphology similar to the heart tube (fig. 4.5). 
Thus, this assay showed how an entire heart can be easily regenerated rather than study 
heart morphogenesis using AC explants in culture that rarely show cardiac functions. We 
also showed that differently from GATA-4 reaggregates, the cardiac cell diversification 
has occurred in the secondary heart which expressed ventricular and pro-epicardial specific 
genes (fig. 4.3; fig. 4.4). Thus, we believed that Xenopus embryo is a valid model to study 
heart organogenesis. The use o f cell types such as embryonic stem (ES) cells and more 
recently induced pluripotent stem (iPS) cells to study the myocardial regeneration has 
attracted substantial interest from the scientific community (Kinoshita et al., 2010). More 
importantly, the ability of the human embryonic stem cells (hESCs) to differentiate into 
contracting cardiomyocytes are anticipated to have a strong impact on how heart disease 
will be treated in the future (Vidarsson et a l ,  2010). The human origin and the intact 
genome let the hESCs to be a suitable in vitro model to study the congenital heart 
malformations which affect about 1% of live births (Bruneau, 2008). However, despite the
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strong potential in the future, stem cells derived cardiomyocytes still resemble simply 
aggregating group of cells which are functionally and structurally different from the adult 
cardiomyocytes (Vidarsson et a l., 2010). Even thought hESCs, IPs and ESC represent a 
valid method for future therapies in heart disease and heart regeneration we must underlie 
that results obtained from in vitro cardiomyocites differentiation are entirely based on the 
knowledge gained from developmental biology study through the use of model organisms 
as Xenopus laevis. It is believed that cardio-inductive signals, involved in the 
cardiomyocytes differentiation, originate from direct cell-cell contact and/or factors 
secreted from the adjacent endoderm (Vidarsson et al., 2010). The future challenge in stem 
cells differentiation will be to design strategies that will allow the cells to reach higher 
degree of maturation in vitro (Vidarsson et al., 2010). This capacity, however, has been 
already showed using induced Xenopus embryo explants from which an entire functioning 
structure has been developed (Ariizumi et al., 2003; Kinoshita et al., 2010). This assay 
clearly demonstrates how the use of the model organism Xenopus laevis can still contribute 
to study different aspects o f heart development like heart morphogenesis. Kinoshita et 
colleagues showed that the secondary heart, previously transplanted into host embryo, 
resembled a structure similar to an ordinary heart (Kinoshita et al., 2010). Physiological 
analysis o f the secondary heart demonstrated that the cardiac contraction appeared to 
originate from the atrium toward the ventricle-like site. Moreover, the histological section 
showed that the secondary heart is composed of a ventricle-like region with a thick 
myocardium and a region atrium-like with a thin myocardium (Kinoshita et al., 2010). We 
showed that the secondary heart, generated from GATA-4 injected reaggregated explants, 
expressed ventricular specific marker M LC lv and pro-epicardial marker Tbxl8 (fig. 4.3; 
fig. 4.4). Moreover, these markers showed a patterning of expression. The ventricle cells or 
the pro-epicardial cells were located in the opposite pole of the atrium cells (fig. 4.3; fig.
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4.4). Thus, the secondary heart showed a high degree of maturation, cardiac cell 
diversification and the physiological activity of beating. We also focused our attention on 
the existing interaction between the host embryo and the reaggregated explants in order to 
develop a secondary functional structure. The results obtained demonstrated that the host 
plays a significant role in the generation of the secondary structure. The reaggregates 
respond to the inductive signal released from the host until late developmental stages (fig. 
4.12) and the host showed a wide range of permissive regions in which is possible to 
generate a secondary heart-like structure (fig. 4.9). GATA-4 injected reaggregates 
cultivated until late developmental stages did not express ventricular and pro-epicardial 
markers. However, if the same reaggregates were transplanted into host embryos they 
developed a secondary beating structure positive to ventricular and pro-epicardial gene 
expression. Transplanted reaggregates into host embryos, previously exposed to the UV- 
light, did not show any cardiac cell diversification and not beating activity has been found 
(fig. 4.7). Thus, the signals released from the host are instructive to let the reaggregate 
develops as a functional secondary heart-like structure.
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6.3 Signalling in Xenopus heart development after cardiac specification
In the previous experiment we demonstrated that GATA-4 reaggregates transplanted into 
host embryos develop a secondary beating heart. The performed experiments elucidated 
that the host plays an important role in the generation of the SH. We believe this happens 
because the host provides signals that influence the SH development. Moreover, we 
showed that there is no cell contribution from the host to the reaggregate (fig. 4.13). In 
order to clarify the mechanism of cardiac morphogenesis, in the heart formation assay, we 
needed to study the signalling pathways which are known to be involved during the heart 
development. Little is known about the signals involved in the heart after cardiac 
specification and just some evidence arises from the Xenopus model. For this reason we 
tested pathways of signal in whole embryos, known to be involved in different aspects of 
cardiac morphogenesis in other model organisms. We used two drugs which are already 
known to inhibit pathway of signals involved in the different steps of heart morphogenesis 
like the chamber formation. W e used FGF pathway inhibitory drug in whole Xenopus 
embryos after the cardiac specification and mainly we found that the inhibition of this 
pathway causes in the heart of the embryos looping defect, irregular ventricle position and 
reduction of the ventricle size (fig. 5.1; fig. 5.2; table 5.1). Similar effect has been found in 
the heart of the embryos treated with A-83-01 soluble drug. The inhibition of the 
activin/TGFp/Nodal pathways causes, in the heart of the treated embryos, defect in the 
heart looping (fig. 5.3). W e compared, then, the results obtained to what is known in other 
model organisms. We found that SU5402 treated embryos showed similar effect to FGF8 
mutant zebrafish embryos which showed small ventricle (Reifers et a l ,  2000). A-83-01 
treated embryos showed in high percentages defect in the L-R axis establishment of the 
heart. Although A-83-01 inhibits TGF(3, activin and Nodal pathways we believed that the 
results obtained from treated embryos were related of the most with the inhibitory effects,
163
6.0 Discussion
found in other model organism, of the Nodal pathway of signal (Baker et a l , 2008; Schier 
and Shen, 2000). The goal of these experiments was to verify the involvement of these 
signals during cardiac morphogenesis in Xenopus embryos and extend in future this 
knowledge in the transplant experiments to clarify the role of the host in the formation of a 
beating SH. However, before extending the use of inhibitory drugs in the transplants 
experiments, we have to gain, in the future, a wider knowledge on the effect of these drugs 
in all the steps of the heart morphogenesis.
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6.4 Conclusion and future directions
The assays described in this thesis showed a simple system to study the cardiac 
diversification and the different aspects involved during the heart morphogenesis. 
Cardiogenic assay provide a simple in vitro assay using GATA-4 injected animal cap (AC) 
explants. These explants cultivated until late developmental stage showed the expression of 
ventricular and proepicardial markers and in rare cases were able to beat. This result 
demonstrated that the AC cells respond to the induction activity of GATA-4 and 
differentiated in myocardial and non-myocardial cell types. Moreover, the ventricular 
marker M LC lv showed patterning of expression when analysed using WMISH with 
MLC2. In contrast to the results found in AC explants, the ventricular and proepicardial 
gene expression was lost in dissociated and reaggregated AC explants. These explants 
expressed ventricular and proepicardial markers only when manipulated with Dkk-1 
mRNA and BMPR inhibitor. In the future it would be interesting to further investigate the 
mechanism that leads cardiac cell diversification through the manipulation of GATA-4 
injected reaggregates with molecules known to be involved during cardiogenesis. For 
example we want confirm the role of BMP in cardiac cell fate diversification using 
molecules as Dorsomorphin known to inhibit BMP type I receptor Alk2, -3 and -6 (Yu et 
a l , 2008). Adding Dorsomorphine to GATA-4 reaggregates at different developmental 
stage will clarify the time-specific involvement of BMP in establishing cardiac cell fate 
diversification. Similarly we want to manipulate GATA-4 reaggregates through the 
overexpression or inhibition of molecules as Retinoic acid known to be involved in the 
establishment of the anterior-posterior polarity in the heart (Hochgreb et a l ,  2003).
When GATA-4 injected reaggregates were transplanted into hosts they developed a 
beating structure in the 46% of the cases demonstrating that the assay was stable and
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reproducible. We showed that the development of the secondary heart (SH) is entirely 
dependent from the host activity. The host provides signals that allow the reaggregates to 
develop a beating structure. Little is known about the signals involved during the heart 
morphogenesis in particular in Xenopus model. For this reason we initiated a study of 
specific signalling pathways (known to be involved during cardiogenesis) in whole 
embryos during the heart morphogenesis. We provided for the first time evidences in 
Xenopus model for FGF and Nodal/TGFp/activin involvement in heart looping and 
chamber growth. The treatments were performed in a time period between the end of 
cardiac specification and the onset o f cardiac differentiation. The experiment performed in 
whole embryos aim to elucidate the role of these pathways in heart morphogenesis. We 
aim in the future to confirm the phenotype obtained using different inhibitors for the 
pathways studied, and extend our understanding though the manipulation of other 
signalling pathways known to be involved in the heart development. The results showed 
can be also extended in transplanted host embryos in order to verify which signalling 
pathways are involved in the development of the SH, by manipulating signalling in GATA- 
4 reaggregates in a period between the end of cardiac specification and the onset of 
differentiation. For example we aim to inhibit FGF pathways via the use of SU5402 
(Mohammadi et a l ,  1997), TGFp/Nodal/activn pathways using A-83-01(Tojo et a l ,  2005) 
and SB-431542 (Inman et a l ,  2002), and verify the role of Wnt signalling with compounds 
such as Lithium Cloride known to activate the canonical Wnt pathway (Klein and Melton, 
1996). The advantage of treating GATA-4 reaggregates with soluble compounds such as 
LiCl, SU5402 or A-83-01 is the ability to stimulate or inhibit signalling pathways 
transiently at different time points before transplantation into host embryos. This allows us 
to verify whether under specific treatments GATA-4 reaggregates have the capacities to 
generate a SH.
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